var title_f1_13_1232="Chest radiograph in myocarditis";
var content_f1_13_1232=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79038&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 475px\">",
"   <div class=\"ttl\">",
"    Sequential chest radiographs in myocarditis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 455px; height: 225px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view sequential chest radiographs in a young man with acute myocarditis (right) and three months later (left). Acutely, cardiomegaly and pulmonary congestion are apparent. Three months later, the lungs have cleared but the patient has developed dilated cardiomyopathy with persistent cardiomegaly.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Walter Abelmann, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1232=[""].join("\n");
var outline_f1_13_1232=null;
var title_f1_13_1233="Algorithm CA cx preg rx";
var content_f1_13_1233=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F58797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F58797&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 610px\">",
"   <div class=\"ttl\">",
"    Algorithm for possible treatment options in patients with early stage invasive cervical cancer diagnosed at less than 20 weeks of gestation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 590px; height: 613px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LVSI: lymphovascular invasion; NACT: neoadjuvant chemotherapy.",
"     <br/>",
"     * Consider radical trachelectomy postpartum in selected cases.",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Muller CY, Smith HO. Cervical neoplasia complicating pregnancy. Obstet Gynecol Clin North Am 2005; 32:533.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1233=[""].join("\n");
var outline_f1_13_1233=null;
var title_f1_13_1234="VSD with prolapsed RCC of aortic valve still frame";
var content_f1_13_1234=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F82621&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F82621&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    VSD with prolapsed RCC of aortic valve still frame",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 425px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this parasternal long axis still frame, the right coronary cusp of the aortic valve (*) is seen prolapsing across the VSD. The arrow denotes the small residual defect, the remainder closed by the prolapsed cusp.",
"    <div class=\"footnotes\">",
"     RV: right ventricle; LV: left ventricle; AO: aorta; MV: mitral valve; LA: left atrium; arrow: VSD.",
"     <br>",
"      * Denotes right coronary cusp of the aortic valve.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1234=[""].join("\n");
var outline_f1_13_1234=null;
var title_f1_13_1235="Gastroschisis2";
var content_f1_13_1235=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57805&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57805&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Large gastroschisis with stomach external to abdomen",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 343px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFXAdQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDlvAP7O1z4y8H6Z4gTxPDaLfI0ggazZymHZcZ3jP3fSue+MnwZn+GeiWOoza7HqK3dx9nCLbGLb8pbOdxz09K+nPgDLt+DfhYZ/wCXeT/0dJXn37Zkm/wLoA/6iTf+imoA+RmY56n86Qux6sfzpKSgBdzep/Ojc3qfzpKKAF3N6n86Nzep/OkooAXc3qfzo3N6n86SigBdzep/Ojc3qfzpKKAF3N6n86Nzep/OkooAXc3qfzo3N6n86SigBdzep/Ojc3qfzpKKAF3N6n86Nzep/OkooAXc3qfzo3N6n86SigBdzep/Ojc3qfzpKKAF3N6n86Nzep/OkooAXc3qfzo3N6n86SigBdzep/Ojc3qfzpKKAF3N6n86Nzep/OkooAXc3qfzo3N6n86SigBdzep/Ojc3qfzpKKAF3N6n86Nzep/OkooAXc3qfzo3N6n86SigBdzep/Ojc3qfzpKKAF3N6n86Nzep/OkooAXc3qfzo3N6n86SigBdzep/Ojc3qfzpKKAF3N6n86Nzep/OkooAXc3qfzo3N6n86SigBdzep/Ojc3qfzpKKAF3N6n86Nzep/OkooAXc3qfzo3N6n86SigCeFm2nk9fWikh+6frRQB90fAqXb8IfC4z0t3/9HSVwX7X8m/wRoQ/6iJ/9FNXWfBKXb8KPDYz/AMsH/wDRslcN+1jJv8G6IM9NQP8A6LNAHy5SUtJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFLjikrV0LS5NSuVBIjtlYCWVuijPT60AX/AAt4Vn8QLOUuI7YKMQtIp2yyf3N3Qcdz7Vjalp9zpt7NaX0Tw3MLFXjcYIP+HvXsNraRw2hSBx9mhTy45UThR2B/WrWq2Nlq9jbQa3G1xDjbBdw5MsPHQMfvD/ZOaAPCiKSuw8S+BdR0i3a8tmTUNOXrPADlP99Oq/y965Egj8aAG0UUUAFFFFABRRRQAUUUUAFFFKMd6AEpQKtWGn3OoXKW9jBLcXDnAjjUk16X4Y+H8GnkXPiIR3M6gE2YlCpECOsrdyP7ooA5bwd4E1TxPvltwLexTg3EqnBOOgA5P8q53UrCfTb2e0vEaO4hco6MCCCPrX0enif7LZKukkQiGPZ9olIVIk6YRP8AJrx/x8sepX/n26SlsFjNJ96X6/0oA4WilNJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBND90/WiiH7p+tFAH2N8G5tvwu8OjPSB/wD0a9cX+1HJ5nhHRhn/AJfz/wCizXRfCSfb8NtAX0hf/wBGvXIftKy7/CukD/p9J/8AIZoA+dTSV1ng/WPDGm2c8fiTwo+uTvIGjlXU5LXy1xjbtVTnnnNReLtU8O6mbQ+G/DbaEIw3nBtQe787ONp+ZRtxg9Oufald3tYDmKKKKYBRRRQAUUUUAFFFFABRRRQAUUUUAFFFWLK2lu7lILeNpJZDhFA6n/CgCbR9Pl1S/gtIB+9lcKCcAKD3JNe6aboi6Bo8ekzWaXlqAZZHDAuhPVvTHHSuXsNBi8NaeiTiO4uZ8F2VCVJ/ug9eP/r10NjPe289sLcxzRovMZYEgZ5WgCq1r5csJ0q4LF23CKQkK+OQDUohaJ3lQNbzZz9lkUmL3I9PrWpdXej6rMVmuVtblD8qMmNz9hkdO1Z3iHQ9ZsJS0rmQph8YJYDHAz2oAm0/V7eFy5klspuF3Mev0fow9jWbr/hfStZzdXNqYJH5NzYKFz7tGeDn1GKzzq/26E2+tWSyRxdXVMNu9wP51o6VGfsguNH1OBogTmCY52/8BPNAHE6j8ONVjXzNJkg1SIjpC22Qcd0bB7ds1yV9Y3NjK0V7bT28qnBSVCpHHvXtn9txKANUtGi8o4MsT7zg9Dg849cVqDU7S6t9ou7WWBBvEN0wb8Qrj+tAHzpRXuF3ofhzUskaZbqM7me3DR5GcnBBI6Z7VQk8B+G5pDIn9qRxNjCQyo+38WXNAHj1Fetr8PPDwiDS6hqiE8gBYiAPrnrTG8AeH1jDm61VkJGCpj6Z5zgHtQB5PSjkgV7JF4Q8MRxeelhdzRoMHzrhvmPHPygDHTj3roLSwt7Te2maJp9gVVZN7RAsOeDlySD1oA8X0bwrrWr82Om3Dx95XXZGMdcscCu00X4cWkcfn63fmVlyTa2PP5yHgZ9ga7AXE+qkpc3dxcyKOqEsoPp6Cqra3HpiBLWCOAMu2V5GMjr0BPoKALlkbfTdLCaZZx6bZycYXhpB/tueW/CsXU/ENnY2ymG3knkBIYE7YiOxBHOa57XtYjneQG7eXYf3bE/e49O1Y1tK+rXyJO5jgRuWc4UL24oA1tTvNSZ21GVVW2kySjYC85IArl7+7aRQpaT1GTwB6AVsa1++k8iOR5reM4iLDgZ64FZNzCXbyY4y20cuT3FAGLKnQ9cjJx2qM1rtYyK33gqkcnHSqN5D5bkp/qyeM96AKtFKaSgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAJofun60UQ/dP1ooA+o/hbMV+HuiL6RN/6MeuT/AGh5N/hnSx/0+E/+OGtr4bTbfAmjDP8Ayyb/ANGNXMfHmXf4d00Z6XR/9ANAHiGaM0GkouAUUUUAFFFFABRRRQAUUUUAFFFFABRRTgDkUAKincPlJ7cV7L4E8Jw6JaWl9rtrIZ70BQ+ObZScFSPUjv749azvhl4RMTf2rrEMiYCtbxleVyf9YQentx3zXqN1dzRJCkxby4z8gIBWRPXj0oAdeaS9zbJBMBJDEdsd0mMheigg1zOreG9R0VFvYEaGZcMGQZVwOufr7VsLfvHOsqsIwRhl35D88HHpXTR3jXMWy5eIQrgoHHYnlelAHm+q6daavY/b45FgvxIBPbbew7++am8OeIdT0UubuI3lgMAJINxX6E8/hXYarodveak1xpSG3ueT8/Ice1UZdOhEbXV3OJFdQpQp+8XB+7xj/GgCC8tNE1+1nu7eEZxvZkUhkPoV9K5fUvAs0vlz2dzA+75g0bDKY9cH9DW/fafa2kwl010jl4Zl34AHqef51LLb6ZO8CqJLa425acZwW99vT8aAOLk0HWtNt52nhd4+GIlGRn2PUVl3cguGDT6apU/J3JHvmvQ7e88QW8UlrFILyzbczPIVc8c9O+eahuLi+kmEMdtZ7ZSMb02cAZ79D7UAecSqy23lIWhBwuN2ADnqPSruk3GsW0Pk2mo3KrtO6NMHJzjOTXbXNlZ3bRHUNNuYHBw0iICN/tjt7VXbSNK2y3AurqK83YjQRMMDONxx2oA5m2i8RzEul75asNjtIqgDPrmrMtxr8llHEb9HjXCgRxpuPOK1JPBzXUMksF0ZFAzl8ndzzxmobHwVeMsyoNrqSWIyGxQBl3MmpWkZSfULqIO24RF+uOoIx6enpWemty2sexBCWZslpIyzN27/AMq6WHwDe394B5dzGEbDMwJ4J6nr+lb9t8OoreaWK+RpU2fu2JCEDuRn09aAPLNX1e4u3CLdSlVxny12L9AKqR27SxSK8jqWHzHrn6mvYYtB8MidYnuLOEqP3jSSZ56YwB1pyjw9a3Nx5EKXipGDHsXAZvfP0oA8ks9CaYGSNGcE4GQcfnW/beGrpLcy3MYgUDKE9iOhH8ua7Vb4Kpaw0oQXDDzCT82PoKj1tNV1GBWum8pWACxgbc/h1oA5K40uFbiCabzWkcE8dCfXH9azbhLJi4RZNzjgjqg75FbGpWFxBeFZ7lXYKAADk49P0rMubPcrSIGIYkBB2FAGBfTruRI4HMWDkhuCfp24rDuQpkEkiEZXO3GeO1dnJp0cbK02GVkwu0dM9qxLrTCpCgHL5ACtk4HqaAOTcYYgU2ti4sXwsJjCyg9fasqRCjlTQAyiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAmh+6frRRD90/WigD6A+H023wXpQ9I2/9Dauc+Ncm/QdPH/Tyf8A0A1peB5tvhLTFz0jb/0Nqwfi7Lv0WxGf+Xg/+gmgDz2wXSDp10b86h9u5+z+Rs8rOON+eevp2rLIwSKUMR0NNoAKKKKACiiigAooooAKKKKACiiigArqfB+iw30rXV9n7LCRiMjiU56fQViadYtdvnawhTl3HYV3UFyyFBbW6+QMBVXgfl/WgD09NcW4gjtrjazRqDujOCQPr1GO1bcOp2srhbbc0brt6AqeOpPbrXl0V3IJSANkQGSHHQ/3c+1belz3EMsT2k4cuNzIRxz1BB/nQB1OsaNFBbrMhAK4GeuD7fpWTa6jc27tA4aRGkBw2cEj1ParkGp3VrJIruptmO1M8jOelXLaC3u2I8xbRy27BzyR39DQAHX713WWKJYImQIY4ju2kdTz1/CpdP8AEto0gkvUMUyN87SLwfVar3djchWjhUTbvuhGIUtnnpzVL7FAfMa48yJA2zykG4hu/XtQB0rxeHbxpt5Nu75Pmlcq2R3qvb+G7OVZZFvfNKj5RE4AI9Rgg/gaxFsrh4D/AGbPHNCrDKjll9eOxpim5hlSKBJANoO9lwRz0460AS3Xh0zvMbK4eaBm/wBWVw2e/T8KNT0Z1KqIrooEyySHO4jpjPpW3ZyaqYbi609YUCrxhssAepAqK31/V/J8udJRIhwAUDAD8c0AV7EXkNvG6s8bgcZIIzjH3cGs17vWpYGuGYqiko0giGEz6Zxx71sNq09wIlk08IyOTkL5YYeuSfWs/UNauZjbpFawgbvnDsDkjufQUAQQ2mvWsTCJIkViGEjQghj15/wq/GdfkaVEe0HBIEcQYkHtmqc+tX0kkZaNHjZSQBuBC5wD6UsOo6tHYvDZWyQkDazKPnkA9zQBY06411JvKm1CdYucLbEISemBxViPwv8AaJHaSWeQuuGFw7SHP171mT3esOn2iKSVEUhvLB5C457dKrtJdizuGecbWYOzNKRu7fL6UAacPhiwt58XUqoWXruwoJzj6cDvUV5a6RZQqCyvCZcja6nIA9e3eqXmwjRZo3mM90x5QnPfgD1qsftV5L9kit1Nsw5SNOQc8cDvQBqfbtPliuDbpGkqgEEDOF9jxzUEupW8pXIaXGNrEgKPxxUL+FruJ2uL66S1gC5UOQCSO201nzPYKGVJWllU7t23PtgCgCK9zcSMLOFSS3y7clXHHzfhWaunwyKPOmcIDg+Tkbz/AHQK3bovZ2RiWORy8fBCFChPb3qgklyipcvKieUmIlCjIOfSgCg9sbG4w8Ri2ZKK/JOen41TvoILaVWjUSznG2MDhD6H1NaE1zNqN4zytcXE8mDt4PPuKp3+mzQPKkLmWVuCzn5k9h6UAcrqUDSzSNEG4JEjnofpWJdWgaPr+7UHYwGMn0rsZ9NkV1jUpHtxuGScjv8AjVaeOIXK21naiR2PDuOF+npQB5/IjRuVcFWHUGmV0viHT4408wyq0+cDbzu45J9vSubIxQAlFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAE0P3T9aKIfun60UAeveD5dvhnTx/sN/6G1Y3xPk36RZj/puf/QTVrwxNt8P2Qz0U/wDoRrI+IUm/TLUZ/wCW3/spoA4KkrTsY9MfT7hr28vIb1c+RFFarJHJxxucyKV59Fb+lZp68GmmAlFFFIAooooAKKKKACiiloASrFnbSXUwjiUsx5PsPWmQRPNKkUS7nY4ArrdPtU0+LYVDsBl3HB/CgA05Y4TJapGYynPzdW9617dZo9yBwgJxg8hvp71UjLGNZlEbAdAetWLWQMT5kbcDcqqeQaANC3hZ43aaZV+XaQwxjB71cQ5k2ljtKggBs8dKzUmLshbIB++rjtU3mIIooo8eaDk5zgigDVtJ45NrpM+UOChHHvgmtqw1ZkSNbq2SWEnKuTtIP1Fc5tdlC2sSb3+983epIop9wjlco+07RnCn/PNAHcafr8ENxIyXFzblSMfLv2sev4VrDV7YtI1xLbzOX2ksCjkf5NedFYyMOWGOdpy3NSmOSMNNnzJAMqQSQBjoaAO3ju7CMx7oCuWICq64P65rXhiggt3eO4milGTgSg7h2wema8ztWmEheXgOvyqF4Y1Ml3bsqCS5ZXPDBeg/CgDv/wCyrBJTJJqLLO/7xS+evpxjmp7TR72aUst+oJ5V1Qbv88V59G0sJxFdeamNqxsx6554rRt9VlN2CkpCMNiKzEDjtwaAOvutF1O5tpYhdvcQgAY+8ynPYe1Yf/CLSy3HkSr8yjK54J5yMkGqT319EkxN9tfbltpILD2ANQR69JGBItzcEMNuJHx+PNAHSxeGPKtiFCtIRnbIS2BnoPQUS+H9VWCTDxwxgcrGPmI9c5rk5NXnknDXV1KqqdqguSo4x2qG8vJXESRXM4x8pwzAce56igDql0rULWyjim1Jbds5+Zuq/wB32FVbvR4Vc4uUlYjgMcjPqfSuWab7QQ175gY9M/MPwqlPeqs5gCoAMBtxyxFAHTskVnKWgvLKWVRvUKOQfx7U0a3cNDFamW1jAJkZ402k+2cetc3cusro9tAqLyHYDn/9VQyxhIhBO4RlwQu7tQBp3l/FvxcsxKrjzZPmZz6ZPH5UtlrLrZPBHbIo7TyD5j7DP9Kw5ZFkZVFwhjQ7uev/AOus24dnlDXGRlTtCt0HsDQBvXGtuY2UndJnneCcD1HeqY1PylfyvMKN8sjNt4z+HesJphvBV3LDsR2qCL7TI5CRyRw5JKtwKAO30vVrewiMkR2SdFRiP++jWbcajFcXEjRKuyQgMRwfduv6VzbzSyl1AddgGWLY4981HM5JSOBgijl5PX2GaANXVtRlupFgtnVVjBwWGcKPbuar/bHggMO6GMycHg72H07VQFzt3OpZpQNvAxnnpUStKQ0mY0mc4JAyQPc96AIb8m2ROUYOcBAAcH1IrF1GzYNvjTAxn3Pvita++SVyQu5R8vr7msma58xgQWUAdSaAM09KSpJcZyM49DUdABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAE0P3T9aKIfun60UAd/oEuNGtQD0U/8AoRrN8avvsLcekv8ASn6PJjTLcZ6A/wAzVHxU+60hGf8Alof5UAcwetJSmkoAKKKKACiiigAooooAKeiksAASx4AHWmiuv8N6M8Km7nVRJtBjVlztB6MfQ0AP0TR1toVml2G4YBhuH3fbHY1qSReYreWhDOQTjrVmLJkJVEJQZf1+oqQQpcRs4YfKCBtOGH4UAFnaxZaEjcjDlh1A/wA9xRLFF5ixAs0q+vX25FXbOaJrbaztuUjtgrUkMG2Es8SyRqPkk/8A1dxQBmxlvMCTEEFflOM1et4lkIW6URyR9HXIDCtAxrLGkckMTSbevRwPeq8ESRyNEY/3o+YFs9PbH8qAFljjmVY4WUbAdrscr+dDB4TGJ2+8M4ADLVxIN2xoYiqE5KPximtChJjblU+7u6UAVZHa4cbgsEgI4UZBA7+9Mt2+8/nSMjHPDcE9OnellUt/rXUIF+U9T+FTLCVhWQE4BwBtwo9xQBbtjNEwd2jCkgiRScgegHapJ2smkEdxEUk7Hbkvz1qP9zLCRMVUjGQq5z9KhunwVZ8TBOQxG3A7cUAXIrGx87zY5JSMZGxvmJ/GiZkby2R5I4X+bcwAx+XesbzWK7k3JIWMgGMKPapBdzFGZ0QuSPvAgfl0oA2S8e35QrMMAluSfTrUx3zjIW3Zo1wO7L7e9YMR3Ab1CnOcE7QPT8KmdbgKxjkCsRxjHH1NAE8qBRtIbJIGcY2/jUa3D2u9HkTzQdoJXJxmi1upWt5bUhivUkjiqltOrm4E1wuTyNqEtn3oAufaxNHKk5KLnJBb7g/Clt1gMqQqWuC6FUOAqj6nr+FNjRViKJD5u5gSfUnvVmREEYBYhVYEhRwT60AUro+U6p5pDbsOgBYAexqo8GLrLqro3dwSQO1br3EJYysrb2TauRgY9RVWOR/s/lFQyk4J6bR7g80AY97YK8eHZYm3feBIH4VipC00pC75Mcglsfn7V0moWsTfKCSjHJLnDD6VlJApeYtgjdgYHT0FAFW4jiVAR/rFJBcZJ4PHsKrzX0syqQWQen97Hc1uB2Ay6s6n7wIGCPoKQafC6iYNH5nOF3Z4NAHOyyusgjikLNIPmBH3fqarAsz7HlEYQntndW3NppgViIWWcKc98/T0rEEPlOwWURuSAwIyfpmgB5hnQGSRdqZ+70LD3quJVCs5ZQ2Mrnr1qS8ErrkylAT3PJqF444VMrSxsx+6Rzj8O5oALueFtzRLukAGS3Q8enc1zs+/au84bOcVfVgIy5i3Y6Mx6n1xVc28rIWwTk4PoKAKRGQSF4HWmsuDU7fJEVBypPJxURBxyDmgCOilIpKACiiigAooooAKKKKACiiigAooooAmh+6frRRD90/WigDotOl22UQ9Af5mquvybraIf7f9KZay7YEHpn+dQao++JBn+L+lAC2Flp02m3U93qn2a6jz5Vt9nZ/O4/vjheeOayyMGlJOOtNoAKKKKACiiigAoorV0TS21GYnafJTG8g4J9h70AXPDOjrdyfaLrC26dN3Rj/hXbiRGKRMy71+UOvBUf1FUrYGGNo5YisKjauKt28ZmjEYVHZOg7kfWgB0CHzWjhZElXILNxuFS/ZWUIY8M+MMccA0xIt4bIOU/hfgqfTNaMV2SMTgQoRk7vX2oApxW3mqNyiMsx+ZTwSO1WrLbY3AV4Va3bAKOTgkdwasJE8gkEILRldykcsD9KvvDLdWaBTGAjAlSAG/z7UAQTWyuftFup2jhkbnA9u9Qqd1ygSMlVU55/hq1GIdxEpZXJ+6jc5qxcR2iXKkCQxZA8xcgqT3OOtAEbQKWjLqzwYxhgcCmQRvHNsgUIgG4fMSD7Voy20cbBDLmN1wQG6nsfaqaWiKJFZmbb82DgEEeh70AUZooCJWeNiO5Vs4Pr9adawRvEpkklkRW4UAKQaWRo5HWWOJ/MJ5A5wR7Utu3msSySu7PlcYAHr70AF0FSHePNjwSCVUMh+vvVNplbY2whiBk9RitWYkOkGHj3NuLDp+VQmzjR2VozKA2duMnn09aAKbwrJGdyExgbic4B+lQpbCV38lm4baBu5x61qvEpt8YSEZx5YTP41XNqZptjYjcgjP3eP8aAIGt4oZX86DfnqQ2ePX61dadXi8tmBiYYCH5VPpz60yRJIHjjPKqMH5OfqakDxww4jIcgZVmJwPUYI4oAypVZspE6gY+YAkgfWkjt5bdQTJEWdgNqIDxUzCI3HmOwtZAd25cndSW0pmZd5GDn5jwTQBc00SyMxDPCvP7wA4AH8quRRm4kMSxyGXOd/QAeopbREbYCCT0aQjBAPb0ArTMaWkDGZflbpiUc+9AFFrForYg/MBxv5z9M1UttzRSGVlAORhUBxn3rRhkWGNS5YO4zwwKAf4iqzSxJIvlwh1TLEheCPWgDLuC6SM7AmBzsUtWbMgF3s2FUI2g5xj3NdHc+RMW+zEsVG4KRu59h2pp8q3jd5FWPIGfNAOT6CgDGtojtWPylcgHlSenv6VbtYIcor5RiuN33iAO/TirSS77ZlAZQR8uxwu761bsbORF3OsZ2LlW3bT9PfFAGRFbNI0rxyyy5bazngfma57WdH8tJZY1JkHUKMA/nzXWw23zySCJ2Qcn5uD7/8A1qgv7YTWsjpxtHzDOT+OelAHm4YzB1aPbgcknrVObLAu7BFPy56YHsK3b6xEd7KyyMPk3AAYz+NYupxYCyAuWA+6aAK0No8sgLTCKA8jPt1qyrJPi3tYmKqck5+9VaxdnPk4DIzfMMc/ga6e3a1t7QfZFVZG5+bk5+tAGHf6csVuLibakrHCp/d/Cq2maWl1OBMxRAcuzHHHv6VrXVlNe3EcxYysFyAOg/H0rN1AvbR7XKui+nAJoAr69Lp+BDp8eIkOPMI5b3FYmK0bW3MySTSEKF6Z9fTFMvbdYUG5h5p5x6e1AFCiiigAooooAKKKKACiiigAooooAmh+6frRRD90/WigCdJdqgfWo7l96Ae9Qsx3H600nNABSVpWNnbzWFxPLqtnayxZKW8qzGSbjPyFY2Uc8fMy/lWcepxQAlFFFABRRU9nbyXVxHBCu6RzgCgCXTLGS/ukhjU4JG5v7or0lbKLT7OGCAqIQMqG7n396oaJpptIFhhIcEF2kx1b6egrbS4MjbSAyf8APNwP0NAFcrHzJN8yBfl9VP8AhU0LxLAHeMKSD8wHSrQuUEpRhiIjhWXqaekaiVhENhY5yRkKaAGRj7ZCqsybxgEhc59M1amjuF0+MuVkWMlcDngUsitJIN6JDIpBLJwGq7p5iDOPMCEncY5T8r0AP057eS3iLMQuTvwfugjjmpp7IW8CvgMrnhs8057Mi4j8tAIm+UFG5BNaUSbLX7PdMxMf8XQr9RQBkWyI7LG8Hm5OVYNhue9XhZokkKFpFx0PT8CO9MtILpdQJtnQxkA5LYIHtV5JvtZkZ+TyjYXOPfPrQBWlhe1jYuwePHzMrZB5/TrWXcRWwYbzIQDhQEPNdI0KQ2zNBMGUrghjuOfYGs5Y4p08uFGFwRkoBx9aAMhmVisaRyo5PBHU/jVmCz8mBQ0yqztwBzt96kNlCJ0a6JLLjJ9KWSBbW8URqJ1f1BBA9vWgCKLTZWQlSQS3+sLZz+HpUptp3aJlRIjGvK8gqO5570uqW7xxMEaZN3Kg8fhmrtu8rWkEalJPl5MnBH19aAKN40kUAOFkBwBwCxqlgmTZcHdGvPPysT6Zq7JJK7tJK0YjjwNyjOcemKrTFURrnC7w25S46/gaAJZPIjIxvjz13DJI+pqNmkXLSRpHHxhk53D0okf7S0SlQ24HeVOP64qFbF4rrc0LYAwCOQRQBUu5HZtsoKHGV28k+xqNIxdqhVBtHDYXnGauzIjTnbcjGCNiLgj+marWkkXzxzPJjsV4INAG9ZfullMYJiVQpDDG4+mc9Kku4xM9uPJjWMg5j8zIP0z1p1gbZLZ8TiP5OGZcjP8AjUNneQSATEiWYEqDJkr+FACLEQ5CxqwI4GOBRFFLFOu775Y5I6EehxVmZBJPHJNgYXOcHj8ulaSTpdgxooZY0yG5GaAMdIRNIHdDGScNt+UL+feq11aM8c0jCJ1jOQ0jDj/69a8FquSghQP94sWxkegJpWtytrIhRI0bgjHGff1oA582jvGWZolC4Kkscj6+9TCxgTZNHL5zyKRuycD161eFl5SSxwzb2bqfu7R7VTt4VgZ9k828DHzfMP1oAdCF8gtMWdAeEwRk1DdSItskf+rZ2G5FGAfxq5JOPLd9rY2g5HIB/KszUnjkLN5rTsBlsggD2oAwPGFuUlLQyqqhMbUGf1rjZ4yUU7BvI5yOTXS6nMbgr5aHHpk4/OubvXBaRcNvboAcAUANCRpZ7ZQyoASdvVj2Fbnh7SHubFpGhbcfmVywwo9a5l5lX5WJJ6AZya27O6f7L+9kDxn5VjD4/TvQBPreoQ6TatbWnztL94Dls+vtXHkmacByzP2DHgVdv45TdkbTuY8DqQPQelQXUItTGHc+Yeqn+tAETYBTaHGCRgnqf8KqSIXlZpWOM8n/AAq0roCXkYyNjgngAUGEMvmS7inXA70AZzxnbvxhTwKiqzPMZH+VQijgKO1RyRMoBPQ0ARUUtJQAUUUUAFFFFABRRRQBND90/WiiH7p+tFAETfeP1pKVvvH60lABRRRQAUUUowTzQAqKXYKoJYnAA712ug2H9nQJIFBupB83PIHoKr+HNH8hEu58EyL8gHO0Hv8AX+VbF7Gu0bSpxyrA/wCeaANAQgp5sEhSUn7nTNJboysFAO8nO3+JaoW14+THITg84/qK07Zo5JUZclxyH7j60AW2w7r1ikxwrH5Sa0LWWNCwcDDj5lI6HvVK4O4B24LDBweKmt/tMO1kdWwPusM/rQBoJ51qJHtAt0ijJUnOR9PWrGnXTPvZlRcDcquMke30rHilWRJNn7qR+oU9DUFreXEMoR2YODgSYxn60AdOAsiGSGNY2PLbQTE319KuyyAwb4543mRsrn+p7isiwupoZ1j89RE4wGxjH19RVtm8sqskEMyngyIeE+tAGqZIy0bKFV3HzQ4II+hpJNPkhYS7vKjPJZeMj0OKWObTVAhuPmfGVBY4B9iOlNhmMr7I7ncFX7pbOfY0ANu5nuIdgbBU/MRg8etVTGpc7NwSPBDnOT7g1Z+0PayEqF+cYZZlIH0zVC71CGGZli3o7D5kHOKALRmebfDH5YwuCpPUfX1pHiuUgQEOqRnAZRlsfXuKzxPHDb/6RK+7kq6Hb19ai/tay3EfaHZhglfvfrQBdMlpLBLHO83mZOx9pIP41SE0FuAj3iyADlt54/CqOp6neyQk2vGTlEPBx6isy3jaQ5uCc9SXQhc0AbsWoCcSRweWIhyVHyk+4NU4tREkwldXkkiBAB6Y9azJLaR5i0UkKgcYjyD+FX7S2jYMLZphNjDeZjj15FAFu31OFrd45ldCvzKQ2M/WrEl1JPZgwSzEk4CuBj8DWbfLAIl3zRrLjh92Fz6Z/pS6coCh55pBF/sDg0ATaf4e1jVXkNlHLKFPBUYJ+tdHp3w+v41We/vI4t4O7DYI9jUOmeLhpjINPeSNl6HJ+b8K0ZvGDXoRb9nKk5ZlTBWgDn7u0n09z50kciDOMYHHr70sTPPbn7Ou1iOwGcevFV9UD390ZLORnVSOqjH696LJ762je4eNZFTh2dfuj2oAvtqgtphulceUu05O0Z+nerNlqccPAQt5w+eZOd3t6AVk+Q95uuJ3aVem0J1/Ouh0R9VFqv2OFDGuQCyAY/CgB7v+7/djdkcFiabFN5aCSR43K9Sx5+tWr3w9qkgR2WQyAh32EEfpUF14b1B4d3lpvZg3lq25gPcYoArQy2b3mIGMinJaRuM+3vTZ5rIF2kaRGz8i4/pSy6dfWQdJI9o52lVHB+nasq70a8lkxLOUlA3bicL9KALUvlOu3AYD3IB9z7VjtrthHKbS78s4zkxHAIrmPEWoaxaq8UkpSIHbmNeCPXNches8oD7hIPryDQB1PiG/sZ7vNk0iwjogJxmqN1BbmNWDo056hTkgVy/nyJJuZgSOme1bulxtcWxc5EKHJKDBY/WgDOvoJDJgRgJ245rpvDdoqaeGhX/SWHykjAjHqSayyD9o3TZWMjhTwB+Het/STO9jIWjkMT/ddlx+VAGBcxiC9f7PcCd8HzJ88A98etY91G3mnzFL57n7x/wro7+3sopQUjeJ8ZPzZJNYd7JHOpKLtPQJ/jQBQunUMRGFA6fSmDzXdUDkk/pU0VuDgv0+n8qdtILvGhBzt3UAQyWwMqxwAcdXzWpbaYHhBAzu4DN398VlxtmQ73yAecd627K4lkOxX2joWx0HoKAOf1SzNpcmMMCvaqRrp7xIXWWFE3Hq7t1rmpF2uQDkZ4NADKKWkoAKKKKACiiigCaH7p+tFEP3T9aKAIm+8frSUrfeP1pKAOr8I+Cb/wAUWk1xY3mj26RSeWy32oRWzE4zkByCR71F4t8IXnhb7INQutLuDc79v2G+judu3Gd2wnb94Yz159K5qj8aEne4B3rpfC2kh5BfXcJa3TlFYcMfXHp/Wqvh/Rm1FjM6n7LGwD4PLHrgf416LZKVUIiiOMDaARkYxwKAM8wpGyyo23J5UdCPWrN5p8LsrRtgPydw4z7+hpkqmFCyZaFzgDuvt71pWLrO8JJG5PyNAGWdNEQeN0Vhnkdx70uDbyRqpTdj73tXQGBLq6eIv5cjjKZ7/wCNZ7RfvlSQBZI/lO4fKwoASLeXCCMZbqj9CPY1Jsa0jY4uowDxjonsap6nKkTKse87RkLnJX6Hrj61JDq08jRia43JjawIwdvv60AMmmKyq5YEsc7wP0NI1+rXCrIFY9ABxkfWpLnT8SNPCfNi65UjOPpT4rRZ2R9mYx37rQBLC00d2N6kIBkHqCK3Be2+F8hRFKfvAnkj2I6isG7VsPEHbjpWho8UhRAqCcZxhVzg0AXLmNIpomadf3hGHD9PqO1TTatDayOsuBJgBNoyGH1qjqgMdwolSEnrnGG+hFUI7u1maSO4hKnsueB9KANm616STTnillTYegY/MKwL24ihiWUB1Zeuw5B+p6iq93bSNMQkcjg9CvIFRJpN7Km8t5a9O+foRQBBcX6lo3jhdmJ4JfcK2tNtozKbhrdwpXLKeAaw9Nh8jVDDdqqseMsPlrqk8v5o4EZ2GDySRj6elAFCeJ7keemI9hwI2OePY1Zlf7Ypi/dFgucNkEke/Sm3E9uyiKTzImzzt5UVZW7aJFV7YzqB96NCSB6njmgCgXkxgRPv/iUEYAq1EoZzLBKqbhgqwwc/1qnItlN+8SeW2mx3GAR9Kuabbw703FjKPmEkGBn3PagCOX5BtZVVS3zFiOKfHPaJGyNACrn5ZRIcfiBTLtDPJLLPvlReAuwFj7mgiRrN0s7ddq/NhY85+uaAKjtASxVWWUHAZecj2rOlkc5KM+5uGXdgn8KvT7yF2QtHhckhgcn6GucmmKXDGYYdTxzyKAO90OGa+t18ry1jjHOX6fXinXNyWkd5JY5Ah2suSQRWFoN0yW0/lNKUK5KA7QfXpVeG/WTetuZI2z825s4/OgDrYRA0aXdzM6bTuCiMlVHrXS6b4q062tZAs91LEwzsKBAx/wAK4qza4xEJnafIJXL4z9farktmocSzIXI5XZyBQB0cvxB1JYxb2lpCgkGFzk/kB3rNm1jxDeMqSzToZRtCfdCn3rHa6kFyklmm7n5g4w2Paugmu3ls/wDSvOVP4B0J/EUARS6newfubl/NCjY/lkMQaqXtzNf2/l2jr9nIxtfgnHc81Qme3jkkKTbJyNp3A557D2pNJs74Pskb90rZ4X/OaAMnV4Li9jNtciWQKPk3LhR/uiuAv7Rra5eJ4sFeWBOK9b1q3uGvwlxGfJK58xztH4CuH8U25UF28lRjaBGcsfck9aAOJlUDlkwP7q9TXS+HoUNqTJK+QflhB4rEtrW4u72G2srd57u4dYoUjUlndjgAD1JIFegQeDNY8N6TFNr1heafLMxESTRmMMe+See/agDldQOJ8vuXnA+XiulsL65ayEAQuyjK84Cr/Ss+fSbq+trieOKWa3tNrTSRRlkj3HC726DJ4Ge9aNtAxsgJ7hIw3BCjH4ZoAq6jaweQGG+WduCq9M+3rXOzQv5rW8dvul9ui13enQRxylky0aqcFhgfkf61V2+bOTp0a4By7t0P1NAHLHQZlZWvZBGx5CA52j3qlPbwvMY4QGVeM5z+Ndfd6S2xrm6lZkY87Rjf/sj296oeVHDGRHbIExuOO1AHHXCqhIUKOcb+34Vc0xiG8x93lLwoPQ0+9zLc4aIDBzgjgVf062eQlpwqwqfoKAINVJuQILQKqjl2HCisuTTtyiIHn7xc+nrXVNp4ZwWUrEOQp4Le/wBKzpLaKa5cq+UTl5M/KfYUAcdNGY5GRuoPao61tXEby7YkII6ep+tZbKVJBGCOuaAG0UUUAFFFFAE0P3T9aKIfun60UARN94/WkpW+8frRigAq/pFjJfXSxgERZHmP0Cj6+tS6Tod1qdvLPBLYpHEcP595FE/TOVRmDN/wEH06119jpy6VD9n3MUOCz9i3uP0ouBet47SyIihidLfA4HP69z71opMrAojboWGUfH3T71lSSxxhU8zaAcFTV6BIgimKRlD/AHcdKAJbMFDJHKfMiPJXqVpiRRiZghYKOhGQR+NSpHIiHegkJOBJGcEH3qS1ijZ2ExaNx0KnGD7igCKQXDsuJyxX7p6fnTy9zFKGlUtGeH7g1r2gsmKmfaGHBb296fdS2PmeXEwXdxtPzKaAMfUIIruBZIUEZTrgdagtbaRDGZFVoj0bH6VszeVFCjMQ0ZOBIh6exrSsntMr5pULjPy4GffHSgCWx05beDf5JdGHGOqn+tM/sw3ELSW8vlrIcHocH0pmreJ7eCxKQAJJGcDa3H4Vx134gmeGR7W4dGY/PGf4vcYoA7K60ZLIRyHec8OemP8AGoriB7Mi5to1wBlsHBYfSuDHjLVHi8tp3fA27Sc1BL4hupYiGlYMBj5un50AdvdTadqUIdrho7lWyDK2PwzVSeXTU3OoZmU/MGYECvNpdRuW3Mpyv8QHP5VWa+fcG8wkEdDxQB6GfFcaSMtnGoWMZAjOPxrKv/EJ1VGFxcCCQdXAI3exx/OuPNwjSBy2W7gcU3zt5AKFQTjrQB2fh+fN2izvu54MnP612BUJKrCFpBk7mjIxiuL0COZlSUFZkXgBODj6128Ky29oj+W8aN1LITQBDfqkh22kRUqNxaRgDS2r6jEEeBYVVgMYbFV5YrRyUubectnIkBODRb3x8swqdsYPLHBOPpQBcul+1SAyiOOcHBbAwfrTBHJHPxLDHkdUzjHoRU1nPE9tLFtIdTvVjFyfxptra/aZPNMjMrHawK5ANADr1QZF2ShsjBLDA/D1qklo0TN5yOm4cMjnDD0q5dfZbKchYPNI4Dgf0NZr+fOx2mQZPQLgAe+KAEv4xEnkyAoWA2lTuzXM6lYmJ1aKZ2kP8IBbFdVbYso2juCzc5DBs/pT7XU4o5CViYK3BYKM0AYejW6G2OPMLjOSARn2xVyK0tI1DF2yTkmMcg/StZL7TpJCpuWiVeQvXcabFFCZZNssu1vTnJ/pQBqaFNbWdxHPNOs69QjLhse5rSury21Gci3V4SCAwRj8w9OawNKtUQTsBJI+/B542+laVlZQXcjIEktzj75O0t+PWgBupWMaq7LE8jjlUABArOt559jIwAMeCByADWjHbIk4MGG8tsktkp+tOvryFXDz+RuY/KoXBbHpigDE2XUtx5rhLi5J6uOF/Guq8M3aWm6bU1UqD03YBP0qPw1r1mt2Td2sUjjs5HH0qt4j1GHUJ5SkuR1SGNQCPyoA6LxjrMF/aIlvFb+cRgeUmPwry7xNautjIZoI1Ynlm6/gK07CHUlaQxjCtjBPBx/jUs9q14HhZoJJ3+VRyDn3J4H1oA4DwTe2uj+PPDV9qExitLTUbeeV8EhESVWY4HJwAff0r37S/HXhy+8a6heSW9glrI92LW+t7eTdudwUmkDEnOAfuqCCx47Bvw3/AGdbW7eLVPF17HNATuWws5AwP+/IP5L+dW/i74U8PaN4lijhu00q2e2WRbS0tC7d13dQP4fXOcmgCG98XaZMPFNlZ6jZ289/Z2yxzxWTvHLLG535BTcWZMDJUDPPHWrN3c+G5VvZxd2kdzeWVlGtlPYMfIeN4zJuI4OQp6EZ5Ga5Hb4N07TradJtXmmYu7vsSBzzhVxmTGME5GfvfgOHu77deO1tHKYmJKiaTLBc8bjgZP4UAerfFjVNK1TTLQ6awnmR3Z0jUiCNTjG0uisOn3eQO1eNTbpHIXzBGSMgZGfp6VqjVLu4spFSTIzg8ZVcdh6ms2K7kKkLh5D/ABP2/CgDpNLQ3MJJTcQNqbuT+A7fWs3UrJ7c7Ywm9vmYk8//AKqtaZfPHDuVSzDgZ4GfWs/VJ/tDShGaR15kYcZP19KAOTuo3F4dxUtzkgZ/ACtCzb/SVMrptj9BnB9vU1Syklz5UakuPvHP6VduPJggyiruUYAHTPcCgCHWbws22IM6k/xH7x9/8KoSuyQhW4Z+ydvp6VEbpnkBdDtXkn19hVpYXeRHk/dKTgDGWPsB/WgCnb26+a7Mv7307L6VR1TTnw0yj5umOpbHUit24voYAfKjGRkKo559z3NZD3UwZ2lfy5H791HoPSgDn8UlX7+0KIsyKVVuNpPP1qjQAlFFFAE0P3T9aKIfun60UAOtLS5vrxbaxt5rm5kYhIoULux9gOTTIInmkVI1LuxwFAySajb7x+ta3haQRaujnPCt06jigDqdC0uOxtAel71dgeVx2HtWg7PKowAsydMfdcVXluixjkDKw9eh+lTWskAkb5WKvyVPr7UAAeKVGjuIVATgE/wn0qgNQe33xLGQqnJ5zx61LeXQWYkMQB8pOOce46EVl3Mqh2Tado5Ujt/h9KANC11l0lf95lX6HPBq9/awZlbzA7kYZW61zNpbNc3IEeCWPc4ya67RNMicn7Q4ini4O5eV/wB4en0oAt2Fu166lXLDGGTdhwPb1rXsFgjka33JM2flVxtcH0rOvI1tmCyRRAjlGQnr6g1TuZppw0kKs8oGSc/McUAdXdWVrIhaFtvmcPGf4TXG65byaWygLIYz0Ge/+fSrmiamrTEXjyLKR/EOn+fWmeI5w0QZOcclScj8KAOVnu2k3GUtgdKz3mUcqeR2JP6Ul5cu29V6E5x6VVQggbjtb9DQBI0r5LA4qMyqwYSF0J5ODkU2SUhWjYgeg7fnUfJI2rk96AASOoxG2R/eHFAIkbLN83qaBGAWMbAkdRmkDbs9AenFAA/zNlBzUloi78SDOT1NVvnXjufTvX0J8Afgzpfjnwfcavq17q1jeRXrQoItgjeMIjBgGU55ZhnOOOlAHD6BbRrAsqyKHXjHl9a6u2vtQsmRYFZ425w5BA/A113jzwT4Z8DwC0fxDc3mrSLmOzWBS/szEH5F+vJ7A1xnyvAiOXyP4XX+tAFrVJ01Hy5JoI4pBx5sIxt9yM1FexRrGhaRJT2KLtxSypbxWiPNs354KnOfrTJWt541d7a48oHDMGGB70ASpq8y2/lzskygcAoAwHsabbXFrLOPKMogxlk3BeaSWwt3ZRZ3DNH2eQYK+2azjA9rKSfLTHV1Jbd+FADHZItSdYH8xmOSccipb+SB1Qec0TfdIViN3vitCxit9Ri877WYJkHXZgGoJpRCGE371weGHOP0oAzAbW3lEbSbmIyDsNRXcOZC4lKr1OCOlNW8QvJF5zbiepHIqO4aaOXbKJZI+25gVPvigDX0rTNP8pZZ5JVQZ+Xdkk/0qa4ltbeYw29tCzydSj8gf41ymoFptpiQkoenIAH1qQNNDHGfPwD2AAH4mgDoALnzNlvEiBz8pkbjNWEspkdkjMU0xHzNGfkB9Mk1i6bfxLhtqAg8gjrXQQyW8pRVSREY52J3NAD9KgngRjeGQCPkbeVz9O9Lq9vcSJ9o+0ZDHJxHtwPTpW/pscbAysnzpjPmSYwPpV6+gt4ofNupBtk4Ujqv0oA4EW9nDZytbwym7f8A5ayKQF/GtjwiltHcrLqy7x1XYcE/U+lP1a2t7myYLcvIf4UbrXKyWs1rdIiuN/cRNyo9KAPX9Zv9Kn0oi1treORuBjP55rzG51ImWeGN7cKCRtXgn3qzrl1ImnwpFuibbgZJJrAsVSzSUsUlnYZJbmgBfDgvodSkubC+ltD3eNypx+Brd8QarqWqyp9t1Se62RiNXkcvIVBJwWPOMk1V0Le0nDEFsbwq5zXQ/ZyJhBEisOrMyc/jQByVtpGpancgJt8pOrN0/CutsPDkbW+LnLsePKReW+voK2dLdIY7iO0ginuCMMQeB7CrmiQ6hE7pOMAf8sYRl2PuewoA5q50xLdfJe3EaYPBwoX6muZubGO2jaXcPJY4Gwcsfauv8Qm4kZo5GSMM3AJyR9a5TVYZz913kjXhn/pQBhX12qhVjEg7YJqtc3ymy+zW4VAeXfqM/wBabcJGlwXUbiOuTwPqar3VxHIvyAFv4QowKAKMNoY1Zoyy5PLMfmaprpTAhAG0kfM7dce3pWvpVhHHEbq+6ryoJ7/4VnXirezySzECIcgHpQBm2RjBaaRsnqGIzk+wprTvMX2D5ydoJOdo96S4uA8ghthlyNu7HSppfJ0uIRg+ddNwFXsaAK8qBVEMQwR1Y9aSzsVjzLMpJJ43dfanQAxTfvNrStyVzwtXo3DOHXLlfX1oAgurNQnm3Bwv90dT/siuVvLfypCR93PTrt9jXaTQSXLqh5J6+w9P/r1la95MFm1vEoZ+Cxx05/nQBy9JSnrSUATQ/dP1ooh+6frRQBE33j9av6HuF8ChwQpNUG+8frV/RHMd8GGc7T0oA6+xsb67srq6hgElnBzM+9FC8Z6Eg/lUMl1BCmd5SRMcnoRWHeOJJtzKAR0OOP8A61bHgyXzPFvh9ZAMHUrXcGGR/rkparUCC7uwQGYAN6jlWFVXuSxAKgjrnPb696674zjwqnjzUF8EM7abuIlC48gTZO4Q/wCx+mc7eMVyOnuqghgNvYN2/wAKIvmVwNjT1hWPzbWRST95G/wrtPD1pbaqm27lAmIwpLYYfQ9x7GvNt5SUlWKdwQc1pWWqGJGG9Xj69eVNMD1jSdGVP9B1mNZYd37uVWwy+/8A9apr7wItkzT2EpmjPzcHB/H0Nee2XiqZWCmQyIDkZ5xXXaH47lIaMsquOCG6EUAYN3am3vMmB5R1O4YNZ2v3kbWYVI9sfoeGU+1bOv64JZTJllBPIBGM1w+tzTyszY8xPXvQBju6MxAVlIPDdahdc5KnIBzj/CtLStC1jXJmTR9NvruVRl/IiZwg9WIGAPc1tv4Sgs1B8Sa/pWnMOsFvN9sn/wC+Ytyg+zOtAHIkMy7lKt26YP5UkHnyyJDFFI8jHCqikkn2Arqxf+ENOb/RNIv9blXpNqc32eE/9sYTu/8AItJeeOtaS28nSrmLR7ZxgxaVbra7h6M6gO//AAJjQAweBNaUJLrS22gxkbvM1acWzEeoiP7xv+AoaGs/BmmpvutR1LXJx/yzsIhawn/trKC//kIfWuWkkkcs+4uznLMSck+tIWywXj+dAHV/8JkdPVR4b0PRtLUfdl8r7VcfXzJt20+6Ba1PDHxe8Z+Hv7Ue31i4uZNRjWOSW8czPEVPDR7iQDgkemD04GOBB28NGGHXIHSnHJXLcr7igDu9EvjqBlnuLqSa5lYvK8xLOWPJJPUmulM7ssUUhmGPutn5TXllhO1q6GItHk/fB4/Ku70jXClqVnh+0JjG7dgqfpQBo/ZZ1kBw8inoxHT8q0beK5SAxGMDf1BHX3qKxjuLkLLFDIkfX923X8KWWe7UFGLxgAjLrk0AG9bYKvnbXIwQDkH8qiiVYgm7z40Yk4C7qejpJEhVhJuGGKJgg+4pscsoieGVXlx9wqKANGGHa4liZCpGT5i4NZOpRpcXvWWNevytx+lW9OiuJHBlElvH/tDmkuovKcqZ4/L6ZY4NAGfLCZ4gYmVh2BUbj9ahvbKRVieSRQT905xirqLA2cupt+hy2TSSoST9mSO5hA4BP3aAK4LhVcCOQIecDP8A+uqeotNeAeYxwSNu9cAfhVrT5Ps7EOSgc4AC8ilWCN5Zdn7xuxJ+7+BoAzREYX2hEY9DJyQPpW/ZXSogWKTcCMMScH8DWd5FxbtuLSMnfy84rodB0iW9ZUtFR93VdwoASC8xLhF4HoxJb8T/AErcivXkhJYb2QZCFM49s1JceDr6zbzWh82X+EMxOz3wKYvh7VWKoshCt/rDk/8A6qAKcc07ZkZYopD94IQmB9a5y9RzOZF2xsTwVBYn6V3y+DLlrTMUIdicjc4rasfCS6eyS6obVZOoy5AUfQUAeSzR6j5REtrP5YBwzDBxXPqLiEnz45ChOdo4z9TXuHia50uC3KrcRyA8ERRHcT9a8p1ZGNw0kEDpGPuhv6igB+gNdPKVgSVW6JEq5/M16PoHhKdo2u9XkEat/Bv3O3tjoK4jwz57Xcbu8w59MA17XoVnZwwq77XnxwZHzj/gI/rQBa0vRtPgtkMNsEVudo/1jcevao/ED3UcL21nCluzL8scY6j1Y9TWqLhbV2lmKIx+4GHzD6DoB9aztRvraTd+8urydvvGPhF+rUAeV6/ZPbO4nlLOR85ABI+noK5yfU/ItPszxhIF+YKRl3+tdf4ptpBOTHICSM7EHNcRqRRVJlMaKPvcZY+1AGLft9ujyke2LPQDAzWTI4tsGRfoink/j2rVu7iVrcrExRT7YGKwZkVG34d5PUj/ABoAmnvDIqmZsAdET/P61m3tzLdHyo1McY7Z5NTyRyIjPyGYYy5wfwqKGB0Tdwme7d6AIYoJE2lBhuwApZoxHMBgvOfT+EepNTvPNEoSLq3WVuPyFVFDvMwJZlHXnr9fSgB5gLyKn3S3ULyT+NbthaiNQiKPMPVuoX1qhpEQlmOGwp6sPSt6+TZaYgURRjgu3GT9KAIL64jjja3siNzcyTnsK4/WZYhbyRQZfpuc+ua0r9gE2mQ7Op/2jWBfsDCQowvYUAZrdaSlPWkoAmh+6frRRD90/WigCJvvH61Z08kXGV6hTVZvvH61YsCVuOOuCKANCdw+GUYbuD0NNjXcCAAG54PSrtlpGoXtndXdvY3k9lb5M9xFAzxw8Z+dgMLxzz2qlJCOGJx7qaQCGRixBz9e9aduYtoEqAkjqKzScdcHHQ0/zSH4NO/cC66iAno6HoQeRUMU8T7kmjwR0kXg/jUAYsGG7OexoVtvBPy/SgC2jRJwW2t1Vx3pzahIHDE4xwWHcVf+H+kWmveOdC0rVZjDY3d5HFK4badpboD2J6Z969Y17wLLq4jS18NaNptl/bq6UsFm066jCAzDD+afKfcihw27uORkgAHk2kXVm15/xObi8NntJxaqrOzdl+YgKPfn6GtX/hKdNsyy6D4ds0Zelxqjm+l/75IWL/yGa7+7+Enh231XQnGtXUWmahBePIZFDFJLdkXb5oUKoYuBvK4BHfIqPX/h34d0Twh4wkurLVv7U0+S1NpMJI5cJLEWU5RtjIWByxGQoGADkUAeZa74s1jXLYQanqVzNbKcrbhtkSf7sa4VfwFc+8akK3zgepr2TUfhl4e0/wAXa/o0Wp6zdjQLOW9vkFtGrzKBFsSE7jn/AFhLMyjGBgHrWhpvwf0eTWb6yl1i8Zyts9naHZBK/nRh9jM+U8xcgbBgng8ZoA8MaMRj5dzH+VNaRsLgjBHPpXrOoeA9K0fTdLk1Ia1c6jfLNNGLeBGggWKVk2SkE5PyneQcLnvXa6z8OfDV548vZNEea1ez8QWtjPaTWkZtQk2cCNQeQNpzu6+goA+cPLjAAZWYnurYxQseGwA5P0r2S3+Gel3/AIW1XVobq5n1eH7bN9kt/LgESQuyhgj48xDtySh+XkAEjFdU3wk0bUfFmrwXF7PFcxSW0VtbWaR2qy7raNyV3fITlsbAQT1J5oA+d/s5EIkV8+qtQmAfmVnHXBWuh1BMzzWqgN5Tsh3rzwccj1rJuYpVVkC4I74xmgChJIS/7kkD0IqxY3bRXCllQ56gtgGltYG3ZdT+FasNhFNgLu3D+E0AdFo2tT2/+rcp7oScfnXRLevqSebM7sw6EjHNcJDazwzfulyo+8pOc1uW+qSLGB9jVZF6dcGgDfkgdZlMTwpKOm18bvrRbXFxFcf6RGPYEfpmlttYa5gQTWUIcH7wTpWjGLWWULcTEqBk7Ov50AQvrF7mSOQIiMPly1ZwlDbgxhdCcfNyQfxrXltNJWXBadCeRuAbNZF/bzBz9iiYL3JQDIoAfLYys4WBUSPGd+OKabAwHclxFcMOisOPzFMWGZJIzMFiJHABwPyNF3bFZRvRQDzleQfyoAq3D3Jdd7RoSeq84+nFSm4fCxmURse7A5P4YpWs71X3RRrHAf7oGPzzU87XEUO24EDg9HQZYUAaljLKYV2EygnGGAA/KtOz1CDSp8ShFY/Mdo3MPy6Vg6c9nAoaa8mz3HB2j6Vs3V5olrpwkRZbnjOWwv6UAddb+NpPsoW22wr3kc9R+NTnxxApjRmkn5BO0DB/KvLDeRXUkbRwtHGTwSeg+pq7JaPsf7G6DPctz/KgDtdR8TTqrtbwqFdsli5yPYVz+p+JC4LNOSewcEjP51zdjBqskhVJcLnBY9BVvU7FbeItcXplkxwoUGgDJ1LW7mWXfIwKj7uAcD8BVeO6lcfvLwkHk7VxioX2zv8AvHZSB/HxUtnYuf3zyRInQZ+8fwoA6vw1bm4bzJGIt16vJJgn6CvR9FS5lQR2ASzXOA4XLN7815doYKOJbhlEKkYU8E100vi9rfKWrsnGAFGAf6mgD0OPQACZrmaS5Ycs0r4X/wDVWFrGv2dkHhguVeRsrsjOQPy/xri7zXb67twbu8k8rtHk5P0FYc14q5doWOeQC3+FAG3qmr3KwzBPLhMgxxzI3+AriHl8lnChHc9z83NaE9tLfAeWuO+W4AotdPt4Y23P50/fjpQBm2cDXcw85ZLhs/JEo2qD6mrOqaV5KeZcvH5p+6kYwqf59a6Gylkt4gzW2E6AdAa53xJfNdEgqFx0WOgDlLu5itCwIG48bjyTVEsz/MSST90HrUt4qCTcQGbufT8arNKrH90Sg/iduv4UARSFy5LZ5qa2tpZiMrmMdB0H4+tJFEhYyZYj+84/kK1rdHlCBS2wep4H1NAFjT4VRmeX7qDOOi1HqdyHcSTvuYcRR9h+H9TWkwhSEbm3t6np+ArnNT2mTnJLdIl6n6+goAoXQV2zv3k9ycgVk3uBG4XoOrHvWg6c4yC/fHQVSvwPIcL90Y5oAyz1pKU9aSgCaH7p+tFEP3T9aKAIm+8frU9kMzdccGoG+8frViwGZ8f7JoAvOuMBh+JGaN5T5WPy+np704njay59s03ZvQZUkL374oATeQuCFIPemo/zAH7w/MU5FjBKc4PSnER7h1OPzoAdIORg4JpgUjkmp8LgHGR2IqLBZsdx15oAaMK2cHI71vXPizXryO1W91/VZ1tXEkHm3kjiFh91lyflI7EdKxY1kWXlW/GpGEZ+V1KZ9RQBuy+MfE73dveSeJNae5h3iKU38u9A2N21t2RnaufXA9Kpya5rQnv5ota1MNqK7LxhdPm5XBG2Xn5xgkYOetY0kTIx2/MnpmnR5bBBwRwQetAGsniPWF1k6r/auoLqpOTfC4cTE4xy+d3TjrU0XirX7SS7mste1aCS7ObmSK7kQzHp85B+b8c1kSBTnO40+Flj4Q8kcgjrQBdsvEGs2ujyafaatqFvYSnMltFdOsbn1KA4P5VYg8QeIVnlni1rU2lmmW4lcXT73lX7rk5yWHY9RWbBC0swCxhG6jtWrFp+yPzXlVHHZeo+ooAvW2s6+ulSWjaxqB012LSWjXTiNixySUzgknknFF14719pJ1t9e1WBpwBORdSKZcKFG4g/NgADnsMVz+pXjszKzhm6A9Kz0BkA3/N+NAGxDMkceQ7K5HUU2G4lJOX3H3FZiBtwT5gPStXT1dWAVBkdexoAlswzMQUc++M11fh/TIrhwZZAj9eRipvDelxuxc3EiyH+DHFdZBYTHCLAzY/i2g0AVodK07zBHI21uuc4rTj0XTHUKrxl+u4AgitXTtI0dY/NvZWeVeSuw8VcMOhTuG04SLJ0zuOPyNAGDptvYQXpjuh5iDnLV2aWemraiS3gTdjIKLn9K4nWrK8gBKeY6Z4+XFVrGbULeVSkskfY5ODQBLqu59UZ4HKP6OuwEfSp3ZY7RpGQeao5Ac80moMHXzbqQ3Dn/npj+dVrbTJmUugXB6ATDj86AMS/1KS7xH9jhiHdgxJqC3hurxgpMYCjHzyFRitGbTLgs+FzIDz8wcCoY4JRKAyCTH3gFJ/SgCGa1ZFEK/ZGOf4G3GntaTxOFjjZDjtzn86spLD5vl8Kc8AIEI9vWtC5mEECkQSSMfVjgUAc5Hpm93a+dY93+xkmtWx8L6Ytm0s+oqgPO0tn9Kpl5J5WL28uwHIO0c/SrUduwXdNK6Rn+EqFIoAr+XFFKI7IiXngSJxiteGfZbutxeLFj+CCE8/UmsKW2RZDIjkknpnNa8ELS24VHU/7JXH5mgBdPtVZmkaVShHy5OP0q0NLtfLZheSB/wC5GoGfxq1aWFpa2+bhVadu2/gU+01TTbctG1sLqb3bIX8BQBzF7p/2ZfMn8pB/CpcFvyrHcO+5pg0cXaRjjFaniG4Rrlnt1ijb0LdPwrl5pDuX7azyNngYyPwzQBv6LJBPiKKd5GBxuIJ/KprueOzvGWNmMn949ayrfWbe2+SMlR3CoSf8BSyatbMpeCF2PeSTrQBoQXDyTkuX2g85q4buwBZoIzPKBgnB2rXOQ3auxA3nd2Heul0vTfNtsz/u0PO0ZJagCAxyyIXiVt8n8Wc4+gpLFmsmI2NuzySMsfxrutA8OXF1Cfs0P2a3Uf6x/lLfiabqGgWlixa/kWQjkKPuj/E0AcNq13PcxER7lA5Jzkj8e1YEl0sUbJwxHVmPH+NdJ4hvomie3skVV746fif6Vxr2Ylk/fOQpOd3TP0FAFK6JlclQGb1P3V/Cs77OWnClzzz7GugntIkj2RZ56s1Yt7GAxwXY+1AEsFupkG58qOw5q/LexoVhhBd/botZILgLG+Sf7o4AFXIEYMqpgMe3SgCaUzFdzHauPlHeqk8Pkx75CwLdcfeb/wCtWuGjhUGTBfsvese/33UhKtgd26mgDLYb3wcKgPQVX1DAtZABgds/UVcl8uIDZlj257/1rPvVb7PIZDljj6DmgDKPWkpT1pKAJofun60UQ/dP1ooAib7x+tWdO/4+f+An+VVm+8frVvSV3XYH+yaAL25Q43MN+eB3qU7c5B4b06itCHUdRsrK5srO8lhtLrPnRIcCQEY5/DiqIAZec5/WlqAxlTjPXtTAnzZUZFPKheGOR2PcU4RrsGM/jTARUHbg+lIockkJx709wyLlQxFWrcCRBtXa/wChoAro5DhXYhfzp4tvMYEtuU+lWJ7UoAWVlB/iB4qxZWfnYCMCfXP86AM97Nom2YPqOOavWulvcAY27u4xiulsdLRVzK4x6OM/rWpDa2YKmJAreqtlaAOMfRbu35kt2aL/AJ6LyPxqey0ieZPuQgddr8Gu61GK6tYlkgCFPQ8iuc1eeeRAJrZFU9xwKAKEc0VjviktWyB3PSsm/la5YiNiB2VuD+B71uxrHLbYeFiR3Dcj8+tZN1Alu43ASKT3ByKAMBkCZDjBz1NMUAHPJPscVr3EDuWMasFzn5jxUMOn7zkOq57saAKccZlkA2n8K6vQrJZJUEx8texkXg/jUGl6W3mr9x/909a7mzgEFsFYK+TgqSCR+FACWNtNDcj7MyCPuRyPxFb9zrE2mW5jWfkjPyHgfnV7Q7OxWzkdJmgYLxmPNcb4rd3ZlSTzBnnK8UAZ174gv3mYm6cZ6HOKdpuv3dvMpDLnOdwzXNiN1YjbgZ+71zWpEEWMFIyHI7dKAPSYtaTU7VdxlaVRgnHyinWohuH5EjMvf71crokU7wM0QlQDrxwfyrrNDtb4kPFHj6DBNAE1za+egSKOLHq6mnWdksTFHlRG9FPFdAnntAIruKGM9i64aq5j8p8ExkepUEmgBh0i1SEf8tC/U7itV7fTYp5TiApEeG5J/pWjcb5IwXMcYA4JArGlvxalgbmRsnjYNooA2D4d0KGNpZI5FyMZccZqKPSNO4a2lZ9vO3bgfmarrf3UkW8uoAH/AC0OcCobjU4ZLORElcPjHHyD88UALcWcYkZyNyg9A20foaPN09nClYRxgJhsk1zeyJyfPvFSTOVVWLE/nT7RlXH2vYSpyADg4/CgDUubTbIWSyPln+IjaPyNMtGhSBxDbOHyQWd1GPoKz9a8QWxhEUdufT52PFcxFcb5iqSjBOcLk0AamsXcaE+ep46Lkszf0rLGoRiZmCsq+hyvPsKsy3MsbeVapKc9ZGTk/SmIqIw+3mNSecsc4/LkmgClNePJNvWN0Hv1/Gql7aTTN58zhVP90ngfjWpq02lxRKLWdmk/2VOCa5y/muPLLTyyBT038fpQBXuniUkQszKOpPFQWs80uFVAUB6HpTY7V5CMNkN0ArotK0yxgYPqd1lcg+XGOfyoA0vCmmLd3iG4lkSPp+7UCvY9HGm6TEH8uFii8b/3sh/AcCuEgvNNihQaZbgkDG6bJx74rOuvEBebyXkYqDyE+RaAO71TxhOLkrbqsKDopxk+59K43WdXm1CVw0oHPzydcD2rMvtWBXEYjbHRVFUZ7qW6i/0keXEOgA5agCtqDhpWjt5yEA5YKBWRO7RPkN1OA78sfoK0ZmwuN6IOoAXJFZMnNxuLHJ6Z5Y/X0oAWWVlH3SWx6ZJ/wFUJJioKxoGlbqTzj6VcZWLEMx21LHZYQuFCk+p/maAMGRXLfMfmPVs5P5VKBIjKIWG4/ePepby3kXIUkqT1H9KilVLZFXYS5554oAhuJZGbYD8vfnr9aWTznhC7RHH3PrU0flqu5iGlbuRwo9h3qEgyE/Oxx/E1AFE5Dktj29ar3w/0NyTyccfiKvvGqE45+h5NUr7/AI8ZOMdP5igDFPWkpT1pKAJofun60UQ/dP1ooAib7x+tXdHBN4ADg7TzVJvvH61oaCu7UAP9k0AauX2lGG5T3HaiMb8h8lugx3qZgVb51II6EVfs4ba5Iw4V/wC90/OgDKkhCEE7ivbIpUSTJEY3g9QRXXWtgkrrb3AGT91yeD7Z/wAa2F8F3S4mtYwzEZ25xn6HoaAOItrQNCW5B7j0qzHpZZN6tnPbHFb02myW8zRzwFX9MYIq5aWUygYiDDpxww/pQBiWcEmwpKoeL68itLTtNt94ZDtbsa6fT/Dt3dMgMG7J6MvUfWu60v4eGaJS1o0e3pIpzj6igDzl9HvAgkMMxjx9+L5h+VOsdLuJ32IgXnh9uM/WvabLwpJpqCSG5wo/hf7p/H+lQ6vJFEgJhCnvIgwV+hFAHnUHh+7t1ZnZlQjuu4Ul1pNpLYNudywHIC5U10rXdm1x8t6VB7qAB+IrA8R6hHZgtbsjk9WQ/wBKAOEutNjhkJSEFOoMbf0rBuTG8jbGYHPIYZ/WtW91JrqViXVyTxgbT+lR29i1weWzk+uD/hQBlLbt5mSrsp9KtpZoRhFH0Jroorb7Imx0Rm+u1v8AA1TvYmnIwrrz1UCgCrpdoqBmz9MDgVuWSQSXKAK+7ue9R2tlN5AK53emBzWvpkMasXnXdjgheCPwoA6qzknt9OKwS280LcPHIvIrGvtImlZpbT7NzyVHSr9jDvlU2ckjHsGHFdhY6HeXcavLYvFnpIhwGoA8b1DSllz8qxyA87emaj03SZ4rhCzgA/QivdLXwZc+a7MkWD/fQHNVNQ8HXgy8awow6qMYoA4mwt4rJg00SS5HGw4/Oun0mOVl8yJDCvXjg1Tm065hkAmiRgvULW7p+qJbReUjtGcdBGrUAR3MkcqES5YjvnBqiYVkXb5j47krkitGbUdOeUG5tWnf1VvL/nSatcWpgDWkTw8cgYf9QaAOW1G3it4j5M0pyfuyLj+tczeXwBaIzOG7DqKu6tcRzyMZhPu6fMDWJODJGdsJCD+MYyPzoA2NIuIolCzX06Oc8KM1Fqhhw5luTNnpvYg1gW7FnJWTKr1JPNRXCJI+8n2yTn+tAF+LU7e3YGSBp3AwArZxUF3qLOfNtoRG3fcRxWT5UMcx8qaOV+p64H1p8EkZYs7BPUKMA0AStqKCUvcxtM59BhR/jWtBPBfxqgiSBR3VOtc87JKWSJ5izdF2Z/WmoHtwYxujLdS3JoA7AT2lnDh7mQ46DHSsyS8hecGKGJpO5ky3H0rnnLklHk2r1yeM1LpziGT5Y9zZwCVyfwoA0r1roy+ZCqBTwG4X8sVg38Tb2Mg3uf4mz/Wt+9PmIC6urnjLHpWLqEIUjdukA9M0AZ0G6MkRj5vXmtJbiaOIbfvnjJAGKpNDNGjOw8tT0Hc0sELzYWKORjnq3SgDa09v3JMkzOzfwqf5mm7AzbYol3k8scmq9taCPi4uo1I7AFv0FXrNzHKS85jj9WIUt+A5oA1bPS3eANdziIdlYY/Qc1Fe2QT5VaSRj0Y8fkKfYxNcSlrZfLX/AJ6SLnNSMohZmvJR5ftgs30FAGQ8LA/PCv581TOnO8pd9kEXdj1/CtW7uYpObW3MYH8TncapNYXd4CAQWbt6f40AVJDDC2y2UN7k8mnR2r3anzMgd9vQf41ctdFNocOUZh1bFXriMiPDny4h/D0L/hQBhMkUJykbMqj7x71mXaNcZcRhEzxmta6WW6mCSuscS8iJep+tZF0x3sI8Ejqx+6v0oAqTRFB1CAjt94/4VUY7V+Xp2qWXcDliTu7nkmgwsw3kdPWgCHy8L0wD3PeqGpKwtZP4V449eRWj/tO2SOgqhqe5rSUnJHB/UUAYR60lKetJQBND90/WiiH7p+tFAETfeP1rT8OQtPqQVDhtjHP4VmN94/WtfwqxTV0ZWwdrUAd9oOv6j4fgmht9N0O8SV97PqOnJcspAxhS3Qe1V/EHiS61uW2a70/SbU24YAabYpa5zjltp+bGOPxqUSLsBP8AF0x0qrcQlmIdMn1XtU8kb3sBs+FZ4JrlBJkKeuRkD8K908Naa6WoFsY54GGfKc5OPY9xXzvpiywSK8b5YHgj+L6mvT/CfjGWzKRyRmSIdVPBU+oqgPRrvw1aXuFmgKnpgjJWpbHwAkf72Pb5f94jIH1FaWk+LNKu7QbWJkxkhvvr+Heub8S+NLiB2NgXUdA6dD9RQB0CQ2WikmUorAdV5X/61VbzxfFFuFvvhbH30PH4joa8zn8U3kxcXBUlup7Ef0rIvNUCP+7ZhjrtbNAHeah4yZCRMHZmyd8Xf6iuYj16UTu4kPkucMr8Cual1KIPuLLg8nYSPzBqhqGpGceXG6tHjuBuH40AbusatAVZfLMT9Qy8qfxrj7rUA5YTKFJ7g9apyvcLJtLMU9D1qxaWLXEqtwef4x1/GgA0y1We73eTuQ9Pm2mu5stPtowD++jk7CVP60zSrUWkYEiGMjnayh0P0rVuZV+yZtUkUjjCH5f1oAx9WgVgykRvt5BjbDCs2GFVdTmTn1Oav3C3M4wyYbP3toB/wqtNC8dvtk8qUf3XXaR+PSgC6llBJPEftTQk84IIro7LS8zDc3mcdeMkVymkW8rtulibYO27diuvW9sba1UqJVlHG5XyPyNAGhF9lspVBLKQ3PO7+ddNba+6wqLeZlUdu35V5hPrMLT7pIyefvg5/SpXv7PIeJXRsclW6/hQB6vc+J702JkKxSoP7rZJrnb7xMsqfvLeZT/eEnT8K84vdWYMRGwVD33f4VHBqkrRnzHVhjjC80AdzFrO9sPIXQ/wkkH863rCLTbvAjinEp7hxXkKXh37mkbGfT+tb1jfBAr+eS/YGgDttc0i4fJitFZB/EBz/OucliEcLJdMyRg9BgGrkF/9tjEbXc0T/wDTNTg1JPaQG1O6+jWQ93U7jQBy1wtnkrHK7A9Ff5cVn3FvZI3yTbSe3UVPf2yO7nzN5T+I9DWHwJe6p1PbNADrwhGDDa0Y7AYqnLL5gA2xhPSNSD+tTTmKQ7Qu89lDk1HECMrNFLEM8DGRQBV8iJy3mF0Hpxk1athAq+WiuzHpuApl5NDbEeX5cjH1GcVnXUkszB1Iye2AtAGuzpE4VfKV/RfvD8ao3Ek0s4SLBYn7xyahha7Tj5AP9gZNWTE0K+YUkZz3JoAtQ2TWuJgqyT9csuT+GasQR3tzKWlhb8AAMU2y1NorYwxxRqxOWcnn9ac9y80ZVZMAdWBPNACy+VCSd/lsP7q7iT9ao3Zjdd+6UOf4qd5kj5jwQg/ixnNUdRPyFYlD54+ZqAKNyVO4qZSo6yM2M/SoBdyN8iE7PXdxUj27FfnKDb0Qck1WMa7gSw3emP6UAWVBUfJKCx67en51p2MiQEMUSSU/xY4FZa7mdRjd7Gr8UdxMVWNNxPGBxQBpTX016RGZGMY/hU7RTjAE4ClmP8I/qTUtlps0Z3SnBH8KL/XtWtYxHzt5id27KvzE/U9BQBQSylmQbyFAHEaL/WrtrE1tAUR4xKeoU5YfXsK1YdB1LUc7QWQnpu2qv17mtOLwTMlrsuGVEHLOTtUfQUAcVmQSlRKhbvg5IqB4JyWk8twnb1P49q7e4h0vRbXy1SORuvyDGfx6msV7qW/3M22CEcKuMH8qAOSvYcxNHFGQerbeBj3Jrn2hdydoAiXuehrqtUg8pWLOViHOHPJ/CuZupZZOEB2diRwKAIpIHZN7MqqOhPf6CqMhydmSwHarE29lwuT6k9f/AK1RpGQv7sD3NAFcqAMFTuqrqKFdOmJHHHXtyK0lG1cswB9+TVTV1H9mzMfbBP1FAHLmkpTSUATQ/dP1ooh+6frRQBE33j9a1PDYJ1NdvXaT1rLb7x+tanhoBtUUN02mgDu7drOeIJNlZPXpV3yzGipKokUcK/Qj8ar2hlis5reKGzZZvvSS26SSLxj5GIyv4VqWdvJHABuEkR6o/Vfoe/40kBXhtGkmDwBfNB+ZW/i+o71trbgokqEwTL05yp9s9aphEUgyKVP8Lmo765Man5GLAc4Jwf8ACmBsWkz3BKSsYZB/Gpqw1tf2gE32wzQnnd1I/LmuSj1SeLBVhJF3Ruq/Q/41C2qu0paOeWJs5GOMfUd6ANnWpGkOQyMcdRxXPzuwwd7hqbcXryTFnVZCR8xQ4z74pkDLJ8sXT+6/WgCG4uiy7ZBlv7wODSxxvKqNDIC3YEVcGlB2AyMN/erY07w9cx7dluzof4lGaAM1fOmxHcIVcdMDn866vw/pWxBLJE0sY+9sOGH4Vs6Vp6Wu1byDehHDMOK1YNkM3+ig27Y4yNyGgDPmhtZYx5E8oj7rIPu0+DR7lIy9pexSIRzHvAatGTfIC1xGit/fhP8AMd6xbmHbKSkbSDuB8tADJkubfesnzZ9RgisYzuGdPOO7+63/ANer91eMh8svKvoJY92PoRVS51JXiKTQ282P4n4P50AMtNXuIEYANkcYwKqXGrB2w0YLHqDxmsm5nt2lOcx47L0rPuZVZsxyux9wRigDoEuUMvICD0ANR3k+WxE+PoayLYncrbmB+tdEtot9EpTHmAeuKAM153EX70wk/wC5iokuJWAXHy+oFbbeHplg3HK+oByDWRLbGAkZ7880ATxPsT5SD9VxV22lfGTIMem0YrCWX95gEcH1rQt5kQHKorf3txoA6OyvNkYCuEb/AGcj+tXhO8oJa8dif4MVzsTb1y5jwfSTaafEEjcuV49Q+6gC5eLsBJYrn+8vNU4Y2mmUGTeOw4Wprie3dRyhPrIc1HDCkvzSSwoB0Kvj9KAJryzihAZ1w5HBQis6W1ZwdrTMO+a3odOEsB2TROfVpMfzrOlsikjfvcDuI3zmgDm5rH96QPx3A8UrW2wriTjtt5rekt2SNm3qOOcjJ/OsoTxIGB7fQUAE0Fy0QUu7fRcVUaEAHe3mkep+7VyW7WW2wJAq91B5NZzFpBzCVXtnjNAFiKGCVgHlwvfau7H41ZmWzWMLbyXDKOrNgD8qoNKu0Rt5UbYx8zZpI4Sv3XWVR19KAJ5GkkUKkxePuM0+3tEmQbSyDuxFWopJJQMRRgL0CpnNTxJM7ZlgcjuEXBoAyL6C1VQkZeV++elV4YISSJASemAMCt24t2clYoNg77jVeOJkOEgMjD0HH50AUI9OLyBY7dgO7A4zXW6Np8NmkYjtS0h6u8lU7e1lCiS5jdV7AnFaFvqq2422kUakcZcZoA6FtFknjEszQwwDnLt/StKxj0O2wJnklK/eA4H+H51ycmoXt7KqyzSvj+GNQoFaGnQQpMrXDcA/cCE/mTQB2kmux+UFsYYYolHG0Fj+fSs+S4v9SQpb275P/LRzwPwpr3EICExEL2BbaD+FN1HULyWAQWTGFCORHxn6mgDA1XR7qBXLSxPIc7nbnH0rAJayiHLZb/lo45P0rduZbiBfnk8w+rfdH59TXM3cjy3DTTsHAPBBPFAGVqj+eSc8AZJI6VzssiljzhR0zyTXV30lu8BDckchEHFcnI37wsBsXPpmgCvcBipO0hfemQ75l252oKsSx70+8EX1Y5NQjbt2RuSB3FAEUwRCFVgPf1qnrCn+zJjzjj+Yq1L5cXEa7mPUnpVPWPMbTZCwwoA/mKAOYNJSmkoAmh+6frRRD90/WigCJvvH61ueDY2l1tEVQxKNwe/FYbfeP1q1pt7LYXIng271/vDPFAHqEUUsUhG3AB+4wwfwNa9pMgXy7kZQ/dkHDL/ve3vXK6R4qgv1SK8Kxy5xhzx+Dfj0P51sXURgw43srDIRjwfpQBoXwMEbRyMzIehHB/8Ar1hPdsqMiuSP4Qwqf7WJF2HzDGD91uq/jUsdrC74YsUbsRgigDH3eb/rPlcdxThbTMcHLDscVsSaSjNticN6ZOGFT2OlTi4XAYYPJoAw001iwxhW69f84rTs9PdSBdjGeQe5+h712VvoYnABRWJ6N0IrpNM8LRLBv8+NmHDRMdp/DPFAGBofhuO4CkS7dw/5aDIrutP09dLs8wqHlUcbTwaZb6R9m2srxmP64/Ctaz0l7kB7Zn255TeOaAMqznkvJ23QgA8EMMDP0rTGkRQASmJ4Se45BqveA6Xcj7TJKEzyHj5/BhW2b7TbvTgbe8MUwHQ96AOZ1SCJ+Nnzf30XBrCe2EZLxSOWHUEV0NxLvyMiY/3krJkM/mtuicp7Ln/69AHN6is9wx8p4yR7YP5Vky6fLJzciPb79P8A61dHqH2d3Pz7W98giuevLn7MW2s7j0BzQBh6raiJT5YQr7EEVivG6qRu4Poa09SuEkO9UKn6VhSPGHJJb8RQBPbvIpBBZiPUV1el6h5MStswcdRXEicK3fHtV6G+ZMfMxFAHdTeJZAmyQLtxjBFcvqeoJOSCcqT92q//AAkMiARLChzx8y5qjdXnmtl441P+zQBailaMbkH4VctpTMTuK/hWKtyeFQEZ9DV6J/kzvx65ODQBvWgttw3KSw/vnitKEqJNri2QHpg81yRlCsHKvj+8D0q0t0TxJM7KegKCgDobuUQghLiP6BB/Os6FyWLGDdz1ROv41VGZvlC/L6qOatWzmA7EzIP9o4xQBcBlEW6NBjuCc0wfbWJx5YU+hxipIknmziSOIeiqabL/AKMNrsoY92H/ANegClfSfZ/vHc31zWbHM0sxLIqDtkVfu0lkP/LM+hAz/SoDFcSYX5W9Acr/AEoAjeGYZaNoc+o61E8dzKmI43PqSM/zrodOsJGixJabs9wxOP1plxYXEsvkxQBB64JoAw4bQxtiTYpPXK5NXorZtoYmR0HZEwBWxa6P9nkBuJMnsFGD+prVSMQFdiyuvfcQR+VAFDRY42GXjf6Px+ldB9n+0RiOKIKTwOoFVmnszKPNcq39xVz+gqf+0p5D5dr5kEY7nAP9TQAyfTIdMjMl1B5zdf7oH4ms248S7ITDp1nChPG4Lk/hVm5tDKGknl3sOcuSTXG6tPHHIyKwQ9NqE5P4CgCzfakxybpmmk7AycL+HSqPnuy7iyIv91OSaqxxsqA7G59Vx+lN8pxLgKcntmgDptLv50jwkZijPT5vmb8avwXcz3GBsHrhtzD6ntXP25toNpnIZ/TeWx+FXZb0sFW22xr7Lk/lQB11lJEHBKFvWRm/zmtebUjFCwt4oySMA4rgLQy+YC8jSPnpjNbiXcoTAcfRVoAzNVkmlnd5Jt03fI3YHsOgrEuZZJ5AnmNx05HJrXuGll3JKVwSThTtH6dam0eCCIl1iUkfxbTgfiev4UAc1Npt7IAI4/3fUj7o+pJ5rLubIqW+cMw7oMgV3GpzvNL5YUyk/wAPRf8AP1rm9UhnDfvpFUDpGnJH9BQBz1xbqkeXGT6uf6VRyqKd5yPRatXjbju5Iz1Jzn8agUY5KrnoDjpQBCzjIIj+b+VVNYkDaXNgE9Mt+Iq3PLHDGXnYID3Pf6DvWDqWqedG0ECgQnGSwwTz6UAZJ60lLSUATQ/dP1ooh+6frRQA1o23HjvSbG9KKKANOwvI4NNureTSrG6klBxcTGTzIcjHybXC+/zKefyqfSNcvtNIiVzNbZ5gkOV/D0/CiihAdz4V1Sz1ecW4D294w4jI3BuMnB/A9f1rqv8AhF/OiMttKQyEloycbff0NFFAFixs/LkXzwGx0PrW7aNDFJuaFljPdSMiiigDUtpmjLbCJIyOhHb8a09GtmaYyIoYEZ2uelFFAHSjS1eATQqvPLKjbT+vFZF5evagi3P1U8H9KKKAMLUL28uz5bu5HUDdxUNtLJbIVJ3EckMAf1oooAgkuwkm7yzGT3Q8VI+sS2+DIhZSOG4zRRQBja1qcd0gZoxn1IBrkL95QxaNl2+mKKKAOevLqYM3ycfWqRnZxtAxn1oooAYqyKcM7A+gwRU6I7p8oDfWiigBwWQDlAPxqCVWbGcj1oooAmggwflY596srDJuz94e5oooAti3ZV3BNo+oqzaF5Wwfu+hxRRQBrww+Wnyrg+zUxl+cEqoPt1oooAubHnTb+8C+zf4mrttpy8eZvOB3bNFFAF2HTmbIMjRR+1SR6JZGYeaDI/8AfYk/pRRQB0dlpFtFB+7MqrjnYFXP9apNp0T3GIvPVe4L5zRRQBPPBZWuC8DPJ7msyW7adykVumP7q8fqaKKAH22lSTHfKfK3dlIBx9RWtY+Fo50LCf7Og5YjLE0UUANn0G0KMLWSWXH3mICj8q5S+tLe3meOGJdw5z3NFFAHO307xkqyAMTgVlT29wTuwBu9DzRRQBZs9PZmBnZVQddvU1s21i08R+zopX1Y0UUAa1taPYx5kXzJW4xuwop8dqZgZLqTCE4AQcD8KKKAJzbW0cWLaPOOrNyfy6VmtdiR2iRn+QYOOMf5/CiigDPlLurGIGGHON2clj9KydQhdkKqg24ydxBoooAwb1lgVnk6AcuRkj6CuWvNalOVtFKr/fbBJoooAxZWmmcvKzOx7sc0zY/pRRQAeW3pR5belFFAEsMbbTx3ooooA//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Courtney D Stephenson, DO.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1235=[""].join("\n");
var outline_f1_13_1235=null;
var title_f1_13_1236="Chronic obstructive pulmonary disease (COPD), including emphysema";
var content_f1_13_1236=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/13/1236/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/13/1236/contributors\" id=\"au1818\">",
"       Stephen I Rennard, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/13/1236/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/13/1236/contributors\" id=\"se5969\">",
"       James K Stoller, MS, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?1/13/1236/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/13/1236/contributors\" id=\"de1810\">",
"       Helen Hollingsworth, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?1/13/1236?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      COPD OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     COPD, or chronic obstructive pulmonary disease, is a condition in which the airways in the lungs become broken down and narrowed, often due to smoking cigarettes. Sometimes the air sacs are also damaged. As the lungs become more damaged over time, it becomes increasingly difficult to breathe through the narrowed airways (also known as bronchial tubes). When the damage is severe, it may also become difficult to get enough oxygen into the blood and to get rid of excess carbon dioxide. These changes all lead to shortness of breath and other symptoms. Unfortunately, the symptoms of COPD cannot be completely eliminated with treatment and the condition usually worsens over time.",
"    </p>",
"    <p>",
"     The term COPD is often used interchangeably with the terms chronic bronchitis and emphysema because chronic bronchitis and emphysema are the most common forms of COPD. Also, the current treatments for COPD, chronic bronchitis, and emphysema are similar. In the discussion that follows, chronic bronchitis and emphysema are referred to collectively as COPD.",
"    </p>",
"    <p>",
"     This article reviews the risk factors, symptoms, and tests used to diagnose COPD. An article that discusses treatment of COPD is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/52/14148?source=see_link\">",
"      \"Patient information: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      COPD CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     To understand why COPD develops, it is important to understand how the lungs work. Normally, air that we breathe passes from the nose and mouth through the airways to the tiny air sacs of the lung, called alveoli. In the air sacs, oxygen that we breathe passes through the walls of air sacs into the bloodstream (",
"     <a class=\"graphic graphic_figure graphicRef67527 \" href=\"UTD.htm?40/17/41237\">",
"      figure 1",
"     </a>",
"     ). Carbon dioxide passes in the reverse direction, out of the bloodstream, back into the alveoli, and is then eliminated by breathing out (",
"     <a class=\"graphic graphic_figure graphicRef73121 \" href=\"UTD.htm?21/46/22245\">",
"      figure 2",
"     </a>",
"     ). Carbon dioxide is a waste product of the body's metabolism, and must be regularly removed.",
"    </p>",
"    <p>",
"     In people who develop COPD, irritating gases and particles are inhaled while smoking or breathing smoke filled air (secondhand smoke) or other fumes or particles. These gases and particles can injure the airways and lungs and cause swelling (inflammation). Over time, the inflammation becomes chronic, damages the lung tissue, and may cause scarring (",
"     <a class=\"graphic graphic_figure graphicRef72806 \" href=\"UTD.htm?28/37/29271\">",
"      figure 3",
"     </a>",
"     ). This lung damage makes it more difficult to breathe in and out and makes it harder for oxygen and carbon dioxide to pass across the walls of the air sacs. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30954?source=see_link\">",
"      \"Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Reasons for airflow blockage",
"     </span>",
"     &nbsp;&mdash;&nbsp;Any disease that interferes with airflow out of the lungs can cause COPD. Most people with COPD have chronic bronchitis and emphysema, and some also have asthma.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h3\">",
"      Chronic bronchitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Chronic bronchitis is the term used to describe people who have a chronic cough that produces sputum. Chronic bronchitis can scar the airways and reduce airflow.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h3\">",
"      Emphysema",
"     </span>",
"     &nbsp;&mdash;&nbsp;Emphysema is the term used to describe damage to the air sacs in the lung. This damage can also restrict airflow.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h3\">",
"      Asthma",
"     </span>",
"     &nbsp;&mdash;&nbsp;Asthma is a chronic inflammatory disorder of the airways. The chronic inflammation leads to recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or in the early morning. Treatment is usually successful in reversing inflammation and airway narrowing. In a minority of people with asthma, the chronic inflammation permanently restricts airflow. When this airway narrowing cannot be completely reversed with treatment, the person is said to have COPD.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      COPD RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     Smoking cigarettes significantly increases the risk of developing COPD. However, approximately 20 percent of people who develop COPD have never smoked.",
"    </p>",
"    <p>",
"     Other factors that increase the risk of developing COPD include an abnormal sensitivity and exaggerated response to inhaled substances (called airway responsiveness), other exposures, such as secondhand exposure to smoke and workplace exposure to environmental dust or organic materials, or exposure to air pollution. COPD can run in families. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/60/6089?source=see_link\">",
"      \"Chronic obstructive pulmonary disease: Risk factors and risk reduction\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Genetic risk factors for COPD include severe deficiency of alpha-1 antitrypsin, a protein that protects the lungs. (See",
"     <a class=\"local\" href=\"#H11\">",
"      'Alpha-1 antitrypsin deficiency'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      COPD SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     COPD usually causes no or mild symptoms at first. As the disease progresses, symptoms usually worsen. The most common symptoms include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Coughing and spitting up phlegm (mucus)",
"      </li>",
"      <li>",
"       Wheezing (a whistling or squeaking noise as you breathe)",
"      </li>",
"      <li>",
"       Shortness of breath with activity or even at rest",
"      </li>",
"      <li>",
"       Fatigue",
"      </li>",
"      <li>",
"       Morning headaches",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      COPD DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     If you have shortness of breath, a chronic cough, or cough up phlegm, your healthcare provider may recommend testing for COPD. The test used to diagnose COPD is a type of a pulmonary (lung) function test (PFT). (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30954?source=see_link\">",
"      \"Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Pulmonary function tests (PFTs)",
"     </span>",
"     &nbsp;&mdash;&nbsp;The pulmonary function test (PFT) that measures airway obstruction is called spirometry, and is the best test for diagnosing COPD. Spirometry can detect COPD even in people who do not yet have symptoms.",
"    </p>",
"    <p>",
"     During spirometry, you take a deep breath in and then blow out as hard and as fast as you can into a tube connected to a machine called a spirometer. The spirometer measures how fast and how much air you can blow out of your lungs. If the measurement is abnormal, the next step is to repeat the test after you use an inhaler (which should improve the measurement). In people with asthma, the test measurements usually return to normal, but in people with COPD, the test measurements may only partially improve.",
"    </p>",
"    <p>",
"     After the diagnosis of COPD is confirmed, spirometry is repeated over time to monitor the status of the disease and the effectiveness of treatment.",
"    </p>",
"    <p>",
"     In some cases, additional pulmonary function tests are performed. These tests include measurements of lung volume, oxygenation, and carbon dioxide. The results of these tests are used to evaluate for lung diseases other than COPD that may be contributing to shortness of breath and to guide treatment.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Measurements of lung volume are usually performed in a box that looks like an old fashioned phone booth. People with more severe COPD may have an increase in lung volume. The same machine can also measure the ability of the lungs to transfer gases like oxygen and carbon dioxide. With emphysema, the ability to transfer gases is typically reduced.",
"      </li>",
"      <li>",
"       Oximetry measures the amount of oxygen in the blood using a device called a finger oximeter, which clips onto the finger like a clip-on earring. Oximetry may also be checked during exercise, such as walking on level ground or climbing stairs. When the oxygen saturation drops to 88 percent or below, supplemental oxygen is usually prescribed. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?13/52/14148?source=see_link\">",
"        \"Patient information: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       An arterial blood gas sample may be obtained to determine if you have problems clearing carbon dioxide from the blood. Arterial blood gas is usually obtained by taking a blood sample from the artery in your wrist.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Alpha-1 antitrypsin deficiency",
"     </span>",
"     &nbsp;&mdash;&nbsp;Alpha-1 antitrypsin deficiency is a genetic disorder which causes 2 to 3 percent of the cases of emphysema in the United States. All adults who have symptoms of COPD should be tested for alpha-1 antitrypsin deficiency. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6281?source=see_link\">",
"      \"Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/62/16361?source=see_link\">",
"      \"Treatment of alpha-1 antitrypsin deficiency\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      COPD TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The first and most important part of any treatment plan for COPD is for smokers to stop smoking. This is true regardless of how long ago you were diagnosed with COPD and how severe your disease is. Studies of people with COPD show that worsening of the disease is slowed in people who stop smoking. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"      \"Patient information: Quitting smoking (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Currently, there is no cure for COPD; however, many treatments are available for the symptoms and complications of this disorder. Most patients require ongoing treatment to keep symptoms under control.",
"    </p>",
"    <p>",
"     A separate topic discusses the treatment of COPD. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/52/14148?source=see_link\">",
"      \"Patient information: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27016093\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27016101\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/59/5043?source=see_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/46/6883?source=see_link\">",
"      Patient information: Shortness of breath (dyspnea) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/30/40418?source=see_link\">",
"      Patient information: Pneumothorax (collapsed lung) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/0/43011?source=see_link\">",
"      Patient information: Cough in adults (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/48/15107?source=see_link\">",
"      Patient information: Chronic bronchitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/1/32785?source=see_link\">",
"      Patient information: Atelectasis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/6/31842?source=see_link\">",
"      Patient information: Chronic pulmonary aspergillosis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/11/43186?source=see_link\">",
"      Patient information: Breathing tests (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/11/24755?source=see_link\">",
"      Patient information: Medicines for chronic obstructive pulmonary disease (COPD) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/9/19603?source=see_link\">",
"      Patient information: Lung transplant (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27016134\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/52/14148?source=see_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/21/8538?source=see_link\">",
"      Arrhythmias in COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28568?source=see_link\">",
"      Bullectomy for giant bullae in COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30954?source=see_link\">",
"      Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/60/6089?source=see_link\">",
"      Chronic obstructive pulmonary disease: Risk factors and risk reduction",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/20/18762?source=see_link\">",
"      Delivery of inhaled medication in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7866?source=see_link\">",
"      Management of infection in acute exacerbations of chronic obstructive pulmonary disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36454?source=see_link\">",
"      Dynamic hyperinflation in patients with COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link\">",
"      Lung volume reduction surgery in COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23641?source=see_link\">",
"      Management of acute exacerbations of chronic obstructive pulmonary disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=see_link\">",
"      Management of stable chronic obstructive pulmonary disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/30/17898?source=see_link\">",
"      Management of the patient with severe COPD and cardiovascular disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/59/8120?source=see_link\">",
"      Mechanical ventilation in acute respiratory failure complicating COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/33/35351?source=see_link\">",
"      Chronic obstructive pulmonary disease: Prognostic factors and comorbid conditions",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/39/19063?source=see_link\">",
"      Nocturnal ventilatory support in COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/39/43639?source=see_link\">",
"      Nutritional support in advanced lung disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/26/21927?source=see_link\">",
"      Oxygen conserving devices",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38840?source=see_link\">",
"      Pulmonary rehabilitation in COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/33/33305?source=see_link\">",
"      Role of anticholinergic therapy in COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/21/5463?source=see_link\">",
"      Role of inhaled glucocorticoid therapy in stable COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/28/25031?source=see_link\">",
"      Role of methylxanthines in the treatment of COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34648?source=see_link\">",
"      Role of mucoactive agents in the treatment of COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/7/10360?source=see_link\">",
"      Role of systemic glucocorticoid therapy in COPD",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/63/3064?source=see_link\">",
"      Use of oxygen in patients with hypercapnia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6281?source=see_link\">",
"      Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/62/16361?source=see_link\">",
"      Treatment of alpha-1 antitrypsin deficiency",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/copdchronicobstructivepulmonarydisease.html\">",
"      www.nlm.nih.gov/medlineplus/copdchronicobstructivepulmonarydisease.html",
"     </a>",
"     , available in Spanish)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Heart, Lung, and Blood Institute",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nhlbi.nih.gov/health/dci/Diseases/Copd/Copd_WhatIs.html\">",
"      www.nhlbi.nih.gov/health/dci/Diseases/Copd/Copd_WhatIs.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Lung Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.lungusa.org/\">",
"      www.lungusa.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Alpha-1 Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.alphaone.org/\">",
"      www.alphaone.org",
"     </a>",
"     )",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Patient Support",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are a number of online forums where patients can find information and support from other people with similar conditions.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <a class=\"external\" href=\"file://about.com/\">",
"        About.com",
"       </a>",
"       COPD Forum",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://copd.about.com/forum\">",
"      file://copd.about.com/forum",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?1/13/1236/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 28, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?1/13/1236?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Executive summary 2006. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from file://www.goldcopd.org. (Accessed April 17, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1236/abstract/2\">",
"      Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1236/abstract/3\">",
"      Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007; 147:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1236/abstract/4\">",
"      U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 148:529.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f1_13_1236=[""].join("\n");
var outline_f1_13_1236=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           COPD OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           COPD CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           COPD RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           COPD SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           COPD DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           COPD TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/17/41237\" title=\"figure 1\">",
"           Normal lung anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/46/22245\" title=\"figure 2\">",
"           Air exchange lungs PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/37/29271\" title=\"figure 3\">",
"           Alveoli COPD PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f1_13_1237="Pelvic floor dyssynergia";
var content_f1_13_1237=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F54087&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F54087&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Dyssynergic defecation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 307px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEzAd4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK8z/aB1nUtF8G6e+mXk2nx3OrWtreXsLFWt7dmO59w+7yFGf8Aar0yobu2gvLaS3vIIri3kG14pUDqw9CDwaAPLfG+up8N7K2Tw7fT395q2oWlkseq6hLeRWPm7wJ23uZNp2HjeASvGMHPPXXxd8SQaxBogt9He+XxRHoE16IJfJkRxw6R+ZlXHdS7CvXrXwl4ctNLudNtfD+kQadcndPax2UaxSnjlkC4boOo7U+Hwt4fgtrO3g0LSo7eym+020SWkYWCX/nogAwrf7QwaAPnzWviB4v8Qv4ZWLUbbTLu18atoc7WcUyw3O0ptZ087JjO47oy3P8AeFdb/wALL8Yx6v43l+waFc6H4UaQXIjWaO6nxCzJsGWUDeBuJPC5wCa9Un8J+HLiyns59A0iW0uLg3c0D2UbJJMesrKVwXP9481b07RdL003J07TbK0NzgzmCBI/NwMDdgfNgcc0AfPPjv4ha1q/gfVtH1qLTLhNW8KLrcU2nRugtgzgeVJudt3X74288bea958Cf8iP4e/7B1v/AOilotfCPhu0tby2tfD+jw296MXUUdlGqTj/AGwFw345rZghit4I4beNIoY1CJGihVVQMAADoAKAH0UUUAFFFFABRRRQAUUUUAFFFFAHHfGO8udP+Fnii7sLia2uobCV45oXKOjAcFWHIPuK8z8H3XiPRLAeLr+71fTfDEXhqOSdtYvG1L7ReEAiZIhMzKhyPl3ITnGF6j3a+s7bULOa0v7eG6tZlKSwzIHR1PUMp4I+tNNhZnTv7PNpbmw8ryfsxjHleXjGzbjG3HGMYxQB8z+Mfir4s1Twl4y0/cmmz2enWmp219bQtaztDJJHxtS4l2Eh1IO/O3IKjPHR6t8QNZ8J67A2orHqstt4N/tRmie4hWSTztqgxGZ4+ARucqXOCQQPlHsFl4M8L2MVxFZeG9Fto7iIwzJDYxIJYyc7GAXlc84PFTWHhbw/pzRtp+haVatHA1shgtI0KxMxZoxgcKWJJXoSSaAPFNV+LfjrSPA+p69f6Lo6xiwtr7T5mZAsnmTRRuphjuZHZQJMh8ryOQCcVV+JPxC8VS+H/iRowurWyu9DgsLqG+06OWGQxzFGKA+YSrDcBvBwQG+Xnj2yLwP4TiguoIvDGhJBdgC4jXT4gswDbhvG3DYYAjPfmrsnh7RZJb6STSNOeS+jWK7ZrZCbhFGFWQ4+YAcAHIAoAh8Fm+bwnpL6tdRXd69sjvNFE0YbIyOGdznBGTu5OTxnA2qqaVptjpFjHZaTZW1jZR52W9tEsUaZJJwqgAZJJ+pq3QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBxPxBsNUvdR0iXS79IobRZ5rqy/tKWya5TC4w0YJwDnk8DPvWh4J1dNW8D2upaZa3P7yKRo7e6uWlcsGYbTK5JIJHBPYj6Vsapo+masIxqunWd6I87PtMCybc9cbgcdKw9MvNZ1LQrV4tA0dLG6tlZbeTUHAEbKPkZfs+OhwR0rDl5ajl3/wCAesqyrYSNG2sGtW0lZ8zta6u3ffRq1r2Zxj/E7VNP0nU5NXs1i1i1iST+zmsZIfLDSBA5lMjB0G4dlyT9au3njjxJplmy6lptjHPcXdtbWdwzoECS7v3kkaTSEKNhx8+Gz14NdHZaVeWMM0Nl4U8MW8M4xKkN2yLIPRgLbn8aitbFLCa20258K6BbafqcxhlWzk3glY3kBdDAoYfIRye4rFQqfzfn/l/kek6+Cd7UE9b7x2VnpaWlrPT3r31d9TqNOS9jt9upXFtcT5Pz28DQrjsNpdzn3zVqqunafZaZb/Z9Ns7e0g3FvLt4ljXJ6nAAGatV2LRHzVRqUm1+VvwWiCiiimQFFFFABRRRQAUUUUAFFFFABXKfETT9T1PTtPttF1GOxuvtqSMGu3tjPGqtujDIC2TweB2z2rq6qalptjqkAg1OytryENuEdxEsig+uGBGaipHmi4nRhK3sK0avbyv+Bzvw31WHVdIvTDb3UD217JbSrPeyXgLqBkpK5JK9PQdeOa5t/iFqunX+ow6/Y/Y54Yria2sRZuTcJGpIK3AkKngEn5BwPpXb6hK2iW+m2Wh6baH7RObeOHf9nijAjeQn5UbH3MYx1NZdhpN5p0zy6f4U8MWsrja7wXZRmB7Ei25rCUZ2UU9VvoerSq4dzqVZ07xl8Kclf75O+vo32a3OVHxD8RWfh651nUdItZLJrBbq1aN0Qs5dFIKiWRmQbwS2FPGCATXougnUns1l1S7sblpVV0NnbtEqgjJ5aRt3seKy/C+n2G/VVbw9pWnXUc32Wf7IissymNJOW8tCR8+CCOoNbOl6RpukrIulafZ2SyEFxbQrGGI6Z2gZqqUJrVu/9f16GWYYjDyThTpqEr30S1VlZbu1u6+K+qReoooroPHCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAM7X9VTRdMa8kt57n97FAkMG3e7ySLGoG5lX7zjqRWd/wkGpf9Chrv/f6y/wDkio/iHKsHhyKZw5SPUtOchELsQL2E8KoJJ9gCTVn/AISrT/8An31r/wAE15/8aqXKMd2a06FWqr04t+iuUrDxbd38DTWnhTXZI1lkhJ8yzGHjdo3HNx2ZWGe+OOKH8W3ceowWL+FNdF1NFJPGnmWfKIUDHP2jHBkT8+OhrO8FeJLGDR7hHg1Yk6lqD/JpV04w15Mw5WMjODyOoOQcEEVFqvivTLfxnpl9cLqUNrBpd95jy6ZcptBktTnBjztAU5boOMkZGV7WHdGqwWJbsqcvuZrX/i27sIFmu/CmuxxtLHCD5lmcvI6xoOLjuzKPbPPFWP8AhINS/wChQ13/AL/WX/yRXLeM/G1nd6dZx2Wma7c2z39jMLtNNlWEhbuJtoLAEsduAADkkDvXT2/jPS5y6iHWBLGQJIzpN0WjJGQGAjOMjBpKtTfUuWXYqKu6b+78+3zIbDxbd38DTWnhTXZI1lkhJ8yzGHjdo3HNx2ZWGe+OOKH8W3ceowWL+FNdF1NFJPGnmWfKIUDHP2jHBkT8+OhrO8FeJLGDR7hHg1Yk6lqD/JpV04w15Mw5WMjODyOoOQcEEUXniSxbx1pE4g1bYmm3qEHSroNlpbUjC+Xkj5TkgYHGcZGX7SHdGf1LEf8APuX3M0dS8W3em6ddX174U12K1tYmnmfzLM7UUEscC4ycAHpVj/hINS/6FDXf+/1l/wDJFY3j7xJY3HgXxHBHBqweTTblFMmlXUagmJhyzRgKPckAd63v+Eq0/wD599a/8E15/wDGqPaQ7oPqWI/59y+5lKw8W3d/A01p4U12SNZZISfMsxh43aNxzcdmVhnvjjih/Ft3HqMFi/hTXRdTRSTxp5lnyiFAxz9oxwZE/PjoazvBXiSxg0e4R4NWJOpag/yaVdOMNeTMOVjIzg8jqDkHBBFF54ksW8daROINW2Jpt6hB0q6DZaW1Iwvl5I+U5IGBxnGRk9pDug+pYj/n3L7maOpeLbvTdOur698Ka7Fa2sTTzP5lmdqKCWOBcZOAD0qx/wAJBqX/AEKGu/8Af6y/+SK5bxz440vUvAGtjSbfVr+K6sJ4hPDp8wij3RsN7OyqAozknPQVq2Xj4BpBrGh6zYRIu83K2FxJCB6EmJWB/wCA496n29Pub/2VjLN+zenTr92/4Fy18W3d1PeQweFNdeS0lEM48yzGxyiyAc3HPyyIcj19c0P4tu49RgsX8Ka6LqaKSeNPMs+UQoGOftGODIn58dDWV4U8VaZJqPiW6hXU5re61COaJ4dMuZAyGztgD8sZxnGQDgkEHoQTJeeJLFvHWkTiDVtiabeoQdKug2WltSML5eSPlOSBgcZxkZr2sO6MXgsSnZ05fczR1Lxbd6bp11fXvhTXYrW1iaeZ/MsztRQSxwLjJwAeldVXB+P/ABLYz+BPEkKQasHk025QF9JukUExMOWaMAD3JAFd5VKSlszGpSqUnapFr1VgooopmZX1K9t9N066vr2TyrW1iaeZ9pO1FBLHA5OAD0rBn8b6PboHuI9aiQusYZ9FvVBZmCqvMXUsQAO5IFSfEf8A5J54o/7Bd1/6Jasbxp4r8PXGj26W+vaTK41KwkKpeRsQq3kLMcA9AoJJ7AE1Lko7s1p0alW/s4t27K5qz+N9Ht0D3EetRIXWMM+i3qgszBVXmLqWIAHckCiXxvo8MkKSx60jzP5cStot6DI20ttUeVydqscDsCe1ZXjTxX4euNHt0t9e0mVxqVhIVS8jYhVvIWY4B6BQST2AJo8R+K/D02seFni17SXSHUnklZbyMhF+x3K7mOeBuZRk9yB3pe0h3Rp9SxH/AD7l9zNVvG+jrcJbtHrQnkRnSM6Le7mVSAzAeVkgFlBPbcPWhfG+jtcPbrHrRnjRXeMaLe7lViQrEeVkAlWAPfafSsq88V+Hm8daRcLr2kmCPTb1HkF5HtVmltSoJzgEhWwO+0+lFn4r8PL461e4bXtJEEmm2SJIbyPazLLdFgDnBIDLkdtw9aPaQ7oPqWI/59y+5mqvjfR2uHt1j1ozxorvGNFvdyqxIViPKyASrAHvtPpRF430eaSZIo9ad4X8uVV0W9JjbaG2sPK4O1lOD2IPesqz8V+Hl8davcNr2kiCTTbJEkN5HtZlluiwBzgkBlyO24etHhzxX4eh1jxS8uvaSiTakkkTNeRgOv2O2XcpzyNysMjuCO1HtId0H1LEf8+5fczVg8b6PcIXt49alQO0ZZNFvWAZWKsvEXUMCCOxBFEHjfR7hC9vHrUqB2jLJot6wDKxVl4i6hgQR2IIrK8F+K/D1vo9wlxr2kxOdSv5Ar3kakq15MynBPQqQQe4INHgvxX4et9HuEuNe0mJzqV/IFe8jUlWvJmU4J6FSCD3BBo9pDug+pYj/n3L7mdnpt7b6lp1rfWUnm2t1Es8L7SNyMAVODyMgjrViud+HH/JPPC//YLtf/RK10VWcwUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFUNU1nTNJ8r+1dRsrHzc+X9pnWLfjGcbiM4yPzpNpasqEJVHywV35GR8RZlt/Dcc8gkKR6lp7sI42kYgXsJ4VQSx9gCT2qT/hMNN/59td/8Ed7/APGag8f3lsnha3vXuIVs11DTpjOXAjCfbIDu3dNuOc9MVP8A8Jz4T/6GjQv/AAYQ/wDxVMlq2jMHwV4q0+DR7hHt9aJOpX7/ACaNeOMNeTMOViIzg8jqDkHBBFYnjvxFYXvirw9GLfVvJeKSOVJNKukZ1+1WbkBWjBYERsDgHqAfvCtzwV4y8MW+j3CXHiPRonOpX8gV76JSVa8mZTy3QqQQe4INY3irxR4eu/iT4JuYfEGkPZ2yXxuJVvYykeUj2BmzgZZeM9cGoqfDY6cHpWUu139yb/Q2PGvirT59Ht0S31oEalYP8+jXiDC3kLHlogM4HA6k4AySBVPxhqOg3OzVE0/WRqMdxaMssmk3qLiO4RhwYwucFhnqc4HYVd8a+MvDFxo9ulv4j0aVxqVhIVS+iYhVvIWY8N0CgknsATT/ABl4y8MXPhu8jt/EejTS/IypHfRMxw6ngBsk8dqVVJwdy8BOUMRDldrtL5XWhH4K8VafBo9wj2+tEnUr9/k0a8cYa8mYcrERnB5HUHIOCCKLzxVp7eOtInFvrWxNNvUIOjXgYlpbUjC+Vkj5TkgYHGcZGV8FeMvDFvo9wlx4j0aJzqV/IFe+iUlWvJmU8t0KkEHuCDSXnjLww3jrSLhfEejGCPTb2N5BfRbVZpbUqCd2ASFbA77T6VocYvj7xVp9x4F8RwR2+tB5NNuUUyaNeIoJiYcs0QCj3JAHet3/AITDTf8An213/wAEd7/8ZrC8feMvDF14F8R29t4j0aaeXTbmOOOO+iZnYxMAAA2SSeMVu/8ACc+E/wDoaNC/8GEP/wAVQBg+CvFWnwaPcI9vrRJ1K/f5NGvHGGvJmHKxEZweR1ByDggis3xl4utE1mK4tbfVvNTRdRijEmlXURMjva7PvRjjIwW6DIyRkZ0/BXjLwxb6PcJceI9Gic6lfyBXvolJVryZlPLdCpBB7gg1h+OPFXh6+8X+Gkg13SpbVo5UuJo7yMpEBcWkvzsDhdwhYc9eaio7RZ0YSKlXhfa936LV/gafizX9Mh+Gms6bbW+tAJpE1vGZNGvI1GISoyzRAKPckAd66b/hMNN/59td/wDBHe//ABmsLx94y8MXXgXxHb23iPRpp5dNuY44476JmdjEwAADZJJ4xW7/AMJz4T/6GjQv/BhD/wDFVaVtDCUnJuT3ZxHwn8SWNlot3HNBqzMXtOYdKupRxp9op5SMjqpx6jBGQQTs3nirT28daROLfWtiabeoQdGvAxLS2pGF8rJHynJAwOM4yM5Hww8S+HtJi8SW954g0eFP7Xk+zF76NRJAsMKRsuW5GExkcZBHate88ZeGG8daRcL4j0YwR6bexvIL6LarNLalQTuwCQrYHfafSop/Ajoxv+8VPV/mL4+8VafceBfEcEdvrQeTTblFMmjXiKCYmHLNEAo9yQB3rv64Dx94y8MXXgXxHb23iPRpp5dNuY44476JmdjEwAADZJJ4xXf1ZzBRRRQBzvxH/wCSeeKP+wXdf+iWrC8a+MvDFxo9ulv4j0aVxqVhIVS+iYhVvIWY8N0CgknsATW78R/+SeeKP+wXdf8AolqPHn/IDtv+wppv/pbBQBheNfGXhi40e3S38R6NK41KwkKpfRMQq3kLMeG6BQST2AJo8R+MvDE2seFni8R6M6Q6k8krLfREIv2O5Xc3zcDcyjJ7kDvWz8Q5o7fw5FPO6xwx6lpzu7HAVRewkk+2Kx9S8SW2p+LPBtpFa30Pm3stzBLcQGNZkWzuAxUH5hjen3gPvDGalySdmawo1Jxc4q6Q288ZeGG8daRcL4j0YwR6bexvIL6LarNLalQTuwCQrYHfafSiz8ZeGF8davcN4j0YQSabZRpIb6LazLLdFgDuwSAy5HbcPWt6+/5KHon/AGC7/wD9HWdFj/yUPW/+wXYf+jryqMjBs/GXhhfHWr3DeI9GEEmm2UaSG+i2syy3RYA7sEgMuR23D1pfDnjLwxDrHil5fEejIk2pJJEzX0QDr9jtl3L83I3KwyO4I7Vu2P8AyUPW/wDsF2H/AKOvKPC//Ic8X/8AYUj/APSK1oAwPBnjPwxa6LcrceItHjf+0dQkCNex7irXkzKQM5IKkEY6gjHWuS8L+LrKS802+k8S6ZbaWusXzpZG6SN2ime5bzZwTlcF0AB47/xDHVqRL4HuNPUbpdR1y9s0T+8G1CYv+UYkY+ymn6f8uiafJ02eJ7vn0ze3C/rux+NYVLt+lj1MGowim1dz5lr0Vunq3a/lpqb3w4/5J54X/wCwXa/+iVroq534cf8AJPPC/wD2C7X/ANErXRVueWFFFFABRRRQAVz2peMdG0vWNU07Ubg282naWNYnLLkG23SKzKBlm2mPkAfxLjJOB0NfMv7Zutahos3hRtKvJLZ7q11KzuAh4lglWBXRgeCCPXoQCMEAgA+kdMv7TVdPt77TbmK6s7hBJFNEwZXU9wRVmvj34L/G5PCHww1jTtaRxe2kTPorvE8kU7lSqxMFxtAZck7hkbsYI+ax4h+N6eMrn4VodSj01l1aKfxDZoWjgQx3EXluzuACmA8m3cQvG4kqDQB9dUUUUAFFFFABRWDqHjPwvpupPp2o+JNFtNQQqrW099FHKpIBAKFsjIII47it4HIyOlABRRVPS9TsNWgefS761vYUkaJpLaZZFV16qSpOCO4oAuUUUUAFQ3d1BZ20lxeTxW9vGMvLK4VVHqSeBU1Y/i29/s/w/d3Q0qbVmj2lbOGPzGkbcNvGD0ODnBxjPapk+VNmlGn7SpGC6tL+r6Fm31rS7nT5L+31KylsYs77hJ0aNcdcsDgVLp2oWWp232jTbu3u4MlfMt5VkXI6jIJFeJf2Pq+qeF9Y1G5s719XvtRt768sFsZolWFGPyJvUCRuckAnoOvfvvh/a3R8S+L9Va2uLbT7+5iNstxE0TPsQh32MAwBJHUDNc1OvKckmt/+D/l+J7eMymjh6U5xqXcf/tdPP4m09mo3trp3NFeM6zF4p+26rcWza/vTxBGkAjebZ9lIO7CfdKdOcYHtQ0Xikah9hU6/9gTxOiK++fcbM5BzJncY+nJOPej61rblYLI04qXto7X/AAT7+a/HsezVntrWlLZzXbanYi0hk8qWY3CbEfONrNnAOSOD615PpUfiuCbSZXOvsYvET2riZpmU2J24ZweGXlsO2frxWbqPhrW5Ph34lVE1cSSay8kenLbKRMplQ+YB5fmEY5yGxx9amWKla6ibU8ipc6jUrKzcV97aff17dz2vUdZ0zTJY4tS1GytJJfuLPOsZf6Anms64kSXxtoskTq8baZelWU5BHm2vINcTqK6z4f8AE3i+/TT5bu5vo0ewn+wSXkciKhzbnyyDHltvJ44z6V0uitcNrPhZr60is7o6NdGW2iTYkTb7TKgZOAPStPauTs11/U5XgY0IxqQle8X17wbdl5bPXda22LfxFnhtfDcdxcyxwwRalp8kkkjBVRRewksSeAAO9Sf8Jz4T/wCho0L/AMGEP/xVHjz/AJAdt/2FNN/9LYK6Kuk8Q4DwV4y8MW+j3CXHiPRonOpX8gV76JSVa8mZTy3QqQQe4INR6n4q8L3HjnQbweI9FMFrZ3gaQX0W1WZoAqk7sZIDEA9dp9K6HwH/AMgO5/7Cmpf+ls9Z811u+MVpa5/1egzS4/3riIf+y1E+i8zpwujlLtF/irfqUvGvjLwxcaPbpb+I9GlcalYSFUvomIVbyFmPDdAoJJ7AE0/xr4y8MXPhDWYrXxHos1w1pL5cUd9EzOwUkKAGySSAOPWtrx5/yA7b/sKab/6WwVu3dul1aTW8ozHMjRsPYjBpyXNFozoVFSqxqPo0/uZwngvxj4YttHuEuPEejROdSv3CvfRKSrXkzKcFuhUgg9wQaLzxl4Ybx1pFwviPRjBHpt7G8gvotqs0tqVBO7AJCtgd9p9KufB1J4/h/Ypd/wDHwLi88z/e+1S5/WtK+/5KHon/AGC7/wD9HWdOL5kmKtT9lUlTfRtfcYXj7xl4YuvAviO3tvEejTTy6bcxxxx30TM7GJgAAGySTxit3/hOfCf/AENGhf8Agwh/+Ko+I/8AyTzxR/2C7r/0S1dFTMzgPBXjLwxb6PcJceI9Gic6lfyBXvolJVryZlPLdCpBB7gg1m+IvE/hu6+I/g+9j8QaM9vZw35llF7GVjLpGqgnOATzjPXBrr/Af/IDuf8AsKal/wCls9N1FFk+IOhHcN0Wn3r478yWw/qaipt81+Z04T43/hl/6SzE8feMvDF14F8R29t4j0aaeXTbmOOOO+iZnYxMAAA2SSeMVu/8Jz4T/wCho0L/AMGEP/xVHxH/AOSeeKP+wXdf+iWroqs5jzLwv440BPGfjKOfXdJisWubaa3me8jWOYm3RX2Nuw2CgBx0NXbzxl4Ybx1pFwviPRjBHpt7G8gvotqs0tqVBO7AJCtgd9p9KPCny/Fbxr38xoPw228H/wAX+lb19/yUPRP+wXf/APo6zqIbNebOnFayi+8Y/gkv0MLx94y8MXXgXxHb23iPRpp5dNuY44476JmdjEwAADZJJ4xXf1zvxH/5J54o/wCwXdf+iWroqs5gooooA534j/8AJPPFH/YLuv8A0S1YXjXwb4Yt9Ht3t/DmjROdSsIyyWMSkq15CrDhehUkEdwSK3fiP/yTzxR/2C7r/wBEtXJ/FHwx4Y0jwZcX1v4d0WF4Lm0YuljEp2/aYgwyF6FSQfUEik3ZXKhFzkordmZ4p0XQL+e1Gg+HdGh02z1SzhuryOxiXz2a6ijaFCF5ADncw442884veK/BmhRfEDwOtt4f0mPT5ZbxLqJLONUlP2csm9QuGwVYjPSptZ8F+HrPwbo+7QdJ+1C60yKWY2ce991zAr7mxk7gWByecnPWtLXvB3hiHVfDiReHNGRJr945VWxiAkX7LO21ht5G5VOD3APasbPlu93b8z0VUi6rpw+GKnb/AMBer83/AJLoRXng3wwvjrSLdfDmjCCTTb2R4xYxbWZZbUKSNuCQGbB7bj60Wfg3ww3jrV7dvDmjGCPTbKRIzYxbVZpboMQNuASFXJ77R6UXng3wwvjrSLdfDmjCCTTb2R4xYxbWZZbUKSNuCQGbB7bj60Wfg3ww3jrV7dvDmjGCPTbKRIzYxbVZpboMQNuASFXJ77R6VueYFn4N8MN461e3bw5oxgj02ykSM2MW1WaW6DEDbgEhVye+0elL4c8G+GJtY8UpL4c0Z0h1JI4laxiIRfsds21fl4G5mOB3JPeks/BvhhvHWr27eHNGMEem2UiRmxi2qzS3QYgbcAkKuT32j0pfDng3wxNrHilJfDmjOkOpJHErWMRCL9jtm2r8vA3MxwO5J70AYmi+FfD0raOr6DpJD65qiPmzjO9EkugiHjlRhcDoNi46CltvCvh4eFluP7B0kyr4hkgLfY48mM6o0WzOPuhSBjpgY6UaB4U8PS3WlpJoOksr6nqyuDZxncsdxMqKeOVUYAHQYHoKSPwr4dHgm9uf7B0rzY9YuU837HHuEa6i67c4ztCDbj+7x0rGXwz/AK6I9Kl/Fw/y/wDS5HcfDj/knnhf/sF2v/ola6Kud+HH/JPPC/8A2C7X/wBErXRVseaFFFFABRRRQAV+en7QPjceO/iVfXsKQCxsQdPs3hcuJoY5HIkLd9xZmGBwCBzjJ/QuvyroAlineKKaNRGVlUKxaNWIAIPykjKnIHIwcZHQkVFRRQB+hX7O/i6Txl8KdJvLy5+0alabrG8c7yxkj+6WZslmaMxszAkEsenIHpVeH/seaVPp/wAIPtM7RmPUtQnuoQpJIQBITu44O6FvXjH0r2q9u7awtJbq+nit7aFS8ksrhERR3JPAFAE1U7vU7G0vrOzuruCK7vGZbeFnAeUqMnaOpwBzXLf27rPin5PCUP2DTG661fQn5x628JwX9nfC9CA4rY8O+F9O0KSW5hEt1qc4AuNQu28y4mx2L9l9EXCjsBQB4D8RvDni658SfF2TSNImuNL1D+y1ljNm5lvIUiG/7K/3S6kYI2v14wQAb/iqHxZfeIfLtL7xVoXhgaVb/wBjvaaZezzRuoXekscEibZcgj98GXHTHU/RlFAHi3h7+15fHOqjx63i1kZ7X+yWsUvIrUqUG4yLakorb/vCUkDnnFef6RoXibw74C1C30iz8WWms2vidbi5jg+2ETWW8jMePklznLbMsQAWzxX1TRQB826lJ45v77VHtR4ujs5vGlp5OFuoiNPKyb9o4Kw/dz0AOM4NMtoPHtjcwzQt4ul+x+ODZwpNJcyq+lEsSzhifMj6fvGzjswr6VooAKKKKACiiigAooooAKKKKACsHWrTU/7d0/UtKgsrjyLa4t5I7m5aH/WNCwIKxvnHlHjA6it6iplHmVjWjVdKXMlfda+asct4/hW78LW8F/BC6zahpyTQn95GwN5AGXkDcvJHI5Hap/8AhBvCf/Qr6F/4L4f/AImoviPHHN4ZSKZnSJ9R09WZJGjYA3kIJDKQVPuCCK4Twhaapf2Tvcab4gvF3ecJz4iuoN0cgEkaovmYYhGAJJHI6k5xMqig0n1NqOEniITqQaXLbdpb37s6PwV4N8MXGj3D3HhzRpXGpX8YZ7GJiFW8mVRyvQKAAOwAFYkHhXw9L8YZLX+wdJ+wJpco+z/Y4/K8xXt237duN2JcZxnHeo/ClgtxpssFlpfiWW8F/emQSa1d20Ma/apeDIspV37HbuywJY87jPpPhNP+E2tH1Mavay3lrfzCL+2LhpI0SSzRAZFlycjLHk9VB+6oVcylJWLVGVCnN1LK6SWqvunsne1lvt95seNfBvhi30e3e38OaNE51KwjLJYxKSrXkKsOF6FSQR3BIrd/4Qbwn/0K+hf+C+H/AOJrB8a+FdPg0e3dLjWiTqVgnz6zeOMNeQqeGlIzg8HqDgjBANb3/CH6b/z867/4PL3/AOPVqcJyXw78O+GtUg19Lrw5o0j2etXlspksYmPliUlQMr0AO0egXHar954N8ML460i3Xw5owgk029keMWMW1mWW1CkjbgkBmwe24+tc3oOj6doz3N/qU+rR6Rd317A88OqXaGGaO8nVS+yQFg67Rk5O5ecl81PPYpceMdMay0rxPJbGwu2TztbuYZpQJLbLIHmDKBkfKxTdnJHyisYzUVys9Cvh6laXto7SS1bSV7a6trW99N+uxvePvBvhi18C+I7i28OaNDPFptzJHJHYxKyMImIIIXIIPOa3f+EG8J/9CvoX/gvh/wDia4PxxawR+EtcjXR/GEVx9hnb/SdXnkhVBG252YXDxkAfwHlumMZNbUWg3lmfK1HTdev27XGmeIrlUb6pNcqVPsC31qvaL+kzL6nUSu2l/wBvL797f15Ml8FeDfDFxo9w9x4c0aVxqV/GGexiYhVvJlUcr0CgADsABWfL4Y8NH4sW2mL4f0YWw0SW5aEWUWwv58ahiu3GQNwB9zVLwpol9PpNw9rpmoFRfXvE3ii8tzkXUo27YywLDoWz8xBJJzkwaJoKan8TLe5uLXX9Ps5NIniRLnVLkXBkimh3/OJd/l/vQAN20lSwHQ0nNSaS/JmtOhKlTqVJNbW0knu0ujfS50nj7wb4YtfAviO4tvDmjQzxabcyRyR2MSsjCJiCCFyCDzmt3/hBvCf/AEK+hf8Agvh/+JrC8feFdPt/AviOeO41ovHpty6iTWbx1JETHlWlIYexBB71u/8ACH6b/wA/Ou/+Dy9/+PVqeecNpHhjw4PiVq1rcaFpJtHmlihiezjKK621i4UDbjOHlb/vs9zW3eeDfDC+OtIt18OaMIJNNvZHjFjFtZlltQpI24JAZsHtuPrVOz8E2GpXfiyFLvVobm31JPss51O5YxSfYrchyDJ8zAsRk844BAAxj/2fcXPivS7WPTNcj1JLC7WdbnXLyOIMJLb545vMLNH3IXruXIyvy5c3I3fqd3sniKcXBq8dHdpdW09baa29V5o6Xx94N8MWvgXxHcW3hzRoZ4tNuZI5I7GJWRhExBBC5BB5zXf15D4v0G+0/wAH+IF1G11W7xp9w6XVprl0YU/dtxLFNPkge28MOw6V69Vxlc5qtJ03ZtP0d/6+eoUUUVRkc78R/wDknnij/sF3X/olq4b4keGrQXui6eLrVWsbmaJrqCfVLqZZ1+2WkWwh5CAMTscjkFVwRXb/ABLYp8O/E5VGc/2ZcjC4zgxMM8kcDr+HGelee+J9ItbrU9LaK28T28UcsCTNe3t2QrPf2QVVkaQjON5wp6qG6qpGdSzXK+v+Z24JSjN1Y/ZT17Pldn9+z7nTeNfCunwaPbulxrRJ1KwT59ZvHGGvIVPDSkZweD1BwRggGs/4iaPZaGPD91DLrDx/2lifzNZvGKQi3naRlJlypCqTkYPUZwSDoeNfCunwaPbulxrRJ1KwT59ZvHGGvIVPDSkZweD1BwRggGs/4ieDreaDSLSwn1Rrm7uLiCMXGrXUq7jY3RXIeQgfMBnjkZByCQXUV4uxlhJKNaLltez9Ho/wNC88K6evjrSIBca1sfTb1yTrN4WBWW1Aw3m5A+Y5AODxnOBgs/Cunt461eA3GtbE02ycEazeBiWlugct5uSPlGATgc4xk55y/hs9N8X6RJ4it9c0u0lsLpYyddu7iUyb7f5SUkJQdBgMQxZcjIFTaNb6UfG+qR63JrGjCWytTZpda9dLLMu+4JZmEuQfSMscYYjGWpe1he1zR4DEKPMo3Xk0/us3e3W23U3bPwrp7eOtXgNxrWxNNsnBGs3gYlpboHLebkj5RgE4HOMZOV8OeFdPl1jxSjXGtARakiLt1m8UkfY7ZvmIlyxyx5OTjA6AAYWgjw5feMdR8691qwilsLU232zWbqCS4HmXGXQmbc6EFCOeNx4BLUWKaDYeI/E0F7L4jFpHexsb2LVLzyIlNrBjzJFl5O4ONxzgAAkDaKPawte5P1HEc3JyO/oP8N+G7GbUtPjefVtrXesfd1W6UjZeMqkESZBwTkjliSWyeaF8N2I+H+tXQn1bzIb3UCq/2rdbCEvJQMr5m0kheSRknk5PNM8BeGoNYuPtqjWE0uGfUkSc6tco0zPeEoUAk3KAisGJwWY5IYjNXdK8G2upeC9YiguNVF091qcMIbVbopuF1OqFk8za3IBOQdxyTkk1PxRlbr/kdCapVqCnpy2v5e83r8jrfhx/yTzwv/2C7X/0StdFXO/Dj/knnhf/ALBdr/6JWuirY80KKKKACiiigAr81Pinp66X8S/FVlFaCzgh1S5EMAj8tUi8xim1ey7SpGOMYxX6V1+cev61deI/ivruoaLIb2XV726t7IXJOZI7gtDGo3EbcJIAMkBcD0xQBw9PijeWRI4kZ5HIVVUZLE9AB6193eCfht4e8LaM1la6fA7zRiO5mkXzHn+UBtxbPynH3R8vJwOa8P8A2hvhbaeG7eLxN4UthZ2kcn+mRpMQI2ZhskjU9BubaQDgfLhQMmgD3L4T6ovh34ceH/C/h3Tb3U9etrYNd20zCNLKaQmSQXEuMR4d2wmGk24+U9a7Oy8IPfXcWo+MbtdYvo2EkNsE2WVq3YxxEncw/vuWb025xXlv7H3i+48Q+Ftd02+5uNOuo5EKRJHEkUiYVEVQAMNE7Hjkvnkk19AUAFFFYT+JrR/EyaHYRTX14nzXjQAGOyXaSplY8BmIACDLc5xjmgDgr/XNdtPjtcaL/bt6+hw6A2tfYvJtwDIJjH5e/wArfsxz13Z744qr4V+Mt54gm8LRf8I5Ba/8JLa3ktix1Ivtlt9+Uk/cjap2feG7Gfumu7n8BeH7jxRJ4ilt71tXkiNu0/8AaNyAYjyY9nmbdmedmNuecZqPSvh34V0d9AlsNL8ltAWcacftEreQJsmTqx3Z3H72cZ4xQB5R4D+Meu2/wz8O6l4ks11jVtZvpLSzeFmVpdrsGaSOGAlAoCgBFkZuuBW9c/GTWUfw9Zw+AdROs6xLdwJY3VybRt0CIwZDNGu5GD/eIXG08EjFbPg/wj8OfE/hCCfw3aSXOgy3TXNsRcXUYgmV2BeEOwaE7i33NuffArX0Dwl4MvpdJ1zRtmpPYTTzWl+upS3f7yQBJSZDI3mHCBfmJxt4xQBxmp/G27019be88Lolro2o22n3hGo5kBlH3kURYbaQRjcM8YPpf174yQ6P4zt9GOn219ZyapHpUl1ZXUztbyuSAJAYFiDAg5QSlhg8cV1eo/DbwnqKasl5pXmLqt1HeXg+0yjzZk+63D/LjPQYHtWY3gD4fX/ii6228Emsw3qavPaRalKDFcHlZ2gWTapPqV596AKXwF1O/wBT07xk2pXt1eNB4nvreE3ErSGONdm1FyThRk4A4Ga9PrJ8OeHNK8NxX0ei2v2ZL67kvrgeY775nxub5icZwOBgegrWoAKKKKACiiigAooooAKKKKAOS+KdmdR8HSWQlaA3N9YwiVM5TddwjcMEcjOetWIfBelQwpFHca4qIoVQNbvQABxwBLgfhSfEWNpvDcccc0kDvqWnqssYUtGTew/MNwIyOvII9Qak/wCEf1L/AKG/Xf8AvzZf/I9KyvcrnfLydDB8FeFdPn0e4d7jWgRqV+nyazeIMLeTKOFlAzgcnqTknJJNF54V09fHWkQC41rY+m3rknWbwsCstqBhvNyB8xyAcHjOcDC+CtD1CXR7hk8U6zCBqV+u1IrMgkXkwLfNATkkZPbJOABgAvND1AeOtIjPinWi7abesJTFZ7lAltcqP3GMHIJyCflGCOcskTxr4V0+DR7d0uNaJOpWCfPrN44w15Cp4aUjODweoOCMEA1vf8Ifpv8Az867/wCDy9/+PVheNdD1CLR7dn8U6zMDqVgu14rMAE3kIDfLADkE5HbIGQRkHd/4R/Uv+hv13/vzZf8AyPQBg+CvCunz6PcO9xrQI1K/T5NZvEGFvJlHCygZwOT1JyTkkmi88K6evjrSIBca1sfTb1yTrN4WBWW1Aw3m5A+Y5AODxnOBhfBWh6hLo9wyeKdZhA1K/XakVmQSLyYFvmgJySMntknAAwAXmh6gPHWkRnxTrRdtNvWEpis9ygS2uVH7jGDkE5BPyjBHOQA8feFdPt/AviOeO41ovHpty6iTWbx1JETHlWlIYexBB71u/wDCH6b/AM/Ou/8Ag8vf/j1YXj7Q9Qh8C+I5JPFOtTomm3LNFJFZhXAib5TtgBwenBB9CK3f+Ef1L/ob9d/782X/AMj0AYPgrwrp8+j3Dvca0CNSv0+TWbxBhbyZRwsoGcDk9Sck5JJovPCunr460iAXGtbH029ck6zeFgVltQMN5uQPmOQDg8ZzgYXwVoeoS6PcMninWYQNSv12pFZkEi8mBb5oCckjJ7ZJwAMAF5oeoDx1pEZ8U60XbTb1hKYrPcoEtrlR+4xg5BOQT8owRzkAPH3hXT7fwL4jnjuNaLx6bcuok1m8dSREx5VpSGHsQQe9bv8Awh+m/wDPzrv/AIPL3/49WF4+0PUIfAviOSTxTrU6JptyzRSRWYVwIm+U7YAcHpwQfQit3/hH9S/6G/Xf+/Nl/wDI9AGF4c8K6fLrHilGuNaAi1JEXbrN4pI+x2zfMRLljljycnGB0AAS88K6evjrSIBca1sfTb1yTrN4WBWW1Aw3m5A+Y5AODxnOBhfDmh6g+seKVXxTrUZj1JFZlis8yH7HbHc2YCM4IHGBhRxnJJeaHqA8daRGfFOtF2029YSmKz3KBLa5UfuMYOQTkE/KMEc5ADx94V0+38C+I547jWi8em3LqJNZvHUkRMeVaUhh7EEHvXf1wHj7Q9Qh8C+I5JPFOtTomm3LNFJFZhXAib5TtgBwenBB9CK7+gAooooA534j/wDJPPFH/YLuv/RLVheNdD1CLR7dn8U6zMDqVgu14rMAE3kIDfLADkE5HbIGQRkHd+I//JPPFH/YLuv/AES1YXjXQ9Qi0e3Z/FOszA6lYLteKzABN5CA3ywA5BOR2yBkEZBADxroeoRaPbs/inWZgdSsF2vFZgAm8hAb5YAcgnI7ZAyCMgniPQ9QTWPCyt4p1qQyak6qzRWeYz9juTuXEAGcAjnIwx4zgg8a6HqEWj27P4p1mYHUrBdrxWYAJvIQG+WAHIJyO2QMgjIJ4j0PUE1jwsreKdakMmpOqs0VnmM/Y7k7lxABnAI5yMMeM4IAC80PUB460iM+KdaLtpt6wlMVnuUCW1yo/cYwcgnIJ+UYI5zB/wAIxcX/AIx1uzvPEWqTxHTbIyGW3sn8wGW6wrKbcrgYJHGfmOSeMT3mh6gPHWkRnxTrRdtNvWEpis9ygS2uVH7jGDkE5BPyjBHOSz0PUD461eMeKdaDrptkxlEVnuYGW6wp/cYwMEjAB+Y5J4wbjTcXdbkMXhq5ufGmr2s/iPVZEXTbJizW9kxYGW6AUg2+3AwcYAPzHJPGG+D/AAxPaX/ia1sPEOqWcEOpKuy3t7JQxNpbsWI+z4B+bHygDgHGSSbFnoeoHx1q8Y8U60HXTbJjKIrPcwMt1hT+4xgYJGAD8xyTxg8OaHqD6x4pVfFOtRmPUkVmWKzzIfsdsdzZgIzggcYGFHGckqyvcfPLl5b6B4K0PUJdHuGTxTrMIGpX67UisyCReTAt80BOSRk9sk4AGADwVoeoS6PcMninWYQNSv12pFZkEi8mBb5oCckjJ7ZJwAMAHgrQ9Ql0e4ZPFOswgalfrtSKzIJF5MC3zQE5JGT2yTgAYAPBWh6hLo9wyeKdZhA1K/XakVmQSLyYFvmgJySMntknAAwAyTd+HH/JPPC//YLtf/RK10Vc78OP+SeeF/8AsF2v/ola6KgAooooAz9f0bTvEOjXek61aRXmnXSeXNDIOGHXqOQQQCCMEEAgggGvNG1DVfhtqU4W9n8R+BbZmF6CwnvfD4IR13tuMk0QDlsFS6R4OSF+b1uuT8f6NqV1YHV/Cskdv4o0+NntGMSOLtR8xtJCxH7uQgAkMpVgrA8cgHSadfWmpWUV5pt1Bd2kw3RzwSCRHHqGGQfwr8/dXurXSf2ib67uJI4rODxPK8p28RILts9RjgDPH6Hp9W6R4RttZ0xdf+Feu6j4Je7LJc2Aska2jlQhJFksn+WOdTEELLj7p+9uyfm342aRp2j+PrnQp9Rtb3U00mWXUtTks1gaS+eWW83BQQN7q0cQIJwrgDpigD7A8xd7IGBdQGKg8gHODj8D+VebftHIj/B/XN7omPJIZs9fOQ44B5OMfjzgZNfP/hn45a/oPh6O1WJb7VY5APtt9NLMHg+chGXcCWDOcNnpgY4BrF+J/wAUtX8fW9ja3ca2ljbojvbIQ6vcAMDKCRuAIfG0scY6k80Aex/sNXEC3XjK2aaMXEiWkiRFhvZVMwZgOpALqCe24eor6smljhiaSZ1RF6sxwBXyn8FdLuNC+HGleNtBudJ067trO/S/lvbF51nh88MSxjdXyggGMZ6kV1Nzdapfol/44hvdVubq7ms9D0FbT7DPq/zbjviZi0Nqvy534JWNXl3fItAHa+K/HUV9pc9zZ6vDoHhaNjHPr87BXuSASY7JTnexVW+cA5xhAx5X0HQdGsNB02Ow0q3W3tkJbAJLOx6szHlmJ5LEkk9a5Dwf8PIbPUh4j8WG21fxZIqDzvKH2fT1XO2G0QjMaLnG77zHLHBYiu/oA8L1l/Fdr8Y0lt11rXtKuL+GIW6jUbCLTo1xufcoW2mTqTuLFsAdzjjvhRqfivWn8JXOnX3ia/uhql2mrS3M1zJZfYwcBSXPlFxk7QvzevavqWqelaXp+kWn2XSbG1sbbcX8m2hWJNx6naoAyfWgD5t+EOjeLfDtv8LEis/EVnDLcajHq9rIk4gjj3ZiMkR+RMliQxAJ9TgU/wAF2njy/fwBba7J4xjt5INVGps811Cwb94YPNcEEH7u3J9MV9N0UAfN/hGXxtNpvgRvHS+Ll0QWd2l/9kS7W7NyJpBEZxB+/wBvlhMHoTyalfQNY034neMdS8N2fiBbm+0SJtDubg3rxyTCDlZnckBhg4Wc8NjgHFfRdFAHy40HjtPAutXFlq3jSbWJdIiD6edMvomhuRPFuaOaWVyzkF+IQEK5OF6V798PdGuNF8NQRXuqavqV1cYuZZNUm8yWN2VcoOBtUEcLjjJrpaKACiiigDyL486je2es+A7ezk1hre71J47m10q8a2luUEedgZZE/VhXD+FPidrWk+CrCSwmk1a41vxHPZWceoymebToeNsMxkkj3y+gaQDB+92r6KvNNsb64tZ72ytrie0fzLeSWJXaF8Y3ISMqfcVRm8K+Hpkvkm0HSZEv5BLdq1nGRcOM4aTj5zyeTnqaAPMF+I/jBbjwzoWpaVpOleINW1G5s5LmVxcW8KRIjgmOKY4kcOAEMuQR3BFVr3UvGNn+0BFp8uu200CeGzeNax2kyW0pWYg4h88gSHHEmTgcbTjNerHwl4bOjjST4f0g6UH8wWX2KPyQ/wDe2bduffFKvhPw6j6e66BpKvp3/HkRZx5tud37vj5OeeMc0AeOeH/jPr2pWfgGWW10jzNetdUnuwkcn7trYSGMJ+84B2DOc55xiotE+LfjDUYtADxaAkms6LdamhFrNiB4C/yked84YJ/s4z3xg+yW3gzwva3QubXw3osNwC7CWOxiVwXXa5yFz8w4PqODU8PhjQYPs3k6Hpcf2aJ7eDZaRjyomzuRcD5VOTkDg5NAHE23iCfxr8HtB1qUfYbrULvTixgwfKf7dEpZNwYcEZG4HtnNdX/wj+pf9Dfrv/fmy/8AkepNW8OQyeHItJ0RbTSo7eeCe3WO2BhjMUySgeWpXglMEAjrUf2TxZ/0G9C/8E83/wAlUAYXgrQ9Ql0e4ZPFOswgalfrtSKzIJF5MC3zQE5JGT2yTgAYALzQ9QHjrSIz4p1ou2m3rCUxWe5QJbXKj9xjByCcgn5RgjnOhpOh+J9LtXt7fXdGZHuJ7kl9IlJ3SyvKw4uRwGcge2OvWiXQ/E8us2uptruiie3t5rZFGkS7SsjRsxI+05zmJcc9z17AGf410PUItHt2fxTrMwOpWC7XiswATeQgN8sAOQTkdsgZBGQd3/hH9S/6G/Xf+/Nl/wDI9UtW0PxPqlqlvca7oyolxBcgppEoO6KVJVHNyeCyAH2z061d+yeLP+g3oX/gnm/+SqAMLwVoeoS6PcMninWYQNSv12pFZkEi8mBb5oCckjJ7ZJwAMAF5oeoDx1pEZ8U60XbTb1hKYrPcoEtrlR+4xg5BOQT8owRznQ0nQ/E+l2r29vrujMj3E9yS+kSk7pZXlYcXI4DOQPbHXrRLofieXWbXU213RRPb281sijSJdpWRo2Ykfac5zEuOe569gDP8faHqEPgXxHJJ4p1qdE025ZopIrMK4ETfKdsAOD04IPoRW7/wj+pf9Dfrv/fmy/8AkeqWtaH4n1jRr/TLnXdFWC9t5LaRo9IlDBXUqSM3JGcH0NXfsniz/oN6F/4J5v8A5KoAwvBWh6hLo9wyeKdZhA1K/XakVmQSLyYFvmgJySMntknAAwAXmh6gPHWkRnxTrRdtNvWEpis9ygS2uVH7jGDkE5BPyjBHOdDSdD8T6Xavb2+u6MyPcT3JL6RKTulleVhxcjgM5A9sdetEuh+J5dZtdTbXdFE9vbzWyKNIl2lZGjZiR9pznMS457nr2AM/x9oeoQ+BfEckninWp0TTblmikiswrgRN8p2wA4PTgg+hFbv/AAj+pf8AQ367/wB+bL/5HqlrWh+J9Y0a/wBMudd0VYL23ktpGj0iUMFdSpIzckZwfQ1d+yeLP+g3oX/gnm/+SqAMLw5oeoPrHilV8U61GY9SRWZYrPMh+x2x3NmAjOCBxgYUcZySXmh6gPHWkRnxTrRdtNvWEpis9ygS2uVH7jGDkE5BPyjBHOdCw0PxPY3WpXEWu6MXv7gXMobSJcBhFHFhf9J6bYlPOeSfoCXQ/E8us2uptruiie3t5rZFGkS7SsjRsxI+05zmJcc9z17AGf4+0PUIfAviOSTxTrU6JptyzRSRWYVwIm+U7YAcHpwQfQiu/rkNa0PxPrGjX+mXOu6KsF7byW0jR6RKGCupUkZuSM4Poa6+gAooooA534j/APJPPFH/AGC7r/0S1YPjW18Tro9ubjV9GdP7S08AJpUqEN9sh2nJuTwGwSMcgEZGcjr/ABHpv9teHtU0vzfJ+3Wstt5u3ds3oV3YyM4znGRWDq2h+J9UtUt7jXdGVEuILkFNIlB3RSpKo5uTwWQA+2enWgDO8a2viddHtzcavozp/aWngBNKlQhvtkO05NyeA2CRjkAjIzkL4jtfE41jwsJdX0VnOpOIiulSqFb7Hc8sPtJ3DbuGBjkg54wdDVtD8T6papb3Gu6MqJcQXIKaRKDuilSVRzcngsgB9s9OtF/ofie+utNuJdd0YPYXBuYgukS4LGKSLDf6T02yseMcgfQgGdeWvif/AITrSFbV9FM5029KONKlChfNtdwK/ackk7cHIxg8HPBZ2vif/hOtXVdX0UTjTbIu50qUqV8262gL9pyCDuycnORwMc6Muh+J5dZtdTbXdFE9vbzWyKNIl2lZGjZiR9pznMS457nr2ItD8Txazdamuu6KZ7i3htnU6RLtCxtIykD7TnOZWzz2HTuAZ1na+J/+E61dV1fRRONNsi7nSpSpXzbraAv2nIIO7Jyc5HAxyvhy18TnWPFIi1fRlcakglLaVKwZvsdtyo+0jaNu0YOeQTnnA0ItD8Txazdamuu6KZ7i3htnU6RLtCxtIykD7TnOZWzz2HTuWGh+J7G61K4i13Ri9/cC5lDaRLgMIo4sL/pPTbEp5zyT9AAZ3gq18Tto9wbfV9GRP7S1AEPpUrkt9sm3HIuRwWyQMcAgZOMk8FWvidtHuDb6voyJ/aWoAh9Klclvtk245FyOC2SBjgEDJxk6Ok6H4n0u1e3t9d0Zke4nuSX0iUndLK8rDi5HAZyB7Y69aNJ0PxPpdq9vb67ozI9xPckvpEpO6WV5WHFyOAzkD2x160AXfhx/yTzwv/2C7X/0StdFWd4c03+xfD2l6X5vnfYbWK283bt37EC7sZOM4zjJrRoAKKKKACsTxt4gg8K+EdX126ETR6fbSTiOSURCVwPkj3HOCzYUcHlhgHpW3Xkv7QF/AINB027sr29tEe61y8t4cCCe3sbd5fJnJDDY8zW64KkH2O3IBleEPiXofgrU08CeJBqf/CRW8E2p6tfmGJrfznha+uGBjIYgbnAATsBz1r5Wi1W58V/Ey98UvHJIUmn1u4hlZnWJIi0iwl8fdwscYYgAFlGOgrE8QeIW1rXNX1ya0sYLzVZJGlitmmUQOxVnkTLn7+XBBLDDv8q/Li14V824g1G10rSJb9n0p3vx5mxUjhuFuHkJ7L5cSp1U5PGTgMAR+GfAXinxPGsuh6He3NuysyzlPLibacECRsKTnsDng+lZMmm3dpNLb39lJbzmOQqLr9wV2MQ5G7GSDHImOu4ED5uK95P7SB0+zW00rw7bmKGR0hHm+XGkIXEaqqqOh9h8qgdTkcB8Rvixe+NbbTlk023sr2xu5LmK+RszopYmONWAXaFBAz1Yqp4OcgHTfAfxXo4fVY/FMT3sWiWd1q+haM74s/ORHkkHzbmMgUfIW3BQZG+9gntNM/aU0/VfH/h/U9W0d9ItLZJ7G4Kyfax5M/lsZMgIUKPBFkbX3Iz4wVAb5mnuonsLe3itxGyLmR2csXfc3zAdFBVkUjv5YPtXcfAvTbTUfihYabqV0IbG8sb6GedHA8qOSxmDNk8AqGPJ4BHNAH6IUVzfw1u7i/8Ahz4VvL2Z57q40q1lmlkOWd2hUsxPckkmukoAwNR8aeFtL1GSw1LxLolnfRkB7a4v4o5FJAIBUsCMgg/iK368GtLW/wBL+O3jzUbqXxVpdhefYfs8+m6O91FebIVDKW+zygAHjIK9Tzxw/UP+ElPxEmKDxgPBH9tRCUR/aPP83ymyU/j+xb9ucfLnOOKAPatO1TT9Ta5Gm31rdm1ma3nEEyyeVIvVHwTtYdweauV8uWugeLPDujfEa28NWfiO31qXXZJoZF+1Os1g0ikyROzbJJTx8wbzSN3NXNVsfGh0uyttG13xpdQT+IrLfImnXlnJaW7JKJQrTvJK8Y+QkyZQEDrngA+l6K+cvF2g+MNP1bxdY6XqPja9s7DQITplx9ruWaa6Drkho8CSTBOQByOorL+Iup/ES5ti+l6d4nstUtdO0+aKe0jv5ftszLGZh5cbiCLaS4ZXjZjjoM5AB9FaX4j0rVda1fSLC683UNJaNb2Ly3XyjIpZOSAGyAfuk471r15X8LtO1K2+KXxLvtQsbq3gvX05oJpYWRJtsDB9hIw2CcHHSvVKACiiigAooooAKKKKACiiigAorK8WajNo/hXWdTtljaeysprmNZASpZELAEAg4yPUVS+yeLP+g3oX/gnm/wDkqgDoqK4zS5/Fl9faxb/2roUf9n3S227+yZj5mYIpd2PtPH+txjn7ue+AapP4ssb7R7f+1dCk/tC6a23f2TMPLxBLLux9p5/1WMcfez2wQDs6K4zxHP4s0Xw9qmqf2roU32G1lufK/smZd+xC23P2k4zjGcGtH7J4s/6Dehf+Ceb/AOSqAOiorjNLn8WX19rFv/auhR/2fdLbbv7JmPmZgil3Y+08f63GOfu574Bqk/iyxvtHt/7V0KT+0Lprbd/ZMw8vEEsu7H2nn/VYxx97PbBAOzornfsniz/oN6F/4J5v/kqs7w5P4s1rw9peqf2roUP261iufK/smZtm9A23P2kZxnGcCgDs6K4zS5/Fl9faxb/2roUf9n3S227+yZj5mYIpd2PtPH+txjn7ue+AapP4ssb7R7f+1dCk/tC6a23f2TMPLxBLLux9p5/1WMcfez2wQDs6K537J4s/6Dehf+Ceb/5KrO8OT+LNa8PaXqn9q6FD9utYrnyv7JmbZvQNtz9pGcZxnAoA7OiuMgn8WS+Ib3S/7V0IfZrW3ufN/smb5vNeZduPtPGPJznPO7tjk1SfxZY32j2/9q6FJ/aF01tu/smYeXiCWXdj7Tz/AKrGOPvZ7YIB2dFc79k8Wf8AQb0L/wAE83/yVV3wnqM2seFdG1O5WNZ72yhuZFjBChnQMQASTjJ9TQBq0UUUAFFY2ta6dN1GzsYNLv8AUbq6ilnVLUwrtSMxhiTJIg6yp0z3rOv/ABbd2ECzXfhTXY42ljhB8yzOXkdY0HFx3ZlHtnnigDqqK53/AISDUv8AoUNd/wC/1l/8kVX03xbd6lp1rfWXhTXZbW6iWeF/MsxuRgCpwbjIyCOtAHVUVyth4tu7+BprTwprskayyQk+ZZjDxu0bjm47MrDPfHHFCeLbuTUZ7FPCmum6hijnkTzLPhHLhTn7Rjkxv+XPUUAdVRXK3Xi27tZ7OGfwprqSXcphgHmWZ3uEaQji44+WNzk+nrijUvFt3punXV9e+FNditbWJp5n8yzO1FBLHAuMnAB6UAdVRXO/8JBqX/Qoa7/3+sv/AJIqvpvi271LTrW+svCmuy2t1Es8L+ZZjcjAFTg3GRkEdaAOqorK0DWRrAvlaxu7GezuPs00FyYywYxpICDG7KQVkXv61q0AFFFFABXmfxVs5dS1+w0mIFJdb0DWdHtp3RvJW4lSB0WRwDtysMp9TsOAa9MrAv8Aw/eXU6yReJdXtgs7TIkcVowQEAbAXgY7R83Od3zkZxgAA/OPxToer+FddvNG16FrTUoQizw+ar4DKrqCykg8FT1P5iul+HUcWn32t6/a3ERt7CzktLYXghj8+4u43t0Qo7lQoDyyEncu2Ehsbq+0PiN8IfD/AMQJopdenvBNGgQS2yW8cpwcjMnlFyMEjbnbznGcEeJ/GX9nGa2tBq3giea+mBhhk05rdFklZn2+YpiVY1A3JkbFAVWYtnOQD598S6FbeHtXutLu9SW5vLZdsrWcYkh83BOwOWBIHygnAIbeMHaC2JBNLbuXgleJyrIWRiCVZSrDjsQSCO4JFa3g3w9deKvENvo9hn7VcJK0ajGWKRs+0ZIHO3HJA5q/4D8JzeIviPpPhi4V1M98Le58qVFZI1b96VZvlyFVyOuSBgHIBAOe1GGK3vZY7aVprfOYpGCqzIeVLKrMFbBGV3HacjPFeifCD4ceM/Fkh1LwraWy2JebT7i+uJ0VI1eErKhXJfDRy4yqEjcMEEEj691H4MeE7q2tUtbdtNuIo0immsYYI1vFXnE8BjMEmWw/MfDKuMAYrp7Lw5fWlnb2yeKdZZYZVcEwWS5jAx5WFtwoT6AN6MKAM+08O+JWtILaXxFaaTaQoI47bQ9MSIRIBhUDTGQYAAHCL9K0NL8IWVjfQX017rGoXsOdkt5qErqCRgkRgiMHB7KK6OigDnP+E10NvEU2h29xdXWpQOkc6WljPcJAz/dEsiIUj/4EwwOTiszR/ij4R1m7s7bTdVeSW9eSK1aSznijmkjzuRZHQKWGPu5zyPUViaz8KTqfxBtvE8epWumSRXaXLnTbSWC4uVXH7qaTzyjqcDJ8sE+2TnlPhb8JNcj0zw+fF1wljFoup3GoQadFEryPIx+R3mWRlK99oUH1NAHTfB/4tWvi3QNBHiKW3s/EOrNceTBDbTJDL5TsCEdsqWCgErvzz05FaWifFvw3eaXpVxfXkaXOpLcSW8NhDdXQkWEkOVPkI3AUkgoO+M9axPC3wY/sGLwGn9vef/wi1xeT5+x7ftXnkHH+sOzbjr82fameEfgr/wAI9d+Epv7f+0f2BHfR7fsezz/tO/n/AFh27d/vnHagDsl+JPhSWx0m7tdTe7TVkeSyjs7Se4mmVCQxEUaFwAQQSVGCDWPpPxY06+8e614ensLyytdOtUuvt9xBPGNpj3t5qNEPJAGfmcgHoOTisbwl8GrjwlH4budE8RRf2xo9tcWZnutPMkNxDLK8uDEJVKlS55D845HatHU/hXJqniTX9SvtZhaDxBpsen6nBHZMpJSPaJIX80+X8wVtrB+mMnOaANg/Fbwatpe3MurSQxWdsl7L51lcRsYHcIsqKyAuhZgNygjmt3wl4q0XxfpsuoeHL5b6zjma3aVEZRvUAkDcBnhhyOK8wPwND+Eb3QTqOhQCayWyW9s/D0cFywEkbh5pBITIcR442Ak5OSBXsGlWn2DTLOz3+Z9nhSLfjG7aoGcdulAFqiiigAooooAKKKKACiiigDnfiP8A8k88Uf8AYLuv/RLUfa/Fn/QE0L/wcTf/ACLR8R/+SeeKP+wXdf8AolqPtfiz/oCaF/4OJv8A5FoAwvDl14nGseKTFpGjM51JDKG1WVQrfY7bhT9mO4bdpycckjHGSeI7rxOdY8LGXSNFVxqTmILqsrBm+x3PDH7MNo27jkZ5AGOcg8OXXicax4pMWkaMznUkMobVZVCt9jtuFP2Y7ht2nJxySMcZJ4juvE51jwsZdI0VXGpOYguqysGb7Hc8Mfsw2jbuORnkAY5yAA8fXXidvAviNbnSNFjgOm3IkePVZXZV8pskKbYAnHbIz6it37X4s/6Amhf+Dib/AORawvH114nbwL4jW50jRY4DptyJHj1WV2VfKbJCm2AJx2yM+ord+1+LP+gJoX/g4m/+RaAMLw5deJxrHikxaRozOdSQyhtVlUK32O24U/ZjuG3acnHJIxxkniO68TnWPCxl0jRVcak5iC6rKwZvsdzwx+zDaNu45GeQBjnIPDl14nGseKTFpGjM51JDKG1WVQrfY7bhT9mO4bdpycckjHGSeI7rxOdY8LGXSNFVxqTmILqsrBm+x3PDH7MNo27jkZ5AGOcgA3ftfiz/AKAmhf8Ag4m/+RawvAN14nXwL4cW20jRZIBptsI3k1WVGZfKXBKi2IBx2yceprd+1+LP+gJoX/g4m/8AkWsLwDdeJ18C+HFttI0WSAabbCN5NVlRmXylwSotiAcdsnHqaADw5deJxrHikxaRozOdSQyhtVlUK32O24U/ZjuG3acnHJIxxkniO68TnWPCxl0jRVcak5iC6rKwZvsdzwx+zDaNu45GeQBjnIPDl14nGseKTFpGjM51JDKG1WVQrfY7bhT9mO4bdpycckjHGSeI7rxOdY8LGXSNFVxqTmILqsrBm+x3PDH7MNo27jkZ5AGOcgA3ftfiz/oCaF/4OJv/AJFrC8A3XidfAvhxbbSNFkgGm2wjeTVZUZl8pcEqLYgHHbJx6mt37X4s/wCgJoX/AIOJv/kWsLwDdeJ18C+HFttI0WSAabbCN5NVlRmXylwSotiAcdsnHqaAEs7rxP8A8J1q7LpGimc6bZB0OqyhQvm3W0hvs2SSd2RgYwOTnhfEd14nOseFjLpGiq41JzEF1WVgzfY7nhj9mG0bdxyM8gDHOQlndeJ/+E61dl0jRTOdNsg6HVZQoXzbraQ32bJJO7IwMYHJzwviO68TnWPCxl0jRVcak5iC6rKwZvsdzwx+zDaNu45GeQBjnIAN37X4s/6Amhf+Dib/AORaPhx/yTzwv/2C7X/0StH2vxZ/0BNC/wDBxN/8i0fDj/knnhf/ALBdr/6JWgDoqKKKAOQ8SalBpfjrQprmO7dG02+QC1tJbhs+baHlY1YgcdcY6eorO8a+KtPn0e3RLfWgRqVg/wA+jXiDC3kLHlogM4HA6k4AySBW9ff8lD0T/sF3/wD6Os6j+ISrJoFvAzyRmbUrCNXjOGQ/aojkZ7jHvSk+VXNKNN1akaa6uxl+JfGcLQ2tnpf9uW13czoDKNFud6QqQ0jKrwkMdo29DgsDjiuc+FviK20zTbS2mfX57d9IsJUjbTrucRyFZBII8RnEeBGAR8pxwSc16Tpeg6fptwbmGJ5LxlKNc3EjTSkE5I3sSQMgcDA4HHFcn8NPlt/D+R9/wzY4/wCAg5/9CFZNPmUmd0akHSnRp7WvdpXbuvXRLpfu+oeCvFWnwaPcI9vrRJ1K/f5NGvHGGvJmHKxEZweR1ByDggiiz8VaevjrV5zb61sfTbJABo14WBWW6JyvlZA+YYJGDzjODje8B/8AIDuf+wpqX/pbPRY/8lD1v/sF2H/o68rY80wvEfirT5dY8LOtvrQEWpO7btGvFJH2O5X5QYsscsOBk4yegJB4+8VafceBfEcEdvrQeTTblFMmjXiKCYmHLNEAo9yQB3rd8Uf8hzwh/wBhST/0iuqPiP8A8k88Uf8AYLuv/RLUAYOteKYL7XLGzin8SWlibaeSdbfR7lZJGDRBBzCXC4MmSuOcZPQVi/C/xPFp+k2Fncy67c2v9kWUsSHSbiTypCriQIUhyY+E2kll67TgYrvH+bx1D28vTX/HdKn/AMR+tc78Nvlt/DeP+Wnhmzz/AMBHH/oRrC3vc3n+h6nN+59lZW5L7Lfmvf1tp6aGt4HvIr/UPFdzAs6RvqiYE8DwuMWdsOUcBh07jnr0rqq53wv/AMhzxf8A9hSP/wBIrWuirc8sKKKp6jp0V+F82W7iZFYKYLmSLGcckKQCeBjIOOfU0AXKKo29jPEW36peTAgAB1i49+EH60txYyTxvG1/dqrjadhRSOc8ELkHHGQenvzQBJqN/Z6ZZS3mpXVvZ2kQzJPcSCONBnGSxwBye9ea+I9fHxE0dNN8K+F5tcsZxFdC+1hJrDTQRveIsGUSXKh40JREKEMMsK7KDwX4bi1X+1DolhNqvmCX7dcxCe4DAAKRK+XGAABzxjiuhoA+Q734Ty/DT4ieEmsdZe/1nVU1aRJo7JIY4XjtMx7IgWBId2OM4PygKMHOz8OvhLd6npvh74gaBqka+KYbu8a8Wd3ihvnF3KhkDx5MR2buAro2FDJgvu1PjF4mh8UfE/4f23w91TRtS1S3XUR5krvLaLvgTIaSPIJ2q/CkkHbkAEZs+AvEvinwz4ch0LU38M+H/sV3ema91J5ZRcBp5ZN8cWYgkZJfBaTJVQ23BBIB6Ta/Eq0srY/8Jno+seGLiJoop3vLV5rRXk2gEXcQaHZucLuZlweoFbln438KXsojsvE+h3EhUuFi1CJyVBxnAbpnjNeG6zLpniCa9vdbsvEPxAlXTJo7S4g0p20veWO6G1aFG2SMQB5uXKhQPMyuK9d+HOkXN58PvDcnjSzt7vXBYxee9zbkyj5RgSeZlvMC7Q+erBqANDUfHvhTT0tzca/pzyXLRrbwW8wnmnMhUJ5cceXfO9T8oPBz05q7pfiCHVNTmtLWw1VUhjDyXNzYyW0QJPCKZQrOxGT8oYDHzEEqD514f+B2hNGuoeLhLf6/NfzarK1neXFvb21zMyswt1VwVClFAY/MdoJPCqvaeBfh94Y8Cfbf+EU0z7B9t2ef/pEsu/Zu2/fZsY3t0x1oA6qiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA534j/8AJPPFH/YLuv8A0S1H/CQal/0KGu/9/rL/AOSKPiP/AMk88Uf9gu6/9EtR/wAJBqX/AEKGu/8Af6y/+SKAMLw5rmoJrHill8La1IZNSRmVZbPMZ+x2w2tmcDOADxkYYc5yAeI9c1B9Y8LM3hbWozHqTsqtLZ5kP2O5G1cTkZwSecDCnnOATw5rmoJrHill8La1IZNSRmVZbPMZ+x2w2tmcDOADxkYYc5yAeI9c1B9Y8LM3hbWozHqTsqtLZ5kP2O5G1cTkZwSecDCnnOAQA8fa5qE3gXxHHJ4W1qBH025VpZJbMqgMTfMds5OB14BPoDW7/wAJBqX/AEKGu/8Af6y/+SKwvH2uahN4F8RxyeFtagR9NuVaWSWzKoDE3zHbOTgdeAT6A1u/8JBqX/Qoa7/3+sv/AJIoAwvDmuagmseKWXwtrUhk1JGZVls8xn7HbDa2ZwM4APGRhhznIB4j1zUH1jwszeFtajMepOyq0tnmQ/Y7kbVxORnBJ5wMKec4BPDmuagmseKWXwtrUhk1JGZVls8xn7HbDa2ZwM4APGRhhznIB4j1zUH1jwszeFtajMepOyq0tnmQ/Y7kbVxORnBJ5wMKec4BAN3/AISDUv8AoUNd/wC/1l/8kVheAdc1CHwL4cjj8La1OiabbKssctmFcCJfmG6cHB68gH1Ard/4SDUv+hQ13/v9Zf8AyRWF4B1zUIfAvhyOPwtrU6Jptsqyxy2YVwIl+YbpwcHryAfUCgA8Oa5qCax4pZfC2tSGTUkZlWWzzGfsdsNrZnAzgA8ZGGHOcgHiPXNQfWPCzN4W1qMx6k7KrS2eZD9juRtXE5GcEnnAwp5zgE8Oa5qCax4pZfC2tSGTUkZlWWzzGfsdsNrZnAzgA8ZGGHOcgHiPXNQfWPCzN4W1qMx6k7KrS2eZD9juRtXE5GcEnnAwp5zgEA3f+Eg1L/oUNd/7/WX/AMkVheAdc1CHwL4cjj8La1OiabbKssctmFcCJfmG6cHB68gH1Ard/wCEg1L/AKFDXf8Av9Zf/JFYXgHXNQh8C+HI4/C2tTomm2yrLHLZhXAiX5hunBwevIB9QKACz1zUB461eQeFtaLtptkpiEtnuUCW6wx/f4wckDBJ+U5A4yeI9c1B9Y8LM3hbWozHqTsqtLZ5kP2O5G1cTkZwSecDCnnOASz1zUB461eQeFtaLtptkpiEtnuUCW6wx/f4wckDBJ+U5A4yeI9c1B9Y8LM3hbWozHqTsqtLZ5kP2O5G1cTkZwSecDCnnOAQDd/4SDUv+hQ13/v9Zf8AyRR8OP8Aknnhf/sF2v8A6JWj/hINS/6FDXf+/wBZf/JFHw4/5J54X/7Bdr/6JWgDoqKKKAOQ8R6Vp2seOtCt9WsLS+gXTb6RY7qFZVDCW0GQGBGcE8+5rE8feFPDdlZ6ObXw9o0DTaxZQOUsYlLI0yhl4XoRwR3Ga2/Emmwap460KG5ku0RdNvnBtbuW3bPm2g5aNlJHPTOOnoK5j4neH9PsY/DCpcauzXOvWUBEurXUmAXOSN0h2njhhgjsRUVPhOnB/wAVPtd/cmztP+EG8J/9CvoX/gvh/wDia8f1LQtIg8A6Q9vo2mm+vfDtuY3Fqm8zM0QaTOM7sOTu68GvYP8AhD9N/wCfnXf/AAeXv/x6vM9J8IQ6haeANr6k8M+hvPcL9vuCARDEFC/PhBukHyrgfKB04rPEJuFl/V9DryecIYpSnsk362XNb52On+HnhPwxqHhn7TceHtFnd769Ad7GInaLuUKOV6BQAB2AAqez8G+GG8davbt4c0YwR6bZSJGbGLarNLdBiBtwCQq5PfaPSsv4ReHrDU/AFheS3Or75Zro/udXu4lP+kSAHasgA6c8cnk8k1qWfhXT28davAbjWtiabZOCNZvAxLS3QOW83JHyjAJwOcYyc6xd0mefWhyVJR7Ni+I/BvhiHWPCyReHNGRJtSeOVVsYgHX7Hcttb5eRuVTg9wD2o8feDfDFr4F8R3Ft4c0aGeLTbmSOSOxiVkYRMQQQuQQec0eI/Cunxax4WRbjWiJdSdG3azeMQPsdy3yky5U5UcjBxkdCQTx94V0+38C+I547jWi8em3LqJNZvHUkRMeVaUhh7EEHvVGY+Lwb4YbxlcQHw5o3kJYROIvsMW3c0kgLY29cKBmsHwR4V8PT2/g/7ToOky/afDyzyeZZxt5sgFvl2yOW+fqefmPvW9aeFdOfxlqcJuNZKRWNqysNZvNwZpLjcC3m5Iwq8E4HUAZOcLwf4bsZbPwM7z6sPtOhFnCardJhtlu3y4kGxevyrhenHyjGP2b+f6npf8veX+5/7Zc6/wAD2NppuoeK7TTrWC0tY9UTZDBGI0XNnbE4UcDJJP411Vcr4Hs4rDUPFdtA07xpqiYM87zOc2dseXclj17njp0rqq2PNCiiigAooooA8Q/aY1y+0uDSoLPW7zSontLu6Is7jyZJnje3TIIdGcpFNPIsYcBmRd2QMVX8P30viLwlBD4UtNb8ZW9wwilu9ekdLVk3CMmQyhVkAVDnyY5CCpLDc2W93ooA+Q/2iNF8a+HND0XxFqGrWNgLS9aysrTSJJAbdZIPvebtTqInG0INoI5OTj0n9nHwTa3fgy28S+Lo01zxHPdS+Xc6iPtMlkIJnRY43dmxiRZH3LjJfvtBqn+2r/ySzSv+wzF/6InrtvgHrs+veC7ma6tra3lW/ln220vmIRdBb1R90YKi6CEc8oTnmgD0miiigAooooAKKKKACiiigAooooAKKKKACiisfXPFGgaBNFFruuaVpksq7o0vLuOEuOmQGIyKANiioLG8ttQs4buwuIbq1mUPFNC4dHU9CrDgj6VFHqdhLqkumx31q+owxiWS1WZTKiHoxTOQD6kUAXKKKKACiisl/EelJ4qj8NtdY1p7Q3y2/lvzDu2bt2Nv3hjGc+1AFP4j/wDJPPFH/YLuv/RLUf8ACYab/wA+2u/+CO9/+M0fEf8A5J54o/7Bd1/6Jaj/AITnwn/0NGhf+DCH/wCKoAwvDnirT4tY8Uu1vrREupI67dGvGIH2O2X5gIsqcqeDg4wehBJ4j8VafLrHhZ1t9aAi1J3bdo14pI+x3K/KDFljlhwMnGT0BIPDnjLwxDrHil5fEejIk2pJJEzX0QDr9jtl3L83I3KwyO4I7UeI/GXhibWPCzxeI9GdIdSeSVlvoiEX7Hcrub5uBuZRk9yB3oAPH3irT7jwL4jgjt9aDyabcopk0a8RQTEw5ZogFHuSAO9bv/CYab/z7a7/AOCO9/8AjNYXj7xl4YuvAviO3tvEejTTy6bcxxxx30TM7GJgAAGySTxit3/hOfCf/Q0aF/4MIf8A4qgDC8OeKtPi1jxS7W+tES6kjrt0a8YgfY7ZfmAiypyp4ODjB6EEniPxVp8useFnW31oCLUndt2jXikj7Hcr8oMWWOWHAycZPQEg8OeMvDEOseKXl8R6MiTakkkTNfRAOv2O2XcvzcjcrDI7gjtR4j8ZeGJtY8LPF4j0Z0h1J5JWW+iIRfsdyu5vm4G5lGT3IHegDd/4TDTf+fbXf/BHe/8AxmsLwD4q0+38C+HIJLfWi8em2yMY9GvHUkRKOGWIhh7gkHtW7/wnPhP/AKGjQv8AwYQ//FVheAfGXhi18C+HLe58R6NDPFpttHJHJfRKyMIlBBBbIIPGKADw54q0+LWPFLtb60RLqSOu3RrxiB9jtl+YCLKnKng4OMHoQSeI/FWny6x4WdbfWgItSd23aNeKSPsdyvygxZY5YcDJxk9ASDw54y8MQ6x4peXxHoyJNqSSRM19EA6/Y7Zdy/NyNysMjuCO1HiPxl4Ym1jws8XiPRnSHUnklZb6IhF+x3K7m+bgbmUZPcgd6AN3/hMNN/59td/8Ed7/APGawvAPirT7fwL4cgkt9aLx6bbIxj0a8dSREo4ZYiGHuCQe1bv/AAnPhP8A6GjQv/BhD/8AFVheAfGXhi18C+HLe58R6NDPFpttHJHJfRKyMIlBBBbIIPGKAEs/FWnr461ec2+tbH02yQAaNeFgVluicr5WQPmGCRg84zg4XxH4q0+XWPCzrb60BFqTu27RrxSR9juV+UGLLHLDgZOMnoCQln4y8ML461e4bxHowgk02yjSQ30W1mWW6LAHdgkBlyO24etL4j8ZeGJtY8LPF4j0Z0h1J5JWW+iIRfsdyu5vm4G5lGT3IHegDd/4TDTf+fbXf/BHe/8Axmj4cf8AJPPC/wD2C7X/ANErR/wnPhP/AKGjQv8AwYQ//FUfDj/knnhf/sF2v/olaAOiooooA5DxHHqMvjrQhpN1aWs/9m3xZ7q2adSvm2nAVZEIOcc57HjnjkvF9l4guNbaS71TSpZLGbS0ixp0iqjS3yfMq+ecHKJuOTuUbRs5Y9D4z1W60v4geFFsLS3uri9tb61UXFw0KKSbd8llRz/yzxjHUisDxBceIXvNUeTS9KDDUtJjfbqUhCstzEyKD5AyCXGTxgMSA2MVnJptLz/S520YTp05zateOnpzJP8AVHcfZPFn/Qb0L/wTzf8AyVWF4BtfE7eBfDjW2r6LHAdNtjGkmlSuyr5S4BYXIBOO+Bn0Fbv2vxZ/0BNC/wDBxN/8i1heAbrxOvgXw4ttpGiyQDTbYRvJqsqMy+UuCVFsQDjtk49TWhxGH8FV1+5+HtiNM1XSoLWKSVFjuNNkldT5jE5YToDyc/d71t2dr4n/AOE61dV1fRRONNsi7nSpSpXzbraAv2nIIO7Jyc5HAxzyngXxZd6LHrtgtloyeVrV0hja+mRYCZMYGy2YCME4DttHXIGK6uzuvE//AAnWrsukaKZzptkHQ6rKFC+bdbSG+zZJJ3ZGBjA5OeMaFlBQvtoelm3NPFTxDi0qj5l89dO+4viO18TjWPCwl1fRWc6k4iK6VKoVvsdzyw+0ncNu4YGOSDnjBPH1r4nXwL4ja51fRZIBptyZEj0qVGZfKbIDG5IBx3wceho8R3Xic6x4WMukaKrjUnMQXVZWDN9jueGP2YbRt3HIzyAMc5B4+uvE7eBfEa3OkaLHAdNuRI8eqyuyr5TZIU2wBOO2Rn1FbHmj9OtvE7eKdZKavowlWK3SRzpUpVuHIAX7TkYDcnJzntjnB8K2/iEaT4AeHVNJjD6aqW+7TZGKKYEba588bzhRyNvK5x2re0i68TnxBr0kekaK0m+GORW1WUBSIgRg/Zznhh2H49a57RL7X7Xwt8P5/wCzNJMEVtGIGbUpAXH2J2y48jCfKpPBbnA6cjH7Hz/U9NK+Isv5P/cZ0fwqvrvUk8T3WoNA1w+rkFoIzGjKttbqrBSzEZUA4yetd1Xn3wZjuItF1NLyOOOdbm3DBHLg/wCgWmDkgHJGCRjgkjJxk+g1pBtxVzjxMYxrTUNk3b7woooqjAKKKKACiisnxXr9j4W8N6jrerSbLKxhaaTBUM2OiLuIBZjhVGRkkDvQB84ftp+IWuH0HwjbeWCEfV7gylUGFV0jCsxAzgTfL1J2AZJwU+Dkuq/DN9LudSee/wBAvtDtb2UwQgeRZyM0hlxsy32aaaQSYdiY7pH2gR7a888bQTa38PvEXxS8QWu+98U6mum6ZCxjK2cCNv8ANDBcswFsYBwhxvY7t9fWlx4AtJPCWgaZDcvDq/h+0SHS9XRMS20qwiPzNoI3KQBuiJKuOCDxgA7C0uYLy1hurOaKe2nRZIpYnDJIhGQykcEEEEEVLXJ+AfDE/hqyWEPBa27+Y0mm2mWtIpWcsZINwDxK2SxiyyqWwp4JfrKACiiigAooooAKKKKACiiigAooooAK8V+KNjfj40+FNVi/t+00+3064jl1DSdNa8aJmJwpHkyjn3X8ute1UUAeD/EiXxTNfI/g2XxjPAdIQ6pM0MsDSJ5sXNtGUQLeFPMJCqoA7A8VTutB1Wx+LGu6todn4h8298OqNGupzdvG12EwqTsSQOn3ZsLnkjNfQlFAHy7aW3jxPBup3MWr+M5Nbk0d459POm3yGO5V1+dJ5ZWBc5OPIAUqPurXTjw34ntNe+GtodX8aX1hqAurjW5JbuYeQzW0QWN2jC+WoZW2g8hi2Dk17TrmtWuiW8c17HfyI7bR9jsJ7tgcZ5WJGIHuQBXOr8UPCD2+jzQ6s066uJvsSwWs0rzGIAyLsVCwYZHykA+goA8Qtb34gT/D/wAOWGqaf4qS/aO/Empkai08TAnykeKB0ZmbChXlyoz6ZrpPhVZ+KLr4k+FNY8TWGqiceEWtrq6u7Z0xMLt8I7EDD7MHB5I5716ivxF8NSeHrXXba6vbvSbhJHW5tNNuZ1QRnDmTZGTHj/b29D6GsjTfiEdX+KmmaFpD2V14fvtA/teO6RW8xn84oADnAXA6Fcg557UAdH8R/wDknnij/sF3X/olqP8AhOfCf/Q0aF/4MIf/AIqj4jHHw98Tn/qF3X/opqI9E1gL5Unie8ECcRtFbQiYj0d3Vgx9wq/4y21srm1OnGafNNR9b/omYXhzxl4Yh1jxS8viPRkSbUkkiZr6IB1+x2y7l+bkblYZHcEdqPEfjLwxNrHhZ4vEejOkOpPJKy30RCL9juV3N83A3Moye5A71X0vwlZ3974vS4luri/ivhHb3k07eZE5s7ch124CsC33gAcADoMVpNftqkXw/vZBiWa9LSL/AHX+w3W4fgcilGTvZoupRgqftKcr2dnpb0tq73s+2xV8feMvDF14F8R29t4j0aaeXTbmOOOO+iZnYxMAAA2SSeMVu/8ACc+E/wDoaNC/8GEP/wAVR8R/+SeeKP8AsF3X/olq1dW1K20q0+0XZk2F1jVY42kd3Y4Cqqgkk1TaSuzCEJTkoxV2zjfDnjLwxDrHil5fEejIk2pJJEzX0QDr9jtl3L83I3KwyO4I7UeI/GXhibWPCzxeI9GdIdSeSVlvoiEX7Hcrub5uBuZRk9yB3pPDU2u6hr/iqXTfsum2jX8bEX9q0sxf7JbjGxZFCjAU5ySd3QYNSeJLHXJdZ8LJfa1AgbUnCPYWIidG+yXJzmR5VPAIxt/i9cVHPfZM6HhlHSdSKfbV/kmvxNr/AITnwn/0NGhf+DCH/wCKrk/DXxC8MaF8N/DputXs5p4bC0hktredJJkby1DZQHI285+mOuBXY/2HqH/Q061/36s//jFYvwz0SAeE/DOo3E9zdXI0uARCZ8pArxJlUUAAcADJBbHUnJyNyaslYqFOhCXNUnzLsr3fzaVv60K3hzxl4Zh1jxS83iPRo0m1JJIy97Eu9fsdsuRluRuVh9QR2pfEfjLwxNrHhZ4vEejOkOpPJKy30RCL9juV3N83A3Moye5A71Ho/hi3XVfFUmgeXpF/baiiW8lvGFj2/ZLZvLeMYDIWZjjqCxIIJzWhNqLar/wgd88Yilm1BjJGDkI/2K6DLn2YEfhTjJ3tJEVaMFD2lKV1e2qs126vfXr01S0vo/8ACc+E/wDoaNC/8GEP/wAVWF4B8ZeGLXwL4ct7nxHo0M8Wm20ckcl9ErIwiUEEFsgg8Yrv6534cf8AJPPC/wD2C7X/ANErVnMYNn4y8ML461e4bxHowgk02yjSQ30W1mWW6LAHdgkBlyO24etL4j8ZeGJtY8LPF4j0Z0h1J5JWW+iIRfsdyu5vm4G5lGT3IHerlxrVlpPxG1OO8acy3Gl2XlRQW8k7uFlu9xCxqxwMjJxjketVPFHiOGXVPDDWNhq1xPFqLusLWE1uZCbO5UANKqrnLDvwAT0BqHUitGzohhK80pRg7PrbT79jc/4Tnwn/ANDRoX/gwh/+Ko+HH/JPPC//AGC7X/0StWNKh1yW5S61a6trePaf9BtU3AEj+KVuWI/2QvTvVf4cf8k88L/9gu1/9ErVRd9bGdWmqb5bp+n9flp5nRUUUUzM87+I8V9J4r8PtpVlPeX0NpdTxJEYxgpPZt8290G0gFTg5+bODzWVqt/rqWF5c6r4V1C2mu9Y0yYLFc20iKEmtlCbvNBLMyEDjHzLkjkjqvEeq6do/jrQrjVr+0sYG02+jWS6mWJSxltDgFiBnAPHsaz/ABr4y8MXGj26W/iPRpXGpWEhVL6JiFW8hZjw3QKCSewBNQ4Jy5jojiZRpOjZWf3rVP8ARfp1N3/hINS/6FDXf+/1l/8AJFYXgHXNQh8C+HI4/C2tTomm2yrLHLZhXAiX5hunBwevIB9QK3f+E58J/wDQ0aF/4MIf/iqwvAPjLwxa+BfDlvc+I9Ghni022jkjkvolZGESgggtkEHjFWc5F4U1W7l8PXtrL4S1i6t5r/URIBJZ7SGu5tyENOORkqe2QcEjBOb4U1fV9M8W6nZ3+garcXCadapCvn2nnG3jluNryZmAJxIFJUnlSTjIFa/grxl4Yt9HuEuPEejROdSv5Ar30Skq15MynluhUgg9wQazL3VfA2seOtQuNW1jQri3TT7NYXe/jCMwkut6ZDYYYZCVORypI6VEou947nTQqQUXTq/C+26ffp6PX8kWtV8UzalqXhe4s/D+pyxx6pIAY7mycSMLS5BQFbggMMknJAwp5zgGx491zUJvAviKJ/CutQI+nXKmWSWzKoDEw3HbOTgdeAT6A1k+Jr/wJNrnhye01rSID9tZbiSx1RYNsYtZwpYxuMYbYobr823OGIMXji68DTeDNdW38S295cixnMEMniCS4DS+W2zEbSkM27GODzjHNK8+y+//AIA+XC3vzSt6L8+b9PkbvhnX7+4l1TVIPCuuS22o3CzQNutUPlrDGnIacdWVyCMgggg1zC3urzfDLwq1n4a1V0sbBJDOHt2V1NjJEGRRKXPMitgqDgHgHivQ/wDhOfCf/Q0aF/4MIf8A4qsLwD4y8MWvgXw5b3PiPRoZ4tNto5I5L6JWRhEoIILZBB4xQ6d4ctyoYvkxCrKOi0t5Wta/p1L3w5MhfxGJrOeykTUIkME7IzptsrUclGZecZ4J4PODxXY1yvge+tNS1DxXd6ddQXdrJqibJoJBIjYs7YHDDg4II/CuqrRaHI25O7CiiigQUUUUAFc1448D+H/HNrbWviiylvba2cyRxC6miQORjcRG6hiBkAnOMnGMnPS0UAeYeOfhpP4j8e/D+/t5rG08OeGXaX7JChilV12NGEwChjzFGCuF2qGwTuG30+iigAooooAKKKKACiiigAooooAKKKKACiiigAorjvijrviPw/oNvdeFNGbVblrlUuFSEztDDglpFiDoZCMABQwyT1rzmz+LmsaxqegWWgX+hzQX9he3U19daZPCI3gLfL5RnyBhcE7j6+1AHu9FfLNv401fxF478MeLrSCzstVbwhd3JinieSHdFLMDhQythtmR83Abvjnam+LmryXFvrMNnapO3gt9Y8pp7gxecs7JjyhKIyvHXbv7b8UAeq/E3wLJ42Oi41GK3h065NxJaXVqbm1u+BhZYt6bsEZGT3PFcp4Q+Cg8OXng6ca8Jx4eub24CCy2Cf7QoG3/AFh2bdvvn2rDf40eINKW7fVdP029X/hFbfxFAtnFJEVeRo0Mb7nfKgvnIxwPxp3xc1fxrb+AfDGqDxFp8L3+qWODpVpPb4EisdrP9obzE6ZGF3Y7UAT2/wAAng0DRtLPiSG5h08XQaK80zzbeQzk/OIvNAEiZ4YluQDjjFdL8P8A4T/8Ijr+h6n/AG19s/szRW0fy/svl+ZmdpfMzvOPvY24PTOe1c/rPxM8ap4p1/RtB0bTb6Tw8lubxpxHbLOGUNJKGkuVMKYzt+WXtkjvveDfGPi3xJ8SPEGmR22hReHdFvfs9w7eaLtlaNim3BKE7gMk4GM4HegDsPiP/wAk88Uf9gu6/wDRLUf8IN4T/wChX0L/AMF8P/xNHxH/AOSeeKP+wXdf+iWo/wCEG8J/9CvoX/gvh/8AiaAMLw54N8MTax4pSXw5ozpDqSRxK1jEQi/Y7Ztq/LwNzMcDuSe9YSeFvDqeINO0+TQtJLxa/NG4azjJeF7O4mRTxygJAA6DywP4eN3w54N8MTax4pSXw5ozpDqSRxK1jEQi/Y7Ztq/LwNzMcDuSe9UPHfgPQpLzw3HpOkaRY3U1+8YYWMZjYC1nk2vHjawLRr1GQOhBqJp6SXQ6cPKDUqVR2Ura9mtm/K118+uxf8feDfDFr4F8R3Ft4c0aGeLTbmSOSOxiVkYRMQQQuQQec0Dwb4avfGBhi8O6Mlnp1vmVUsYgJZpPuq3y8hUUnB7up7VyXi+HQP8AhEtasrfwRpdv4hgsp3uVSxjRbVFjJMyyheQf4Mck+mDjvtI+HPhXT9PitpNC0u8kXJaa5s4nd2JyTyvAz0AwB0AqeZVGktjd0ZYOLlU0k1ZLye79Grpd73RneHPBvhibWPFKS+HNGdIdSSOJWsYiEX7HbNtX5eBuZjgdyT3o8R+DfDEOseFki8OaMiTak8cqrYxAOv2O5ba3y8jcqnB7gHtR4c8G+GJtY8UpL4c0Z0h1JI4laxiIRfsds21fl4G5mOB3JPejxH4N8MQ6x4WSLw5oyJNqTxyqtjEA6/Y7ltrfLyNyqcHuAe1annm7/wAIN4T/AOhX0L/wXw//ABNYXgHwb4YuvAvhy4ufDmjTTy6bbSSSSWMTM7GJSSSVySTzmt3/AIQbwn/0K+hf+C+H/wCJrC8A+DfDF14F8OXFz4c0aaeXTbaSSSSxiZnYxKSSSuSSec0AHhzwb4Ym1jxSkvhzRnSHUkjiVrGIhF+x2zbV+XgbmY4Hck96w18K+Hk17TrGTQdJLR+IZ4nBs4zvieynnRTxyoLLgdBsH90Y3PDng3wxNrHilJfDmjOkOpJHErWMRCL9jtm2r8vA3MxwO5J71ieMvB2j6T4o0G/tfDmmXWn3FyIZdPgsY95Zbe5YlQcKQQQxXqTEmMnpnPRqR1YZKcZ0r6u1umqff0bO4/4Qbwn/ANCvoX/gvh/+JrC8A+DfDF14F8OXFz4c0aaeXTbaSSSSxiZnYxKSSSuSSec0s1n8NoNPtryfSvDUcVym+BGsIhLKM4wse3eWzxtAznjFcp4S8IaP4l0Lw5BFoyWdsujqb69GkwI085SILteaJi3HmnenB4O40OrHpqxwwVV6zXLHW7adtPlv0t3NLwb4d8Pap408Ts/h/Rn0zyrZrKL7DFsVRJcRMwG3HzNETkdRt9q2PEfg3wxDrHhZIvDmjIk2pPHKq2MQDr9juW2t8vI3Kpwe4B7UzTvBfhhfG2q2h8PaQ9vDpliyJJZxthjJdBm5H3iFXJ6naM9Kf4j8G+GIdY8LJF4c0ZEm1J45VWxiAdfsdy21vl5G5VOD3APaqgrKzMsRUVWo5R22XotF+Bu/8IN4T/6FfQv/AAXw/wDxNHw4/wCSeeF/+wXa/wDolaP+EG8J/wDQr6F/4L4f/iaPhx/yTzwv/wBgu1/9ErVGJ0VFFFAHO33/ACUPRP8AsF3/AP6Os6PHn/IDtv8AsKab/wClsFaOr6HpOteV/bGl2GoeTny/tVukuzOM43A4zgdPQVnf8IN4T/6FfQv/AAXw/wDxNAHRVzvw4/5J54X/AOwXa/8AolaP+EG8J/8AQr6F/wCC+H/4mj/hBvCf/Qr6F/4L4f8A4mgA8B/8gO5/7Cmpf+ls9Fj/AMlD1v8A7Bdh/wCjryj/AIQbwn/0K+hf+C+H/wCJo/4Qbwn/ANCvoX/gvh/+JoAPFH/Ic8If9hST/wBIrqj4j/8AJPPFH/YLuv8A0S1H/CDeE/8AoV9C/wDBfD/8TR/wg3hP/oV9C/8ABfD/APE0AdFXO/Dj/knnhf8A7Bdr/wCiVo/4Qbwn/wBCvoX/AIL4f/iaP+EG8J/9CvoX/gvh/wDiaADwv/yHPF//AGFI/wD0ita6KqWlaVp2j27W+k2FpYwM/mNHbQrEpYgDJCgDOAOfYVdoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAM3W9C0jXoI4dd0qw1KGNt6R3lukyq2MZAYHBx3rm9W+GHhbVde0jUrzToHh0u2e0g03yIjZ7GOeYihGQeRggCu2ooAy28PaK00UzaRpxlitzZxubZNyQEYMQOOE5Py9Paof+ET8OBAn9gaRsFsbIL9jjwICdxixt+5kk7eme1bVFAGZD4f0aC4WeHSNOjmW1FisiWyBhbjpCDjPl8D5entVKHwT4Vgsrmzh8M6HHaXRVp4EsIgkpXO0uu3DYycZ6ZNdBRQBg3fg3wxeG0N34c0Wc2kaxW5lsYm8lF+6qZX5QMcAdK0rLTLCxubu4srG1tri7cSXMsMSo0zDozkDLH3NXKKAK+pWVvqWnXVjex+ba3UTQTJuI3IwIYZHIyCelYv/CH6b/z867/4PL3/AOPV0VFAHm8fh7fq+sRaNYXTJb3KxzTTeKdQheaQwRNuIUNnCsi5JzhfTFSS+Er+aSF5dM3vC/mRM3i/USY22lcqdnB2swyOxI71qadr+j6Vr/ieDVNW0+ymbUI3EdxcpGxX7JbjIDEHGQefatP/AITLwx/0Mei/+B0X/wAVWCkne8u/buerOhKPLyULq0Xe09bxT6M5i58I31zBLBc6X50EyGOSOTxfqLK6kYKkFMEEE8VL/wAIzqv/AD4yf+FjqX/xFdF/wmXhj/oY9F/8Dov/AIqj/hMvDH/Qx6L/AOB0X/xVPmj/AD/kR7Kr/wBA34T/AMzH8N+GNH1HRbPVYv7Ztn1KGK8lVdcvSSzRr95vNG4hQq5PZRV+XwRo80kLyya07wv5kTNrV6TG20ruU+bwdrMMjsSO9WfAP/Ii+HP+wbbf+ilrdrSDbimzkxMFTrThHZNr8Tnf+EP03/n513/weXv/AMeqO28EaPa28VvbSa1DBEgjjjj1q9VUUDAUAS4AA4xXTUVRgcNrvhnTNF0+a8sk1aW5uLmCModfvYhLJJJHCGdxIx4BXnBOFA9KqS+Er+aSF5dM3vC/mRM3i/USY22lcqdnB2swyOxI710fjyaK28Pxz3EiRQxahYu8jsFVFF3CSST0AHepP+Ey8Mf9DHov/gdF/wDFVjKXvWcrfd5no0aLdBTjS53dq/vdFHs13Zx9l4Dksbme4stCt7a4uDumlh8V6gjSHOcsRHk8knmrNt4Sv7W3it7bTPJgiQJHHH4v1FVRQMBQAmAAO1dP/wAJl4Y/6GPRf/A6L/4qj/hMvDH/AEMei/8AgdF/8VSTitp/l/kXKFebvLD3fpP/AOSOc0Tw5bT69qNtqVtqFpfRW1vIZrbxJfTebGzTBVLFkPylHIHI+c+9bUvgjR5pIXlk1p3hfzImbWr0mNtpXcp83g7WYZHYkd6ZoGpWGq+M9Zn0u9tb2FdPskMlvKsihvMujglSRnBHHvXU1dN3je99/wAzlxlNU6vKo8ukdNesU3vqc7/wh+m/8/Ou/wDg8vf/AI9W1ptlb6bp1rY2UflWtrEsEKbidqKAFGTycADrViitDlCiiigArM8RajLpWl/abe3S4maeCBI3lMalpZUjBLBWwAXz0PStOue8eTRW3h+Oe4kSKGLULF3kdgqoou4SSSegA71FR2i2jowkFUrwhJXTaVu+pJ9q8T/9AjRf/BrL/wDI1H2rxP8A9AjRf/BrL/8AI1H/AAmXhj/oY9F/8Dov/iqP+Ey8Mf8AQx6L/wCB0X/xVRzR/n/I6vZVf+gb8J/5j9G1S/udWvdP1SytbWa3ghnDW9006usjSr/FGhBBiPY9a2q5bQNSsNV8Z6zPpd7a3sK6fZIZLeVZFDeZdHBKkjOCOPeupqqbvG977/mc+MpqnV5VHl0jpr1im99QooorQ5TF1nVL+21ay0/S7K1upriCactcXTQKixtEv8MbkkmUdh0pn2rxP/0CNF/8Gsv/AMjVT1/UrDSvGejT6pe2tlC2n3qCS4lWNS3mWpwCxAzgHj2q5/wmXhj/AKGPRf8AwOi/+KrDmXM05W+7semqEvZU5Qo8109fe/ma6O3QvaBqH9raFp2peV5P2y2juPL3btm9Q2M4GcZ64q/WF4B/5EXw5/2Dbb/0UtbtawbcU2ceJgqdacI7JtfiFFFFUYBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFI7KiMzsFVRkknAApayvFOmz6zoF5ptrd/Y3uk8pp9m4qhPzYGRyVyOvGc0pNpXRdKMZTUZuyb1fbzKHgTxZaeMNKnvbIbBDcyQFCecA/K34qVP1yO1dJXmfwg8HHw219dWmoyS2k81xbSW8iDO6G4eNHDD/ZU5GOp68Yr0ysqEpyppz3O7NqWHo4ucMK7wT08u617MKKKK2POCiiigAooooAxPGevw+GPDV9q06h/IT5IyceY5OFX8SR+Ga0NJv4NV0u0v7Rt1vcxLKh9mGfzri/jN4dk17wrcSNfNb2enQT3rQomTNIkZKAnPAHzdjnPbFbvgXw7J4W0P+yjfNeW0UjNbs6bWRDztPPODuOeOvTisFKftXG3u2PUnQwqy+NVT/euT0120+V1v6PyOiooorc8sKKKKACiiigAooooAK5nwr4usvEWsa7p9rgPpdwIc5z5i4wWH/Ag4/AHvW9qMdxNYXMVnMsFy8bLFKy7gjEcNjvg84ry74a+AG8OeLNTvLLVpZRaT/Y7iOWMfv0aCKXOQflId/fgY96wqympxUVp1PUwVDC1MNXlWnaaS5Vr3V7+uy9b9D1miiitzywooooAK5mw8XWV5451Hw1Hj7RaW6Tb933mP3l/AMn5n0rpWzg469s15BoPw7uLH4jzaiutySanbpBfTSNDhJvOknWRMZyBtj4OTjNYVpzi48ivrqepl1DC1adaWJnytR93fe67dOj9b9D2CiiitzywooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAp2Npb6VZyojlYfNmuXaRhwZJGkc59Msfwqvp3iHRdTuPs+m6vp15Pgt5dvcpI2B1OAScVNrqNJomoRxqzu1vIqqoySSpwAK828ApJZeBEstSm8VJNHZSB7KPT5IjEd2R5Uiwqxfpgbz1OR6YTqOElFbWPUw+EjiaM6823LmS++93s/0Wu56vRXh+pXfiaw8GeIrnW7jWbbU47G0NrKjyJEsZKBuRgCfOd+efTjNOvl8VXOjeI38Pya+bRrK1eBpnnErThkMnk7/n2ld+dvB7cYrJ4v8Auv8Aq/8Akd0eH29XVildK/T7PX/t78Geva7rFhoOmyahq0/2e0jKq0mxnwSQBwoJ6kVoV4V4yi8Qa3b+Llis9cnspYtPNpBLbzAbgU8zYjDrkEnA9zXSSNr0PxIyg1LVdOmuwuP9MtUskHBPaGRR/wACLY96axLcrW0/4L/yJnkkY0VL2nv2ba/7dg0uln7zTu+llqek2F7a6hbLc2FzBdW7EhZYJA6Eg4OCOOtWK8T0T/hKP7L8O/8ACQf8JJ/Z2y7+1+R5/wBp83c3lb9n7zbjbjt68U6yt/Gdy+mR6y2tq39hXDSGCSVB54ZzFuKEDzNuzjqe/ehYptL3X/Vv8/zKqZDGMpWrRsm/PZy22u/d12tePc9g1Wxi1TS7ywudwguoXgk2HB2spU4Prg1arn/AMmoS+DdIbWRONQ8gCb7QpWTcOPmB5zjHWugrpi+ZKXc8OvCVKcqLd1Fv07XXrYKKKKoxCiiigAooooAKKKKAK9/e2un2r3N/cw2tsmN0s0gRFycDJPA5IH41n+H7rR7ufUrjRdRtb5ridZrgwXCShG8tIx908fLGOvvWD8ZrK61D4carbWFtPdXLmHbFDGXdsSoTgDk8Ams7Vpr2TwmyaXeeKLrVVmhFsZLJ7YpJno2Iow0XB3bsjHviuedVxna2yv8AmexhcDGthlUUrOUnF9kvdd3ptd9WttL7Ho9FeJ6xf6tZW2hrqV1r1vez+IfKvwHmVZIyx+WAL1j24wF5z74qxZnxVbJpd1INebS49ekIR/OkuPsRxt81OXZRzwwJ/So+ta2sdDyFqKl7Ra3t52vt3vbTydz1TUdYsNOvbC0vZ/LuL+QxW6bGO9gMkZAwPxxVq7uYLO2kuLuaKC3jG55ZXCqo9STwK8X0u08QXV/4euNTttXkNvrl3IZLiGR2ihKLsPIyF647elNhPiyHTtct0XWtQn+xO8Wpqb23feWGEEEmF3cHmNeBj3qVinr7v9WNZZDT91Kqr9e3xNaPZaJb3bvome2xSJNEkkTq8bgMrqchgehB7ioI7GKPVLi/Ut588MUDZPG2NpGXA9cyN+leQ6x/wleb7zv+Eg+1fYLP+yPsnm7PN2r5vnbfl3bs583tn2qHXYvGPkeLrlG177dbzWTWK27zeWxIxL5aD5XX1ABFN4n+69P+D/l+JFPI76KtFKVl97j+Ccld9HF9j26ikUkqCeuKWuw+dCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAgvbS2vrWS2vreG5tpOHimQOjc55B4PIqVEWNFSNVVFACqowAB2Ap1FK3UfM7ct9AooopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigCtd2NpePA15awXDQSCWEyxhjG46Mueh9xVmiiiw3JtJN7BRRRQIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Defecation normally involves the coordinated relaxation of the puborectalis and external anal sphincter muscles as pressure is building in the rectum (control panel, left). However, in patients with dyssynergic defecation (patient panel, right), ineffective defecation is associated with a failure to relax, or inappropriate contraction of, the puborectalis and external anal sphincter muscles as pressure increases in the rectum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Preston DM, Lennard-Jones JE, Dig Dis Sci 1985; 30:413.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1237=[""].join("\n");
var outline_f1_13_1237=null;
var title_f1_13_1238="Golimumab: Patient drug information";
var content_f1_13_1238=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Golimumab: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35206?source=see_link\">",
"     see \"Golimumab: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7710508\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Simponi&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F10165746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Simponi&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700828",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       TB (tuberculosis) has been seen in patients started on this drug. These patients were exposed to TB in the past, but never got the infection. You will be tested to see if you have been exposed to TB before starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may add to your chance of getting lymphoma or other cancers.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700487",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad infections have happened in patients who take this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691734",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arthritis. The arthritis is most often moderate to very active and may not have been helped with other kinds of care.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691726",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat ankylosing spondylitis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692033",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat psoriatic arthritis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702215",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to golimumab, polysorbate 80, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a latex allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hepatitis B testing may be done. A hepatitis B infection may get worse during care.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-term use may raise your chance of cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad infections have been reported with use of this drug. If you have any infection, are taking antibiotics now or in the recent past, or have many infections, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697192",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have cancer, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697206",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor. You may be more likely to get infections.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697311",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have MS (multiple sclerosis) or other nerve disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027495\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027497\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699024",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in your legs or belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699004",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad back pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3424302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Night sweats.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3424303",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698578",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will need a TB (tuberculosis) test before starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to give closely if you or a family member is giving the shot at home.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Move the site where you give the shot with each shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw syringe away after use. Do not use more than one time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not shake.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12212 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-BD1901CB76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1238=[""].join("\n");
var outline_f1_13_1238=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7710508\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10165746\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027488\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027490\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027489\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027494\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027495\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027497\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027492\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027493\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027498\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027499\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35206?source=related_link\">",
"      Golimumab: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_13_1239="Metatarsal fracture nonunion";
var content_f1_13_1239=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57130&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57130&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Metatarsal fracture with nonunion and growth arrest",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 586px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple metatarsal neck fractures were complicated by nonunion and growth arrest in this 11-year-old boy. A) Initial x-ray shows fractures of the second, third, and fourth metatarsals with dorsal displacement. B) Patient was treated in a molded short-leg cast. Early remodeling is evident after cast removal. C) At 4.5 years after injury, the patient has growth arrest of the second metatarsal with shortening, hallux valgus, and clawing of the second toe. D) Clinical appearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Jarvis JG, Moroz PJ. Fractures and Dislocations of the Foot. In: Rockwood and Wilkins' Fractures in Children, 6th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1239=[""].join("\n");
var outline_f1_13_1239=null;
var title_f1_13_1240="Histologic changes in thromboangiitis obliterans";
var content_f1_13_1240=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F59478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F59478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histologic changes in thromboangiitis obliterans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 470px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three phases of thromboangiitis obliterans have been described pathologically. In the acute phase (shown above), occlusive inflammatory thrombus develop within the vessel. Polymorphonuclear leukocytes, micro-abscesses, and multinucleated giant cells may also be present. The intermediate phase is characterized by progressive organization of the thrombus. In the chronic phase, only organized thrombus and fibrosis remain; the inflammation is no longer present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rubin, E, Farber, JL. Pathology, 3rd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 1999. Copyright &copy; 1999 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1240=[""].join("\n");
var outline_f1_13_1240=null;
var title_f1_13_1241="Fatal anaphylaxis";
var content_f1_13_1241=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Fatal anaphylaxis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/13/1241/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/13/1241/contributors\">",
"     S Allan Bock, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/13/1241/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/13/1241/contributors\">",
"     F Estelle R Simons, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/13/1241/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/13/1241/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/13/1241/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death. It has been estimated to be fatal in 0.7 to 2 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In humans, fatal anaphylaxis is difficult to study because it is rare, unpredictable, and often unwitnessed. In addition, there may be few postmortem findings and laboratory tests may be negative.",
"   </p>",
"   <p>",
"    This topic will review the incidence, etiologies, epidemiology, clinical characteristics, possible risk factors, and postmortem diagnosis of fatal anaphylaxis, as they pertain to these fundamental questions. The diagnosis and management of anaphylaxis in adults is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18778?source=see_link\">",
"     \"Pathophysiology of anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The annual incidence of fatal anaphylaxis is not known precisely, although the following estimates are available:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A centralized register of fatal anaphylactic reactions from all causes was established in the United Kingdom (UK) in 1992 [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3\">",
"       3",
"      </a>",
"      ]. France also has a system for reporting anaphylactic deaths [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/4\">",
"       4",
"      </a>",
"      ]. In the UK, one case of fatal anaphylaxis per three million individuals yearly (approximately 20 deaths a year) has been reported over the past decade [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the United States (US), a registry of fatalities from food-induced anaphylaxis has been maintained by the American Academy of Allergy, Asthma and Immunology (AAAAI) and the Food Allergy and Anaphylaxis Network (FAAN) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. Estimates of anaphylactic deaths (from drugs, foods, insect stings, and latex) in the US are 0.002 percent annually [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/8-10\">",
"       8-10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study of anaphylaxis deaths within a single US state from 1996 through 2005 reported approximately 5 cases per 10 million individuals in the population annually [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A 2009 study from Australia identified 112 anaphylaxis fatalities during a nine year period, or about 0.64 anaphylaxis deaths per million population per year [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study from New Zealand estimated the rate to be approximately one per one million [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Studies have drawn conflicting conclusions about whether the incidence of fatal anaphylaxis is increasing [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3,14-16\">",
"     3,14-16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Possible underdiagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fatal anaphylaxis may be underdiagnosed because of the absence of specific findings at autopsy and lack of definitive diagnostic tests [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. Examples of situations in which anaphylaxis is likely overlooked as the cause of death include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asthmatic patients (especially children and adolescents) with concomitant food allergy may suffer food-induced anaphylaxis with prominent respiratory symptoms and be misdiagnosed as having a fatal asthma attack.",
"     </li>",
"     <li>",
"      Older adults with chronic pulmonary disease may die at home from antibiotic-induced anaphylaxis and be misdiagnosed as a cardiac or respiratory arrest due to either the chronic condition or the recent infection.",
"     </li>",
"     <li>",
"      Unrecognized insect stings may cause collapse and sudden death and be misdiagnosed as cardiovascular events, particularly if anaphylaxis involved myocardial ischemia or an arrhythmia. The cardiovascular aspects of anaphylaxis are reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18778?source=see_link&amp;anchor=H23#H23\">",
"       \"Pathophysiology of anaphylaxis\", section on 'Cardiovascular system'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ETIOLOGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fatal anaphylaxis can occur following a variety of triggers, although the most common culprits are medications, foods, and insect stings. Approximately one-half of all anaphylactic fatalities each year in the UK register were attributable to medications or agents administered during medical procedures (such as contrast media) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3\">",
"     3",
"    </a>",
"    ]. Reactions to foods and insect venoms each accounted for nearly a quarter of the total cases, with other causes accounting for the remaining cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta-lactam antibiotics (ie, penicillins and cephalosporins) appear to cause more fatalities than other drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/5,20\">",
"     5,20",
"    </a>",
"    ]. Multiple other agents have been implicated in smaller numbers of cases, including the following [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3,13,20-24\">",
"     3,13,20-24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Radiocontrast agents",
"     </li>",
"     <li>",
"      Neuromuscular blockers and anesthetics",
"     </li>",
"     <li>",
"      Allergen immunotherapy",
"     </li>",
"     <li>",
"      Other antibiotics",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Foods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peanuts and tree nuts account for the majority of food-induced fatalities [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3,6,7,25,26\">",
"     3,6,7,25,26",
"    </a>",
"    ]. Cow's milk and seafood are also leading causes of severe and fatal reactions. A variety of other foods have been implicated less commonly. At least two cases of fatal food-induced, exercise-associated anaphylaxis have been reported, although exercise or exertion is likely an unrecognized co-factor in other food-induced deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14808?source=see_link\">",
"     \"Clinical manifestations of food allergy: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Insect stings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stings of hymenoptera species (yellow jacket, honey bee, wasp, hornet, and imported fire ants) are one of the three leading causes of fatal anaphylaxis in the United States and United Kingdom [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/29-33\">",
"     29-33",
"    </a>",
"    ]. Men are more often stung by insects, perhaps due to higher rates of outdoor occupations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/1/12313?source=see_link\">",
"     \"Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7994?source=see_link\">",
"     \"Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other reported causes of fatal anaphylaxis include latex, rupture of a hydatid cyst, infestation with the parasite Tinea Solium, dental impression material, and the herbal preparation Houttuynia Cordata [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3,34-38\">",
"     3,34-38",
"    </a>",
"    ]. In some cases, no cause can be identified and the etiology is designated idiopathic [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/5,39,40\">",
"     5,39,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals of any age can develop anaphylaxis, and fatalities have been reported in infants as young as five months and adults as old as 91 years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/7,41\">",
"     7,41",
"    </a>",
"    ]. Certain trends are detectable, however. Adolescents and young adults are at highest risk for fatal anaphylaxis from foods, middle-aged adults are the most frequent victims of venom-induced deaths, and older adults account for most cases of fatal medication-induced anaphylaxis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Food-induced reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adolescents and young adults are the most frequent victims of fatal food-induced anaphylaxis, as mentioned previously [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/5,25\">",
"     5,25",
"    </a>",
"    ]. The following were observed in the UK register over a 10 year period [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fatal cow's milk reactions affected mostly children (median age was 8 years).",
"     </li>",
"     <li>",
"      Fatal peanut reactions affected mostly young adults (median age was 21 years).",
"     </li>",
"     <li>",
"      Fatal tree nut reactions affected mostly adults (median age was 27 years).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The reasons for the higher rate of food-induced deaths in adolescents and young adults are not clear. Contributing factors may include physiologic characteristics, risk taking behaviors related to cognitive and emotional development, the increasing prevalence of food allergy in younger generations, or other factors.",
"   </p>",
"   <p>",
"    In an internet-based anonymous survey of 176 adolescents and young adults with food allergy, more than one-half reported purposefully ingesting a potentially unsafe food, and 17 percent reported both eating foods that \"may contain\" allergens and not consistently carrying epinephrine [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Drugs and venoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of fatal anaphylaxis in adults over 50 are radiocontrast media and medications (peak incidence in patients 60 to 75 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/41\">",
"     41",
"    </a>",
"    ]. Adults make up the majority of victims in venom-induced fatal anaphylaxis, with a peak incidence in patients 45 to 70 years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/43\">",
"     43",
"    </a>",
"    ]. The elderly may be at increased risk for venom-induced death as well [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Gender",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not clear if gender contributes to the risk for fatal anaphylaxis, although some trends have been noted. As examples, the sex ratio is approximately equal for food anaphylaxis overall; however, young boys are affected more by fatal cow's milk reactions, and adolescent girls by peanut reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/5,6,44\">",
"     5,6,44",
"    </a>",
"    ]. Fatalities from contrast media and insect stings appear to affect males more than females [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Race",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of ethnicities have been represented in studies of anaphylaxis; however, there are not enough data to determine if racial differences in mortality exist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Location",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case series reveal that fatal food reactions occur in the patient's home, the homes of friends, restaurants,",
"    <span class=\"nowrap\">",
"     work/office",
"    </span>",
"    settings, and schools [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3,6,7,26\">",
"     3,6,7,26",
"    </a>",
"    ]. Most food-induced anaphylaxis is triggered by food that was not prepared by the patient themselves [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    High-risk foods for patients with peanut and tree nut allergies include baked goods, candy, and desserts. Issues pertaining to food allergen exposure are reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3705?source=see_link\">",
"     \"Food allergy in schools and camps\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fatal stings can be sustained outdoors or indoors. Although outdoor occupations are often cited as a possible explanation for the predominance of male victims, a 10 year UK registry reported that only 15 percent of stings occurred at work, while 32 percent occurred in the patient's yard, and 39 percent inside the home (including 5 percent in bed) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Medication-induced fatal anaphylaxis often occurs in a medically supervised setting:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most reported fatal anaphylactic reactions to medications and contrast agents occur in the hospital setting, which may reflect the wider range of agents used in this environment, intravenous administration, or patient-related factors [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/13,47\">",
"       13,47",
"      </a>",
"      ]. General anesthesia was associated with more fatalities than other hospital procedures in one series [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"       44",
"      </a>",
"      ]. Alternatively, it is possible that community cases are underrecognized and underreported. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Possible underdiagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fatal anaphylactic reactions to allergen immunotherapy occur approximately once per 2.5 million injections administered, and account for three to four deaths per year in the United States [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/24\">",
"       24",
"      </a>",
"      ]. These reactions are most prevalent in the 20 to 30 minutes immediately following administration, and most allergists require patients to wait this amount of time in the clinic after each set of injections [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/23\">",
"       23",
"      </a>",
"      ]. Rare deaths still occur despite this precaution.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CLINICAL CHARACTERISTICS OF FATAL REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case reports and series have provided valuable information about the clinical characteristics of fatal anaphylactic reactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Previous reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Victims of fatal anaphylaxis may not be aware that they are allergic to the implicated allergen [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/9\">",
"     9",
"    </a>",
"    ]. In one series of 25 fatalities, the history of a previous reaction could be elicited from the patient's relatives or medical records in just one-third of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/41\">",
"     41",
"    </a>",
"    ]. Even in patients with known past reactions, the severity of previous reactions cannot be relied upon to predict the severity of future reactions, a finding which has been noted in multiple series [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3,6,7,25,26,39,43\">",
"     3,6,7,25,26,39,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In fatal food anaphylaxis, most individuals did have previous reactions to the culprit food and were supposed to be avoiding it. In many cases, however, these reactions were so mild that it is unlikely that most clinicians would have advised the patient to carry an epinephrine autoinjector. It is possible that these patients represent an unfortunate minority whose initial severe reaction proved fatal. Perhaps other patients' symptoms escalated gradually, prompting them to seek medical evaluation and thus be better prepared for re-exposure. The frequency of these different patterns is not currently known.",
"     </li>",
"     <li>",
"      In contrast, victims of venom and medication-induced anaphylaxis often had no known history of a previous reaction. In many cases of venom anaphylaxis, the individual was stung in the past and did not have systemic symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"       44",
"      </a>",
"      ]. Similarly, no history of previous reactions to the causative medication can be elicited in some drug-induced fatalities [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3,44\">",
"       3,44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Less than 60 minutes elapses between allergen exposure and death in most cases of fatal anaphylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/5,25\">",
"     5,25",
"    </a>",
"    ]. Most fatal reactions are uniphasic, present fulminantly and progress rapidly, although a few follow a more protracted or biphasic course, typically over several hours [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/25,48,49\">",
"     25,48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An analysis of 202 fatalities over a 10-year period in the United Kingdom determined that the interval between exposure and the onset of symptoms varied with the type of allergen and route of exposure, as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Following medications, symptoms appeared after a mean of five minutes in hospitalized patients and after 10 to 20 minutes in ambulatory patients",
"     </li>",
"     <li>",
"      Following insect stings, symptoms appeared after a mean of 10 to 15 minutes",
"     </li>",
"     <li>",
"      Following foods, symptoms appeared after 25 to 35 minutes",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Allergen dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;It seems logical that the higher the allergen dose, the more rapid and severe the reaction, although patients may have very different threshold levels beyond which they will experience anaphylaxis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fatal food anaphylaxis has been reported in response to a wide range of allergen doses, from trace amounts to doses in excess of 100 grams. In keeping with the impression that nuts are especially potent allergens, one review found that the dose of nuts that was most frequently implicated in fatalities was approximately one gram, while the dose most often reported in fatal anaphylaxis from other foods was about 10 grams [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Most insect sting fatalities result from a single sting [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Most drug-induced fatalities occur in response to normal doses of the culprit medication [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     CAUSE OF DEATH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory arrest",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    shock with cardiovascular collapse are responsible for most fatalities [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. The cause of death appears to be determined, at least in part, by the type of allergen. In a review of 56 cases of fatal anaphylaxis for which autopsy data were available, all food-induced reactions involved difficulty breathing, and respiratory arrest was the cause of death in 13 of 16 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/47\">",
"     47",
"    </a>",
"    ]. In contrast, shock without respiratory compromise was the presentation in most cases of venom or medication-induced anaphylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/52\">",
"     52",
"    </a>",
"    ]. This correlation between allergen type and mechanism of death has been noted in many studies and is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18778?source=see_link\">",
"     \"Pathophysiology of anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a very small number of cases, massive epinephrine overdose or disseminated intravascular coagulation appeared to be the immediate cause of death [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     POSSIBLE RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most consistently noted risk factor for fatal anaphylaxis is concomitant asthma. Other possible risk factors include delayed or no administration of epinephrine, upright posture, and other cardiopulmonary diseases (",
"    <a class=\"graphic graphic_table graphicRef76871 \" href=\"UTD.htm?3/40/3723\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Asthma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asthma may be the single most important risk factor for fatal food-induced anaphylaxis. In the 10 year UK series, all fatal food reactions occurred in patients taking daily medications for asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"     44",
"    </a>",
"    ]. Although current guidelines state that all patients with daily symptoms should be treated with inhaled glucocorticoids, many were not taking these agents and some were using short acting beta-agonists excessively. In another series of 32 food-induced fatalities, all but one patient had asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Asthma also appears to be common among victims of drug and venom-induced anaphylaxis, although the correlation is not as strong as that for food [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not known if controlling asthma reduces the risk of death from anaphylaxis. Most series have not reported the status of the individuals' asthma at the time of their deaths, but the study above implies that at least some patients have poorly controlled symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"     44",
"    </a>",
"    ]. In contrast, one study of 13 fatal or near-fatal food reactions reported that 12 patients had asthma that was well controlled [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Delayed or no administration of epinephrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early administration of epinephrine appears to be critical for survival after severe anaphylaxis. A series of 13 fatal and near fatal food-induced anaphylactic reactions in children and adolescents suggested that epinephrine is most effective when given in the initial 30 minutes of the reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/25\">",
"     25",
"    </a>",
"    ]. Epinephrine was administered within this time period in six of seven children who survived, whereas only two of six patients who died received the drug within the first hour.",
"   </p>",
"   <p>",
"    Several series have found that only a minority of individuals with fatal anaphylaxis receive epinephrine promptly or at all [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3,25,41\">",
"     3,25,41",
"    </a>",
"    ]. A UK series of anaphylactic deaths occurring from 1992 to 1998 found that only 20 percent of patients were given epinephrine at any point in their treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The number of food and venom-allergic individuals who do not carry their prescribed self-injectable epinephrine is large and discouraging. Furthermore, many of those who do carry it are unable to self-administer it promptly and correctly in a panic situation because they have not been instructed in how to use the device, or have not practiced with the trainer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     No response to epinephrine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even when epinephrine is available and administered without delay, it is not always effective for a number of reasons (",
"    <a class=\"graphic graphic_table graphicRef61580 \" href=\"UTD.htm?15/8/15501\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/53\">",
"     53",
"    </a>",
"    ]. There are reports of anaphylaxis, typically during medical procedures, in which the victim succumbed despite receiving appropriate treatment, including prompt administration of epinephrine. Thus, both clinicians and patients should understand that the current recommended management of anaphylaxis is not universally effective.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Other cardiopulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other cardiac or pulmonary conditions are identified in a significant proportion of middle- and older-aged patients who succumb to anaphylaxis from all causes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3,41,54\">",
"     3,41,54",
"    </a>",
"    ]. In one study, 88 percent of victims had one or more comorbid conditions, including 11 of 25 with symptomatic ischemic heart disease, as well as others with heart failure, hypertensive heart disease, and chronic obstructive pulmonary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/41\">",
"     41",
"    </a>",
"    ]. Other series found lower rates of concomitant diseases, although cardiac and pulmonary conditions consistently predominated [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/13,41,47\">",
"     13,41,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is biologically plausible that these comorbid conditions directly contribute to the fatal outcome, as the heart and lungs are the primary shock organs in anaphylaxis and could be expected to fail more readily if compromised by pre-existing disease. It is also possible that patients with cardiac disease are at increased risk for adverse reactions to treatment (especially intravenous boluses of epinephrine) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/55\">",
"     55",
"    </a>",
"    ]. At present, however, the precise interplay between cardiopulmonary diseases and anaphylaxis are unclear. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18778?source=see_link\">",
"     \"Pathophysiology of anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Upright posture during anaphylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulseless electrical cardiac activity has been identified at the time of death in some subjects with anaphylaxis, which is believed to result from inadequate cardiac filling during severe hypotension and subsequent cardiac arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. The term \"empty ventricle syndrome\" has been applied to this phenomenon [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/58\">",
"     58",
"    </a>",
"    ]. Patients, caregivers, clinicians, and \"first responders\" must understand the importance of placing the patient in the supine position with legs elevated if signs of hypotension are present during an allergic reaction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Conscious individuals with bronchospasm may resist being placed supine, as sitting upright may ease the sense of dyspnea. In this setting, providing oxygen and explaining the reason for lying down are important, at least until the cardiovascular status can be assessed. Individuals who are vomiting and also hypotensive should be placed on their side rather than supine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Initial misdiagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaphylaxis can be mistaken for a variety of other conditions, such as asthma exacerbation, panic attack, myocardial infarction, and choking. In some cases, valuable time is lost or inappropriate medications are given before the correct diagnosis is recognized [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3,44\">",
"     3,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Systemic mastocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with systemic mastocytosis (SM) may be at higher risk for fatal anaphylaxis, even in the absence of IgE-mediated allergy. In the UK register, 2 of 164 individuals had SM [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/3\">",
"     3",
"    </a>",
"    ]. One died following a bee sting, and the other during anesthesia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6170?source=see_link\">",
"     \"Clinical manifestations, pathogenesis, and classification of mastocytosis (cutaneous and systemic)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Other atopic conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly all patients who died of anaphylaxis were known to have had one or more allergic conditions, or were clearly atopic by retrospectively-gathered history [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"     44",
"    </a>",
"    ]. Venom- and medication-induced anaphylaxis, however, typically afflict non-atopic individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Exacerbating factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The severity of anaphylaxis is believed to be increased in some cases by concurrent medications, foods, alcohol, exercise, premenstrual state, or other co-factors. These co-factors have been noted in both non-fatal and fatal anaphylaxis.",
"   </p>",
"   <p>",
"    Beta-blocking agents and angiotensin-converting enzyme inhibitors interfere with the pharmacologic treatment of and compensatory physiologic responses to anaphylaxis, respectively. The presence of these medications has been noted in some studies of venom-induced fatalities and experimental sting challenges [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Patients taking these drugs, however, are not clearly over-represented in the literature on fatal anaphylaxis, and the impact of these medications requires further study.",
"   </p>",
"   <p>",
"    A variety of other medications, including aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs), opioids, alcohol, and anti-ulcer therapies, have been implicated in worsening the severity of anaphylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/61\">",
"     61",
"    </a>",
"    ]. These agents are occasionally reported as co-factors in fatal anaphylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     POSTMORTEM DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of fatal anaphylaxis is determined by the clinical presentation and historical information. Autopsy findings and laboratory testing may support the clinical impression, although they are not necessary or sufficient, in isolation, to make the diagnosis. In cases of sudden death of uncertain cause, femoral venous blood can be collected and the serum can be separated and frozen for later analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Serum tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood collected during or shortly after the event may be analyzed retrospectively for the mast cell-derived mediator tryptase, and for evidence of IgE to the suspect allergen.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tryptase is a mediator released by mast cells upon activation and is relatively specific to this cell type, although basophils also make a small amount. Any elevation is consistent with anaphylaxis. Tryptase levels that are within normal limits do not exclude the diagnosis. Tryptase is seldom elevated in food-induced anaphylaxis. The use of postmortem tryptase levels in the evaluation of possible fatal anaphylaxis is reviewed in more detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40809?source=see_link\">",
"       \"Laboratory tests to support the clinical diagnosis of anaphylaxis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Quantitative IgE immunoassays may be helpful in detecting the presence of allergen-specific IgE in the victim's serum as a means of confirming that the patient was allergic to the allergen in question. Serum IgE levels do not change substantively as a result of anaphylaxis. Positive tests for allergen-specific IgE suggest the presence of sensitization; negative assays do not exclude sensitization. Serum tests for sensitization to allergens are reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/22/44391?source=see_link\">",
"       \"Overview of in vitro allergy tests\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one retrospective review, there were 56 cases of fatal anaphylaxis in which autopsy information was available [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/47\">",
"     47",
"    </a>",
"    ]. Of these, 21, 19, and 16 fatalities were due to medications, insect venoms, and food allergies, respectively. Laboratory test results were not available in most cases; however, in the 16 cases of fatal anaphylaxis (due to a variety of agents) in which tryptase levels were measured, elevations were found in 14. In a series of 25 selected cases of fatal anaphylaxis, serum total tryptase concentrations were elevated in four of seven cases tested [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Autopsy findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many victims have no distinguishing gross pathologic features at autopsy, particularly if shock develops rapidly [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/13,41,47\">",
"     13,41,47",
"    </a>",
"    ]. When present, however, findings include upper airway edema, mucus plugging and hyperinflation of the lungs, and cerebral edema [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the series of 56 cases mentioned previously, all individuals collapsed after allergen exposure, and 23 had a documented asthmatic component [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/47\">",
"     47",
"    </a>",
"    ]. Dermatologic signs and symptoms were uncommon. The following macroscopic findings were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Laryngeal or pharyngeal edema (41 percent)",
"     </li>",
"     <li>",
"      Hyperinflation of the lungs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      mucus plugging (27 percent)",
"     </li>",
"     <li>",
"      Cerebral edema, suggesting cerebral hypoxia (27 percent)",
"     </li>",
"     <li>",
"      Petechial hemorrhages in the airway mucosa, suggesting asphyxiation (18 percent)",
"     </li>",
"     <li>",
"      Cutaneous erythema or urticaria (5 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In cases where anaphylaxis to food is suspected at the time of death, the pathologist can be asked to preserve some of the stomach contents for later analysis for suspected food allergens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The literature provides some insight into predicting which individuals are at greatest risk for fatal anaphylaxis. These individuals most often have allergy to foods, medications, or insect venoms, accompanied by one or more of the following characteristics:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Concomitant asthma, particularly patients with food allergy",
"     </li>",
"     <li>",
"      Comorbid cardiovascular conditions, particularly older patients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, clinicians should be mindful of classic patient profiles, such as young patients with food allergy and asthma, or older patients with insect sting or medication allergies and cardiopulmonary diseases. Such high-risk patients should be supplied with and trained to use epinephrine autoinjectors. Clinicians should repeatedly reinforce important concepts in anaphylaxis preparedness (",
"    <a class=\"graphic graphic_table graphicRef68300 \" href=\"UTD.htm?2/45/2779\">",
"     table 3",
"    </a>",
"    ). Careful attention to asthma control may reduce risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23832?source=see_link\">",
"     \"Prescribing epinephrine for anaphylaxis self-treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prevention of anaphylactic deaths in patients that are not known to have an allergy is a public health issue that will need to be addressed by campaigns to improve public awareness of anaphylaxis and specific protocols for first responders [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1241/abstract/63\">",
"     63",
"    </a>",
"    ]. Similar approaches have been applied to community management of myocardial infarction, stroke, and choking. Anaphylaxis is rare compared to these events, although it often afflicts otherwise healthy people in the prime of life, and is generally responsive to proper treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/57/15250?source=see_link\">",
"       \"Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/14/41186?source=see_link\">",
"       \"Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anaphylaxis is rare, although estimates of incidence are probably lower than the true figures. Anaphylaxis is believed fatal in up to 2 percent of cases. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Incidence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common causes of fatal anaphylaxis are foods, medications, and insect stings. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiologies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adolescents and young adults are at highest risk for fatal anaphylaxis induced by foods. Middle-aged and older adults account for most fatalities from venom and medication-induced reactions. There are no clear differences between genders or among racial groups. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients with food-induced deaths were aware of the allergy and were supposed to be avoiding the culprit food; however, many had experienced only minor past reactions. Some patients with venom and medication reactions had no recognized reactions in the past. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Previous reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fatal anaphylaxis typically results in death within 30 to 60 minutes. The amount of allergen is usually unremarkable (eg, variable amounts of food, one insect sting, a normal dose of medication). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Timing'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Allergen dose'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most fatal food-induced reactions involve difficulty breathing and culminate in respiratory arrest. In contrast, venom or medication-induced anaphylaxis more often cause shock and cardiovascular collapse. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Cause of death'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Concomitant asthma is a significant risk factor for fatal anaphylaxis, particularly for adolescents with food allergy. Older victims of anaphylaxis (from all causes) often have underlying cardiopulmonary conditions. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Possible risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Characteristics of unsuccessful treatment include delayed or no administration of epinephrine, either due to initial misdiagnosis, failure to properly administer epinephrine, or unavailability of this drug. Maintaining the patient in an upright position after collapse can lead to pulseless electrical activity and cardiac arrest (empty ventricle syndrome). Occasionally, victims succumb despite receiving prompt and appropriate treatment. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Possible risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of fatal anaphylaxis is based upon clinical course and historical information, supported by laboratory and autopsy findings. Femoral venous blood can be collected and the serum separated and frozen for later assays of tryptase and allergen-specific IgE. Autopsy findings may be minimal. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Postmortem diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fatal anaphylaxis is unpredictable, although certain patients are at higher risk, such as those with concomitant asthma or cardiopulmonary disease. Clinicians should optimize asthma control and repeatedly reinforce important issues regarding anaphylaxis preparedness (",
"      <a class=\"graphic graphic_table graphicRef68300 \" href=\"UTD.htm?2/45/2779\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H34\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/1\">",
"      Moneret-Vautrin DA, Morisset M, Flabbee J, et al. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/2\">",
"      Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: A review of 142 patients in a single year. J Allergy Clin Immunol 2001; 108:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/3\">",
"      Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/4\">",
"      Moneret-Vautrin DA, Kanny G, Morisset M, et al. Severe food anaphylaxis: 107 cases registered in 2002 by the Allergy Vigilance Network. Eur Ann Allergy Clin Immunol 2004; 36:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/5\">",
"      Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004; 4:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/6\">",
"      Bock SA, Mu&ntilde;oz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/7\">",
"      Bock SA, Mu&ntilde;oz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/8\">",
"      Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 2001; 161:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/9\">",
"      Yocum MW, Khan DA. Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clin Proc 1994; 69:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/10\">",
"      Yocum MW, Butterfield JH, Klein JS, et al. Epidemiology of anaphylaxis in Olmsted County: A population-based study. J Allergy Clin Immunol 1999; 104:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/11\">",
"      Simon MR, Mulla ZD. A population-based epidemiologic analysis of deaths from anaphylaxis in Florida. Allergy 2008; 63:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/12\">",
"      Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009; 123:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/13\">",
"      Low I, Stables S. Anaphylactic deaths in Auckland, New Zealand: a review of coronial autopsies from 1985 to 2005. Pathology 2006; 38:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/14\">",
"      Sheikh A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000; 320:1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/15\">",
"      Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 2001; 31:1571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/16\">",
"      Colver AF, Nevantaus H, Macdougall CF, Cant AJ. Severe food-allergic reactions in children across the UK and Ireland, 1998-2000. Acta Paediatr 2005; 94:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/17\">",
"      Foucard T, Malmheden Yman I. A study on severe food reactions in Sweden--is soy protein an underestimated cause of food anaphylaxis? Allergy 1999; 54:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/18\">",
"      Schwartz HJ, Yunginger JW, Schwartz LB. Is unrecognized anaphylaxis a cause of sudden unexpected death? Clin Exp Allergy 1995; 25:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/19\">",
"      Pumphrey RS, Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999; 353:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/20\">",
"      Gruchalla RS. 10. Drug allergy. J Allergy Clin Immunol 2003; 111:S548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/21\">",
"      Srinivasa MR, Phelan C. Death due to anaphylactic shock after ingestion of Imodium instants (Loperamide). Allergy 2007; 62:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/22\">",
"      Fasting S, Gisvold SE. [Serious intraoperative problems--a five-year review of 83,844 anesthetics]. Can J Anaesth 2002; 49:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/23\">",
"      Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TA. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993; 92:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/24\">",
"      Bernstein DI, Wanner M, Borish L, et al. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 2004; 113:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/25\">",
"      Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992; 327:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/26\">",
"      Pumphrey RS, Stanworth SJ. The clinical spectrum of anaphylaxis in north-west England. Clin Exp Allergy 1996; 26:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/27\">",
"      Noma T, Yoshizawa I, Ogawa N, et al. Fatal buckwheat dependent exercised-induced anaphylaxis. Asian Pac J Allergy Immunol 2001; 19:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/28\">",
"      Flannagan LM, Wolf BC. Sudden death associated with food and exercise. J Forensic Sci 2004; 49:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/29\">",
"      More DR, Kohlmeier RE, Hoffman DR. Fatal anaphylaxis to indoor native fire ant stings in an infant. Am J Forensic Med Pathol 2008; 29:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/30\">",
"      Johansson B, Eriksson A, Ornehult L. Human fatalities caused by wasp and bee stings in Sweden. Int J Legal Med 1991; 104:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/31\">",
"      Harvey P, Sperber S, Kette F, et al. Bee-sting mortality in Australia. Med J Aust 1984; 140:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/32\">",
"      Mosbech H. Death caused by wasp and bee stings in Denmark 1960-1980. Allergy 1983; 38:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/33\">",
"      Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973; 52:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/34\">",
"      Ji KM, Li M, Chen JJ, et al. Anaphylactic shock and lethal anaphylaxis caused by Houttuynia Cordata injection, a herbal treatment in China. Allergy 2009; 64:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/35\">",
"      Gangemi S, Spagnolo EV, Cardia G, Minciullo PL. Fatal anaphylactic shock due to a dental impression material. Int J Prosthodont 2009; 22:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/36\">",
"      Minciullo PL, Spagnolo EV, Cascio A, et al. Fatal anaphylactic shock and Taenia solium infestation: a possible link? Ann Allergy Asthma Immunol 2009; 103:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/37\">",
"      Zimmerman B, Urch B. Peanut allergy: children who lose the positive skin test response. J Allergy Clin Immunol 2001; 107:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/38\">",
"      Ownby DR, Tomlanovich M, Sammons N, McCullough J. Anaphylaxis associated with latex allergy during barium enema examinations. AJR Am J Roentgenol 1991; 156:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/39\">",
"      Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 2003; 33:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/40\">",
"      Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 2006; 97:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/41\">",
"      Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 2007; 98:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/42\">",
"      Sampson MA, Mu&ntilde;oz-Furlong A, Sicherer SH. Risk-taking and coping strategies of adolescents and young adults with food allergy. J Allergy Clin Immunol 2006; 117:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/43\">",
"      Hoffman DR. Fatal reactions to hymenoptera stings. Allergy Asthma Proc 2003; 24:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/44\">",
"      Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp 2004; 257:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/45\">",
"      Lantner R, Reisman RE. Clinical and immunologic features and subsequent course of patients with severe insect-sting anaphylaxis. J Allergy Clin Immunol 1989; 84:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/46\">",
"      Lenler-Petersen P, Hansen D, Andersen M, et al. Drug-related fatal anaphylactic shock in Denmark 1968-1990. A study based on notifications to the Committee on Adverse Drug Reactions. J Clin Epidemiol 1995; 48:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/47\">",
"      Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000; 53:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/48\">",
"      Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986; 78:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/49\">",
"      Lee JM, Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics 2000; 106:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/50\">",
"      Sampson HA, Mu&ntilde;oz-Furlong A, Bock SA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/51\">",
"      Brown SG. Anaphylaxis: clinical concepts and research priorities. Emerg Med Australas 2006; 18:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/52\">",
"      Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 2007; 119:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/53\">",
"      Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004; 113:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/54\">",
"      Sasvary T, M&uuml;ller U. [Fatalities from insect stings in Switzerland 1978 to 1987]. Schweiz Med Wochenschr 1994; 124:1887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/55\">",
"      Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007; 7:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/56\">",
"      Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005; 5:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/57\">",
"      Kudoh O, Warabi K, Yamaguchi K, et al. [A case of anaphylactic shock in an elderly man following protamine sulfate administration during emergent off-pump coronary artery bypass grafting]. Masui 2006; 55:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/58\">",
"      Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003; 112:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/59\">",
"      Ober AI, MacLean JA, Hannaway PJ. Life-threatening anaphylaxis to venom immunotherapy in a patient taking an angiotensin-converting enzyme inhibitor. J Allergy Clin Immunol 2003; 112:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/60\">",
"      Hepner MJ, Ownby DR, Anderson JA, et al. Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections. J Allergy Clin Immunol 1990; 86:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/61\">",
"      Fujita H, Osuna H, Kanbara T, et al. [Wheat anaphylaxis enhanced by administration of acetylsalicylic acid or by exercise]. Arerugi 2005; 54:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/62\">",
"      Shen Y, Li L, Grant J, et al. Anaphylactic deaths in Maryland (United States) and Shanghai (China): a review of forensic autopsy cases from 2004 to 2006. Forensic Sci Int 2009; 186:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1241/abstract/63\">",
"      Murphy KR, Hopp RJ, Kittelson EB, et al. Life-threatening asthma and anaphylaxis in schools: a treatment model for school-based programs. Ann Allergy Asthma Immunol 2006; 96:398.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 390 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-3384FBAA07-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1241=[""].join("\n");
var outline_f1_13_1241=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H36\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Possible underdiagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Foods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Insect stings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Food-induced reactions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Drugs and venoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Gender",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Race",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Location",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CLINICAL CHARACTERISTICS OF FATAL REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Previous reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Timing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Allergen dose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      CAUSE OF DEATH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      POSSIBLE RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Asthma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Delayed or no administration of epinephrine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      No response to epinephrine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Other cardiopulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Upright posture during anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Initial misdiagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Systemic mastocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Other atopic conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Exacerbating factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      POSTMORTEM DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Serum tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Autopsy findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/390\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/390|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/40/3723\" title=\"table 1\">",
"      Fatal ANA poss RFs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/8/15501\" title=\"table 2\">",
"      Reasons for Epi nonresponse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/45/2779\" title=\"table 3\">",
"      Epi issues preven fatal ANA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/1/12313?source=related_link\">",
"      Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14808?source=related_link\">",
"      Clinical manifestations of food allergy: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6170?source=related_link\">",
"      Clinical manifestations, pathogenesis, and classification of mastocytosis (cutaneous and systemic)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3705?source=related_link\">",
"      Food allergy in schools and camps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40809?source=related_link\">",
"      Laboratory tests to support the clinical diagnosis of anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=related_link\">",
"      Management of food allergy: Avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/22/44391?source=related_link\">",
"      Overview of in vitro allergy tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18778?source=related_link\">",
"      Pathophysiology of anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/57/15250?source=related_link\">",
"      Patient information: Anaphylaxis symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/14/41186?source=related_link\">",
"      Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23832?source=related_link\">",
"      Prescribing epinephrine for anaphylaxis self-treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7994?source=related_link\">",
"      Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_13_1242="Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract";
var content_f1_13_1242=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/13/1242/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/13/1242/contributors\">",
"     Mary Lee Krinsky, DO",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/13/1242/contributors\">",
"     Kenneth Binmoeller, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/13/1242/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/13/1242/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/13/1242/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/13/1242/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/13/1242/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A subepithelial mass or a bulge encountered during an endoscopy can arise from within any layer of the gastrointestinal tract wall (intramural) or outside of the wall (extramural). They are usually found incidentally during routine imaging with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    contrast radiography or endoscopy. The differential diagnosis includes a number of benign and malignant non-epithelial gastric wall tumors, intramural vessels, and extrinsic compression from extramural structures.",
"   </p>",
"   <p>",
"    Endoscopy alone cannot accurately distinguish between intramural and extramural lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/1\">",
"     1",
"    </a>",
"    ]. By contrast, endoscopic ultrasonography (EUS) has provided a major breakthrough for characterizing such masses. This topic review will provide an overview of the most common subepithelial lesions that can be identified endosonographically. Discussions on the individual lesions are also available on the corresponding topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES FOR IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;EUS provides a number of methods for characterizing subepithelial lesions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It provides an understanding of whether the lesion arises from the bowel wall (intramural) or from a structure outside the bowel wall (extramural) compressing the gastrointestinal wall. Extramural lesions may be a normal adjacent structure (eg, spleen, aorta, gallbladder) or pathologic structures (eg, splenic artery aneurysm, cyst, tumor). Rarely, the distinction between an intra- and extramural lesion may be difficult when there is invasion into the gastrointestinal wall.",
"     </li>",
"     <li>",
"      It can determine the originating layer of intramural lesions, an important clue for achieving a diagnosis (",
"      <a class=\"graphic graphic_table graphicRef73389 \" href=\"UTD.htm?43/34/44587\">",
"       table 1",
"      </a>",
"      ). Stromal cell tumors, for example, can typically be seen as evolving from the muscularis propria or muscularis mucosa, whereas lipomas typically evolve from the submucosa.",
"     </li>",
"     <li>",
"      The echogenicity, vascularity, margins, size of the lesion, and absence or presence of adjacent lymph nodes also help to narrow the differential diagnosis.",
"     </li>",
"     <li>",
"      EUS-guided fine-needle aspiration or trucut biopsy of the lesion may be helpful in some settings. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=see_link\">",
"       \"Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/8/14471?source=see_link\">",
"       \"Endoscopic ultrasound guided trucut biopsy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Technical considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following are basic principles that should be understood by endosonographers attempting to visualize subepithelial lesions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The lesions should be localized endoscopically or by cross-sectional imaging (CT, MRI, US) prior to endosonographic evaluation.",
"     </li>",
"     <li>",
"      The gastrointestinal tract wall echo structure, five layers of alternating bright (hyperechoic) and dark (hypoechoic) lines of approximately 3 to 4 mm thickness should be understood (",
"      <a class=\"graphic graphic_figure graphicRef56258 \" href=\"UTD.htm?31/48/32527\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Endoscopic ultrasound imaging should be performed adjacent to the lesion. Water instillation may be helpful to provide adequate acoustic coupling while achieving a focal distance that permits optimal imaging. The focal length for a 7.5 MHz transducer is approximately 2.0 centimeters. Imaging can be optimized by using a minimally inflated, water filled balloon and instilling deaerated water to distend the lumen while providing a medium to transmit the ultrasound waves without reflection.",
"     </li>",
"     <li>",
"      For small (&lt;1 cm) or flat lesions, imaging with through&ndash;the-scope, high frequency catheter ultrasound probes (\"miniprobes\") may be technically easier than using a dedicated echoendoscope. Miniprobes are approximately 3 mm in diameter and operate at 12, 15, 20, and 30 MHz frequencies, permitting more detailed imaging of the gastrointestinal wall compared with the lower-frequency standard echoendoscopes. However, they have relatively shallow depth of penetration limiting visualization of large tumors and surrounding lymph nodes. The miniprobes can be introduced through the working channel of a diagnostic endoscope and directed to the lesion endoscopically. A balloon sheath can be used to optimize acoustic coupling, although it increases the diameter of the probe, requiring use of a therapeutic endoscope.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Description of the lesion's characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary characteristics that should be determined include the layer of origin or extramural origin, size, echogenicity, and vascularity. Echogenicity has been described as the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anechoic &ndash; The echogenicity of water or clear fluid (ie, black with no internal echoes). Anechoic lesions are typically associated with acoustic enhancement, which is a brighter echo located behind a fluid filled structure. Common examples are cysts, vessels, and the gallbladder.",
"     </li>",
"     <li>",
"      Hypoechoic &ndash; Echogenicity that is equivalent or lower than that of the second (lamina propria) and fourth wall layers (muscularis propria). Common examples include leiomyomas, gastrointestinal stromal tumors (GIST), or",
"      <span class=\"nowrap\">",
"       mucin/debris",
"      </span>",
"      filled cysts.",
"     </li>",
"     <li>",
"      Hyperechoic &ndash; Echogenicity that is equivalent to or higher than the first (superficial mucosa), third (submucosa), and fifth layers (serosa). The most common example is a lipoma.",
"     </li>",
"     <li>",
"      Isoechoic &ndash; Echogenicity that is equivalent or nearly equivalent to the involved layer of the lesion. This appearance can be somewhere in between hyperechoic and hypoechoic.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     General principals of tissue sampling",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of methods are available for obtaining tissue samples.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Standard biopsy &ndash; Specimens obtained by standard endoscopic forceps have a low diagnostic yield due to their superficial sampling. Taking a biopsy within the site of a previous biopsy (\"tunnel\" or \"well\" biopsies) may permit sampling of deeper lesions.",
"     </li>",
"     <li>",
"      Endoscopic mucosal resection (EMR) &ndash; The diagnostic yield of a tissue biopsy can be improved by resecting the overlying mucosa or a portion of the lesion using a snare, a maneuver that creates access to deeper tissue. This technique has also been referred to as \"unroofing\". Various approaches are used to facilitate EMR, including the use of a double channel endoscope, band ligation, and a cap attachment (EMR-c). A prospective study comparing biopsy and EMR techniques showed a marked increase in diagnostic yield between the two modalities (17 versus 87 percent, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/2\">",
"       2",
"      </a>",
"      ]. Another study reported a 94 percent yield for diagnosis and assessment of risk for malignancy using the \"unroofing\" technique in subepithelial tumors originating from the muscularis propria on EUS [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/3\">",
"       3",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Although EMR improved diagnostic yield, it may also increase complications such as bleeding [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4970?source=see_link\">",
"       \"Overview of endoscopic resection of gastrointestinal tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endoscopic submucosal dissection &ndash; An alternative to EMR is the use of the needle-knife to incise the overlying mucosa. This approach, known as endoscopic submucosal dissection, was first described in 2003 in a patient with a metastasis from colon cancer presenting as a submucosal gastric tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/5\">",
"       5",
"      </a>",
"      ]. Endoscopic submucosal dissection has been used primarily for the treatment of mucosal gastric and esophageal cancers in Japan and Germany [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. More recently, ESD has been described for the resection of subepithelial tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/8,9\">",
"       8,9",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Careful dissection using a modified needle-knife such as the Insulated Tip (IT) knife enables en bloc resection of a submucosal tumor.ESD requires an exceptional level of operator skill, is time consuming, and is associated with significant complication rates, especially bleeding and perforation. As a result, ESD should be reserved for centers specialized in this advanced procedure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4970?source=see_link&amp;anchor=H14#H14\">",
"       \"Overview of endoscopic resection of gastrointestinal tumors\", section on 'ESD techniques'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fine needle aspiration&nbsp;(EUS-FNA) &ndash; Standard 19, 22, or 25 gauge needles may be used for fine needle aspiration to provide a tissue sample for cytological diagnosis. This is often used in conjunction with immunohistochemical staining, such as for c-kit (CD 117). FNA is limited by a small sample size that may be insufficient for immunohistochemistry and calculation of the mitotic index [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/10-12\">",
"       10-12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=see_link\">",
"       \"Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Trucut biopsy &ndash; Large caliber cutting needles were designed to acquire larger tissue specimens than can be obtained with FNA that preserve tissue architecture to provide a histologic diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/8/14471?source=see_link\">",
"       \"Endoscopic ultrasound guided trucut biopsy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ACCURACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have evaluated the accuracy of EUS in characterizing subepithelial lesions. Studies focusing on specific lesions are presented below. As a general rule, the ability of EUS alone to distinguish among subepithelial lesions is variable. As a result, histology is still considered to be the \"gold standard.\"",
"   </p>",
"   <p>",
"    Some representative studies have shown the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective study evaluating the accuracy of EUS in characterizing 100 consecutive patients with subepithelial lesions found that EUS findings alone correctly predicted the specific lesion type in only 48 percent of cases where biopsy confirmation had been obtained [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/1\">",
"       1",
"      </a>",
"      ]. Most misclassifications occurred in hypoechoic lesions in the third and fourth layers, which include carcinoids, GISTs, aberrant pancreas, and granular cell tumors.",
"     </li>",
"     <li>",
"      In a second study, the results of endoscopic resection or biopsies after unroofing in 54 submucosal lesions were compared with the EUS findings [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/13\">",
"       13",
"      </a>",
"      ]. The overall accuracy of EUS in determining the layer of origin and location of lesion was 80 percent; six lesions were located deeper in the GI wall than estimated by EUS and five were more superficial. EUS and pathology findings coincided in 74 percent of lesions.",
"     </li>",
"     <li>",
"      In a third study, 22 patients underwent EUS prior to endoscopic resection of gastric subepithelial lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/14\">",
"       14",
"      </a>",
"      ]. EUS alone correctly diagnosed 10 (46 percent) of the lesions. The lesions that were incorrectly diagnosed included pancreatic rests (n = 5) and gastritis cystica profunda (n = 2).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     EXTRAMURAL LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal anatomic structures and extraluminal benign and malignant tumors can compress the gastrointestinal tract and mimic an intramural tumor. Incidental lesions are being detected more commonly with the increasing use of total body scans in healthy patients. EUS can assist in further characterizing such findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Endoscopic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extramural lesions are commonly seen as a bulge located in the gastrointestinal (GI) tract with normal overlying mucosa, usually with a smooth border and no significant irregularity (",
"    <a class=\"graphic graphic_picture graphicRef53780 \" href=\"UTD.htm?18/56/19328\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Endosonographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;A normal appearing five-layer gastrointestinal wall structure is seen interposed between the lesion and the bowel lumen. Specific echo features vary depending upon the type of structure identified. As an example, the splenic vessels appear as an anechoic structure that can be followed longitudinally. The spleen may appear to have a homogeneous echogenicity. A pancreatic pseudocyst originates from a region of the pancreas, and is commonly hypoechoic or anechoic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Knowledge of normal endoscopic ultrasound anatomy is required to determine if a structure is normal or abnormal. Common normal extrinsic structures include the splenic artery, spleen, gallbladder, left lobe of the liver, and the pancreas [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/15\">",
"     15",
"    </a>",
"    ]. Abnormal structures include pancreatic pseudocysts, enlarged lymph nodes, aneurysms, omental metastasis, and hepatic and pancreatic tumors. One group reported 100 percent accuracy in distinguishing extramural from intramural structures [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL STROMAL TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nomenclature of gastrointestinal mesenchymal tumors is evolving with an increased understanding of molecular, histologic, and clinical features that distinguish different types of tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. One of the most common mesenchymal tumors in the gastrointestinal tract, gastrointestinal stromal tumors (GISTs), were initially thought to be of smooth muscle origin. However, a more complete understanding of their molecular markers and biologic behavior has demonstrated that they encompass a heterogeneous group of tumors with respect to cell of origin, cellular differentiation, and prognosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=see_link\">",
"     \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    GISTs are most frequently diagnosed in older individuals, in whom they are most common in the stomach (60 to 70 percent), small intestine (20 to 25 percent),",
"    <span class=\"nowrap\">",
"     colon/rectum",
"    </span>",
"    (5 percent), and esophagus (&lt;5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/18\">",
"     18",
"    </a>",
"    ]. The differential diagnosis includes a multitude of lesions that can occupy the submucosal layers. These include leiomyomas, leiomyosarcomas, schwannomas, inflammatory myofibroblastic tumors in children, lipomas, liposarcomas, metastatic tumors, and desmoid tumors. Distinction from these other tumors is made based upon clinical, histological, and molecular features.",
"   </p>",
"   <p>",
"    A distinguishing molecular feature of GISTs is that they are positive for c-kit (a stem cell factor receptor referred to as CD117). This immunohistochemical stain distinguishes GIST from other kinds of spindle cell tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/5\">",
"     5",
"    </a>",
"    ]. Other tumors that are positive for c-kit (such as angiosarcomas and metastatic melanomas) can usually be distinguished based upon clinical and histologic features. Additional markers found in GISTs include CD34 (a hematopoietic cell progenitor cell antigen present in approximately 70 percent), smooth muscle actin (present in 20 to 30 percent), and s100 protein (marker of neural differentiation) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It was previously thought that some GISTs (less than 1 to 2 cm in size and with a low mitotic rate) were benign. However, the current thinking is that virtually all GISTs, especially those greater than 1 cm, have malignant potential. The main factors associated with malignant potential are tumor size, mitotic rate, and primary location (with small intestinal GISTs being more aggressive than those in the stomach) (",
"    <a class=\"graphic graphic_table graphicRef60930 \" href=\"UTD.htm?35/23/36220\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=see_link\">",
"     \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Endoscopic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;A GIST commonly appears as a bulge located in the GI tract with normal overlying mucosa and can vary in size from several millimeters to over 30 centimeters. It usually has a smooth and regular appearance without major mucosal irregularities. In some cases, the overlying mucosa can be ulcerated or appear inflamed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Endosonographic findings in GISTs",
"    </span>",
"    &nbsp;&mdash;&nbsp;GISTs are typically hypoechoic, homogeneous lesions with well-defined margins, although they can rarely have irregular margins and ulcerations. Most GISTs originate from within the muscularis propria (fourth layer of the GI tract); small lesions may originate from the muscularis mucosa (second layer). Infrequently, the tumors are inhomogeneous, which has been attributed to liquefaction necrosis, connective tissue, and cystic and hyaline degeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specific endosonographic characteristics can be helpful for predicting benign versus malignant tumors. Large tumors with a heterogeneous echo texture (particularly those in the esophagus) are more likely to be leiomyosarcomas and leiomyoblastomas.",
"   </p>",
"   <p>",
"    One study demonstrated that endosonographically determined tumor size (diameter &gt;4 cm), irregular extraluminal border, heterogeneity, echogenic foci, and cystic spaces greater than 4 mm were associated with malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/20\">",
"     20",
"    </a>",
"    ]. The sensitivity for detecting malignancy by preoperative EUS ranged from 80 to 100 percent. However, overall interobserver agreement for specific echo features was poor.",
"   </p>",
"   <p>",
"    Other endosonographic features suggestive of malignancy in another report that included 56 histologically proven tumors were irregular extraluminal margins, the presence of cystic spaces, and enlarged lymph nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/22\">",
"     22",
"    </a>",
"    ]. The presence of at least one of these features had a sensitivity, specificity, and positive predictive value of 91, 88, and 93 percent, respectively. The presence of two of these features had a positive predictive value of 100 percent for malignant or borderline malignant tumors. The features most predictive of benign tumors were regular margins, a tumor size &le;3 cm, and a homogeneous echo pattern. All lesions that demonstrated all three of these features were benign.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Histologic diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A definitive diagnosis of a GIST can only be made histologically. Endoscopic biopsy is unlikely to be helpful because the lesion is beyond the mucosa and thus the grasp of the forceps. Endosonography-guided fine needle aspiration (EUS-FNA) can target the lesion, but the diagnostic yield of cytology is low.",
"   </p>",
"   <p>",
"    Some investigators have found that the addition of immunohistochemical characterization of specimens obtained by EUS-FNA may improve the accuracy for diagnosis of malignant GISTs compared to EUS alone [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. In one report, the overall accuracy of EUS with fine needle aspiration and histologic staining compared with EUS alone for determining malignancy was 91 versus 78 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/23\">",
"     23",
"    </a>",
"    ]. The addition of Ki-67 immunohistochemical staining increased the accuracy to 100 percent. Experience with EUS guided trucut biopsy is limited. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=see_link\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/8/14471?source=see_link\">",
"     \"Endoscopic ultrasound guided trucut biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endoscopic resection using endoscopic submucosal dissection has been described in two series [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Successful endoscopic resection is reported, but remains controversial because of the risk of positive margins, tumor spillage, and perforation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/25\">",
"     25",
"    </a>",
"    ]. Surgical and endoscopic options for treatment of localized GISTs are discussed in detail elsewhere, as is neoadjuvant",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/1/17434?source=see_link\">",
"     imatinib",
"    </a>",
"    for large or borderline resectable tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/7/34938?source=see_link\">",
"     \"Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/34/33321?source=see_link\">",
"     \"Adjuvant and neoadjuvant imatinib for gastrointestinal stromal tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Observation versus resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;It was previously thought that intramural mesenchymal tumors of the gastrointestinal tract smaller than 3 cm in maximal diameter had a low enough malignant potential to justify observation rather than resection. However, many of these tumors prove to be GISTs, and the current thinking is that all GISTs have the potential to behave in a malignant fashion, particularly if they are over 1 cm in size. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=see_link\">",
"     \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stable submucosal lesions &lt;1 cm with EUS findings suggestive of benignity may be followed conservatively. An optimal surveillance strategy for asymptomatic lesions has not been established. We suggest following a protocol similar to that used for esophageal leiomyomas (ie, performing an EUS every 12 months). Resection is advised if lesions become symptomatic, increase in size, or show sonographic malignant features. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/7/34938?source=see_link&amp;anchor=H6#H6\">",
"     \"Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract\", section on 'Leiomyomas and leiomyosarcomas'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H14\">",
"     'Endosonographic findings in GISTs'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Given that endoscopic appearance is almost never diagnostic, and that an EUS-guided fine-needle aspiration biopsy may not be sufficient to distinguish between a GIST and a leiomyoma, larger tumors should be surgically resected. In addition, these lesions should be resected because of an increased frequency of complications and the difficulty in excluding malignancy preoperatively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/7/34938?source=see_link\">",
"     \"Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     LEIOMYOMAS AND LEIOMYOSARCOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;EUS is the most accurate method for diagnosing leiomyomas and distinguishing them from other submucosal lesions including leiomyosarcomas (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53147 \" href=\"UTD.htm?39/40/40582\">",
"     image 1",
"    </a>",
"    ). These lesions arise from the fourth and rarely the second gastric wall layer. Immunohistochemical studies on aspirates are positive for smooth muscle actin and desmin and negative for c-kit (CD 117). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=see_link\">",
"     \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The epidemiology, clinical presentation, diagnosis, and surgical management of leiomyomas and leiomyosarcomas are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=see_link\">",
"     \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/7/34938?source=see_link\">",
"     \"Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     LIPOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipomas are benign intramucosal tumors of mature lipocytes that are commonly incidental findings on colonoscopy and endoscopy. They can be seen in any part of the gastrointestinal tract, although they are most common in the lower gastrointestinal tract. Lipomas are rarely symptomatic, but may result in hemorrhage, abdominal pain, and intestinal obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/26\">",
"     26",
"    </a>",
"    ]. They have no malignant potential.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Endoscopic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;A lipoma commonly appears as an isolated solitary bulge located in the GI tract with normal overlying mucosa, a yellowish hue, and a smooth regular appearance. When probed, they are soft and usually collapse to create an indentation known as the \"pillow or cushion sign.\" Biopsy forceps may grasp the overlying mucosa to create the \"tenting sign,\" by pulling the mucosa away from the submucosal growth. They are commonly small (less than 4 centimeters). In one report of seven lesions (six of which were proven to be a lipoma by EUS) a pillow sign on endoscopy had low sensitivity (40 percent) but high specificity (99 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Endosonographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The five layers of the gastrointestinal tract should be easily identified using low frequency imaging. Lipomas are hyperechoic, homogeneous lesions with regular margins arising from the submucosa (third layer of the GI tract) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56823 \" href=\"UTD.htm?31/38/32356\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Diagnosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis is almost always made by a characteristic endoscopic and endosonographic appearance. Biopsies usually show only normal mucosa. However, a tissue diagnosis may be made by either fine needle aspiration or a technique called a \"tunnel biopsy,\" which permits the acquisition of lipocytes. The technique involves creation of a mucosal defect (using a needle knife incision, the biopsy forceps itself, or electrocoagulation) through which deeper biopsies can be obtained.",
"   </p>",
"   <p>",
"    Lipomas found incidentally should be followed expectantly. Endoscopic and endosonographic surveillance are not necessary. Local excision is advised for symptomatic lipomas or when the lesion cannot be distinguished from a malignant neoplasm (such as a liposarcoma). Endoscopic snare resection using polypectomy technique has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. However, snare excision may be associated with perforation and hemorrhage, the risk of which is particularly increased for lesions greater than 2 cm in diameter [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. To reduce the risk, endoloop ligation prior to resection has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/29\">",
"     29",
"    </a>",
"    ]. Endoloop ligation as stand-alone therapy (without resection) has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/30\">",
"     30",
"    </a>",
"    ]. This approach was successful in a series of 10 patients with pedunculated submucosal tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/31\">",
"     31",
"    </a>",
"    ], six of whom had lipomas, with no reported complication. However, a drawback was the lack of a reliable surgical specimen for pathology. Patients were instructed to retrieve specimens from stool, but this was successful in only 60 percent of cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     CARCINOID TUMOR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carcinoids are rare intramucosal tumors of endocrine cell origin with malignant potential and are commonly asymptomatic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/60/969?source=see_link\">",
"     \"Clinical characteristics of carcinoid tumors\"",
"    </a>",
"    .) They are commonly discovered incidentally during endoscopy, surgery, or autopsy. In the United States, carcinoids are most commonly found in the appendix, rectum, and ileum, while in Japan they are often located in the stomach, rectum, and duodenum [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/28,32\">",
"     28,32",
"    </a>",
"    ]. Rare complications include hemorrhage, abdominal pain, intestinal obstruction, and endocrine syndromes due to secretion of functionally active substances (particularly when they metastasize to the liver). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/60/969?source=see_link\">",
"     \"Clinical characteristics of carcinoid tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39897?source=see_link\">",
"     \"Treatment and surveillance of non-metastatic carcinoid tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Endoscopic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carcinoids appear as small, round sessile or polypoid lesions with normal overlying mucosa that rarely ulcerates [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/33\">",
"     33",
"    </a>",
"    ]. They range in size from a few millimeters to a few centimeters. Gastric and ileal carcinoids are commonly multiple, while those arising elsewhere are typically solitary (",
"    <a class=\"graphic graphic_picture graphicRef72300 \" href=\"UTD.htm?21/8/21632\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Endosonographic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carcinoids are homogeneous hypo- or isoechoic with regular margins. They arise from the",
"    <span class=\"nowrap\">",
"     mucosa/lamina",
"    </span>",
"    propria (second layer of the GI tract) and can invade the submucosal layer (third layer) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51383 \" href=\"UTD.htm?32/53/33617\">",
"     image 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Diagnosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis and treatment of carcinoid tumors is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39897?source=see_link\">",
"     \"Treatment and surveillance of non-metastatic carcinoid tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     GRANULAR CELL TUMOR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Granular cell tumors (GCT) are rare submucosal tumors of Schwann cell origin that are usually incidental findings on endoscopy and colonoscopy. They are most common in the oropharynx, skin, subcutaneous tissue, or breasts, but they can involve any part of the intestinal tract and the biliary tree [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/35-38\">",
"     35-38",
"    </a>",
"    ]. Most intestinal tract lesions are found in the middle to lower third of the esophagus. Immunostaining is usually positive for the S-100 protein. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/18/2346?source=see_link\">",
"     \"Benign lesions of the esophagus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Granular cells tumors are considered benign, although malignant GCTs have been reported particularly when larger than 4 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/37\">",
"     37",
"    </a>",
"    ]. These lesions are rarely associated with complications such as bleeding and lumen obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Endoscopic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Granular cell tumors usually appear as small isolated nodules or polyps located in the GI tract with normal overlying mucosa and a yellowish hue. The majority are small (&lt;4 cm) and solitary, although multifocal lesions have been described (",
"    <a class=\"graphic graphic_picture graphicRef74526 \" href=\"UTD.htm?41/0/41999\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Endosonographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;GCTs are usually hypoechoic, homogeneous lesions with smooth margins arising from the mucosa",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    submucosa (second or third layer of the GI tract) (",
"    <a class=\"graphic graphic_picture graphicRef74526 \" href=\"UTD.htm?41/0/41999\">",
"     picture 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Diagnosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveillance endoscopy is recommended for asymptomatic GCTs. GCTs that are not excised should be monitored by EUS for an increase in size every one to two years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/28\">",
"     28",
"    </a>",
"    ]. Local endoscopic snare excision or removal with multiple biopsies can be performed for small tumors limited to the mucosa. Thermal ablation of granular cell tumors by laser was reported in four patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     DUPLICATION CYSTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duplication cysts (DC) are benign, rare anomalies that arise during early embryonic development. They are most frequently found in the proximal small intestine, although they can also be found in the esophagus, stomach, and colon. There are two general types: those that are adjacent to the lumen (having lost communication to the gastrointestinal wall), and those that are tubular and communicate directly with the lumen [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Duplication cysts are lined with stratified, ciliated, or columnar epithelium and contain a mucoid fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cysts are typically discovered incidentally on endoscopy or radiologic imaging since they only uncommonly cause symptoms. Complications are rare but may include dysphagia, abdominal pain, bleeding, and pancreatitis when located near the ampulla of Vater [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/45\">",
"     45",
"    </a>",
"    ]. While they are believed to have a low malignant potential, case reports have described malignant transformation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Endoscopic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duplication cysts can appear as a bulge with normal overlying mucosa, or as a diverticulum that can vary in size from several millimeters to over 5 cm. They have a smooth and regular appearance without mucosal irregularities. They are most commonly diagnosed by CT scan or MRI since they are infrequently seen endoluminally (",
"    <a class=\"graphic graphic_picture graphicRef53780 \" href=\"UTD.htm?18/56/19328\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Endosonographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duplication cysts are usually anechoic homogeneous lesions with regular margins arising from the submucosal (third layer) or extrinsic to the gastrointestinal wall. Their walls can be characterized by three- or five-layer structures. They also can contain septae, fluid levels, or echogenic material consisting of layering debris or mucin (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65472 \" href=\"UTD.htm?25/44/26309\">",
"     image 4",
"    </a>",
"    ). Occasionally, a cyst appears as a solid lesion on CT scan due to the higher density elicited from debris particles within a cyst. EUS is helpful in discriminating a duplication cyst from a solid mass.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Diagnosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis can usually be made by the characteristic endoscopic and endosonographic appearance. EUS-guided FNA has been used to establish a diagnosis of an esophageal cyst [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/47\">",
"     47",
"    </a>",
"    ], although this is not necessary and has a risk of causing infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Management of asymptomatic cysts is usually expectant, but resection has been recommended based upon their potential for complications, including malignant transformation. However, prospective studies evaluating the natural history of duplication cysts are lacking. When symptomatic, duplication cysts can be treated surgically or endoscopically [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/49\">",
"     49",
"    </a>",
"    ]. Successful endoscopic management of endoluminal cysts has been described using fine needle aspiration, needle knife cystostomy, and, when small, snare excision [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     PANCREATIC REST",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pancreatic rest (also known as ectopic pancreas, aberrant pancreas, and heterotopic pancreas) refers to ectopic pancreatic tissue. These rare submucosal tumors most commonly consist of cystically dilated exocrine cells. Endocrine pancreatic tissue or a combination of exocrine and endocrine cell types may also be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pancreatic rests are most frequently found in the distal stomach, duodenum, or proximal jejunum, but have also been reported within a Meckel's diverticulum, the gallbladder, bile ducts, and the minor and major papillae [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/51\">",
"     51",
"    </a>",
"    ]. They are typically discovered incidentally during endoscopy, surgery, or autopsy. They are also occasionally found on CT scan. CT findings that may help differentiate pancreatic rests from other submucosal lesions identified in one study included [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/52\">",
"     52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A flat-ovoid shape (long diameter to short diameter ratio of greater than 1.4)",
"     </li>",
"     <li>",
"      Location of the lesion in the antrum, pylorus, or duodenum",
"     </li>",
"     <li>",
"      An endoluminal growth pattern",
"     </li>",
"     <li>",
"      An ill-defined border",
"     </li>",
"     <li>",
"      Prominent enhancement of the overlying mucosa",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The study found that the presence of at least two of the above findings had a sensitivity of 100 percent and a specificity of 82.5 percent for diagnosing a pancreatic rest in the upper gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/52\">",
"     52",
"    </a>",
"    ]. The specificity increased to 100 percent if three of the above findings were present.",
"   </p>",
"   <p>",
"    However, while pancreatic rests may be detected with CT scan, if a submucosal lesion is noted on upper endoscopy, we suggest endoscopic ultrasound with endoscopic mucosal resection for further evaluation, as small lesions may be missed on CT scan. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'General principals of tissue sampling'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Complications of pancreatic rests are rare, but may include ulceration, gastric outlet obstruction, and malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/50,53\">",
"     50,53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Endoscopic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pancreatic rest appears as a submucosal nodule, usually with a central umbilication that corresponds to a draining duct.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Endosonographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic rests are hypoechoic or intermediate echogenic heterogeneous lesions with indistinct margins. They most commonly arise from the third or fourth layer, or a combination of the two layers of the GI tract. Anechoic areas within the lesion correlate with ductal structures [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Diagnosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis can be made histologically from tissue obtained by biopsy forceps or snare excision, although techniques to obtain deeper biopsies (using jumbo biopsy forceps, tunnel biopsy, endoscopic mucosal resection, or EUS-guided FNA) may be required [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/50\">",
"     50",
"    </a>",
"    ]. The management strategy should be guided by symptoms and suspicion for malignancy. Asymptomatic lesions can be followed expectantly. Endoscopic resection can be performed by standard snare, band ligation-assisted, or cap-assisted polypectomy technique [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/54\">",
"     54",
"    </a>",
"    ]. Surgical resection is preferred to endoscopic resection when the muscularis propria is involved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h1\">",
"     VARICES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Varices are blood vessels that distend as a result of a hypertensive portal or splenic venous system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Endoscopic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Varices can be visualized in the esophagus, stomach, duodenum, and rectum. They typically appear as bluish enlarged vessels that are commonly tortuous and easily compressed with instrumental pressure. Gastric varices may be confused with thickened folds or a submucosal lesion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Endosonographic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Varices are round anechoic structures arising from the lamina propria or submucosa. Color Doppler can be used to detect blood flow, which will immediately confirm a vascular structure, distinguishing a varix from other anechoic subepithelial lesions such as a cyst. A potential problem using a dedicated echoendoscope to image small varices is the tendency to compress the varix by the instrument or with inflation of the transducer balloon. This can be overcome by using a catheter ultrasound probe (miniprobe) inserted through the working channel of an endoscope. The miniprobe permits precise endoscopic targeting of the varix with a small diameter (about 3 mm) transducer that will not compress the varix. However, miniprobes lack Doppler capability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     Diagnosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis is based on the typical endoscopic and endosonographic features. Treatment depends upon the clinical context. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/56/1928?source=see_link\">",
"     \"General principles of the management of variceal hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35689?source=see_link\">",
"     \"Endoscopic variceal ligation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=see_link\">",
"     \"Treatment of active variceal hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h1\">",
"     UNCOMMON LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of uncommon submucosal lesions can be seen endosonographically, including esophageal fibrovascular polyps, inflammatory fibroid polyps, pneumatosis cystoides, thickened folds, fibromas, Brunner's gland nodules, gastrointestinal wall hematomas, and esophageal hemangiomas. However, their endosonographic descriptions have been heterogeneous and scarce [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/55\">",
"     55",
"    </a>",
"    ]. Thus, use of EUS to diagnose these lesions should be made on an individual case basis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h1\">",
"     AMERICAN GASTROENTEROLOGICAL ASSOCIATION GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Gastroenterological Association has issued a guideline on the management of gastric subepithelial masses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/13/1242/abstract/56\">",
"     56",
"    </a>",
"    ], which can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    . The following general comments were included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endoscopy alone is not reliable for detecting the etiology of a subepithelial gastric mass.",
"     </li>",
"     <li>",
"      Cross-sectional imaging techniques such as transabdominal ultrasonography, computed tomography, and magnetic resonance imaging are adequate for detecting the presence of normal or abnormal structures outside the gastric wall, but do not reliably distinguish between the various causes of masses arising within the gastric wall.",
"     </li>",
"     <li>",
"      EUS is the most accurate imaging test for detecting the component of the gastric wall from which the mass arises, information which, combined with the echogenicity of the mass, helps narrow the differential diagnosis.",
"     </li>",
"     <li>",
"      Patients with symptoms attributable to the mass should undergo endoscopic or surgical resection.",
"     </li>",
"     <li>",
"      Optimal management of incidentally detected, asymptomatic masses is unclear.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endoscopic ultrasonography (EUS) has provided a major breakthrough for characterizing subepithelial lesions. It is complementary to other methods for diagnosis (and treatment) of subepithelial lesions (",
"      <a class=\"graphic graphic_algorithm graphicRef80192 \" href=\"UTD.htm?13/39/13938\">",
"       algorithm 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The sonographic appearances of some lesions are highly suggestive of the diagnosis, while for others EUS provides complementary information to other diagnostic modalities. Hypoechoic lesions in the third and fourth layers are most prone to misclassification.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/1\">",
"      Hwang JH, Saunders MD, Rulyak SJ, et al. A prospective study comparing endoscopy and EUS in the evaluation of GI subepithelial masses. Gastrointest Endosc 2005; 62:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/2\">",
"      Cantor MJ, Davila RE, Faigel DO. Yield of tissue sampling for subepithelial lesions evaluated by EUS: a comparison between forceps biopsies and endoscopic submucosal resection. Gastrointest Endosc 2006; 64:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/3\">",
"      Lee CK, Chung IK, Lee SH, et al. Endoscopic partial resection with the unroofing technique for reliable tissue diagnosis of upper GI subepithelial tumors originating from the muscularis propria on EUS (with video). Gastrointest Endosc 2010; 71:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/4\">",
"      Hunt GC, Smith PP, Faigel DO. Yield of tissue sampling for submucosal lesions evaluated by EUS. Gastrointest Endosc 2003; 57:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/5\">",
"      Rodriguez SA, Faigel DO. Endoscopic diagnosis of gastrointestinal stromal cell tumors. Curr Opin Gastroenterol 2007; 23:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/6\">",
"      Yahagi N. Is esophageal endoscopic submucosal dissection an extreme treatment modality, or can it be a standard treatment modality? Gastrointest Endosc 2008; 68:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/7\">",
"      Probst A, Golger D, Arnholdt H, Messmann H. Endoscopic submucosal dissection of early cancers, flat adenomas, and submucosal tumors in the gastrointestinal tract. Clin Gastroenterol Hepatol 2009; 7:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/8\">",
"      Lee IL, Lin PY, Tung SY, et al. Endoscopic submucosal dissection for the treatment of intraluminal gastric subepithelial tumors originating from the muscularis propria layer. Endoscopy 2006; 38:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/9\">",
"      Park YS, Park SW, Kim TI, et al. Endoscopic enucleation of upper-GI submucosal tumors by using an insulated-tip electrosurgical knife. Gastrointest Endosc 2004; 59:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/10\">",
"      Polkowski M, Bergman JJ. Endoscopic ultrasonography-guided biopsy for submucosal tumors: needless needling? Endoscopy 2010; 42:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/11\">",
"      Watson RR, Binmoeller KF, Hamerski CM, et al. Yield and performance characteristics of endoscopic ultrasound-guided fine needle aspiration for diagnosing upper GI tract stromal tumors. Dig Dis Sci 2011; 56:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/12\">",
"      Hoda KM, Rodriguez SA, Faigel DO. EUS-guided sampling of suspected GI stromal tumors. Gastrointest Endosc 2009; 69:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/13\">",
"      Kojima T, Takahashi H, Parra-Blanco A, et al. Diagnosis of submucosal tumor of the upper GI tract by endoscopic resection. Gastrointest Endosc 1999; 50:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/14\">",
"      Karaca C, Turner BG, Cizginer S, et al. Accuracy of EUS in the evaluation of small gastric subepithelial lesions. Gastrointest Endosc 2010; 71:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/15\">",
"      Motoo Y, Okai T, Ohta H, et al. Endoscopic ultrasonography in the diagnosis of extraluminal compressions mimicking gastric submucosal tumors. Endoscopy 1994; 26:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/16\">",
"      Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000; 7:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/17\">",
"      Suster S. Gastrointestinal stromal tumors. Semin Diagn Pathol 1996; 13:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/18\">",
"      Miettinen M, Lasota J. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/19\">",
"      Graadt van Roggen JF, van Velthuysen ML, Hogendoorn PC. The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 2001; 54:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/20\">",
"      Chak A, Canto MI, R&ouml;sch T, et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc 1997; 45:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/21\">",
"      Krinsky ML, Savides TJ, Behling C. Ex-vivo correlation of endosonographic features with pathologic findings in gastric stromal tumors. Gastrointest Endosc 2001; 53:AB170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/22\">",
"      Palazzo L, Landi B, Cellier C, et al. Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours. Gut 2000; 46:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/23\">",
"      Ando N, Goto H, Niwa Y, et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002; 55:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/24\">",
"      Hunt GC, Rader AE, Faigel DO. A comparison of EUS features between CD-117 positive GI stromal tumors and CD-117 negative GI spindle cell tumors. Gastrointest Endosc 2003; 57:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/25\">",
"      Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 2007; 5 Suppl 2:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/26\">",
"      Maderal F, Hunter F, Fuselier G, et al. Gastric lipomas--an update of clinical presentation, diagnosis, and treatment. Am J Gastroenterol 1984; 79:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/27\">",
"      Nakamura S, Iida M, Suekane H, et al. Endoscopic removal of gastric lipoma: diagnostic value of endoscopic ultrasonography. Am J Gastroenterol 1991; 86:619.",
"     </a>",
"    </li>",
"    <li>",
"     Savides TJ. Endoscopic Ultrasonography. In: Gastrointestinal submucosal masses, 1, Gress F (Eds), Blackwell Science, 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/29\">",
"      Murray MA, Kwan V, Williams SJ, Bourke MJ. Detachable nylon loop assisted removal of large clinically significant colonic lipomas. Gastrointest Endosc 2005; 61:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/30\">",
"      Raju GS, Gomez G. Endoloop ligation of a large colonic lipoma: a novel technique. Gastrointest Endosc 2005; 62:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/31\">",
"      Lee SH, Park JH, Park do H, et al. Endoloop ligation of large pedunculated submucosal tumors (with videos). Gastrointest Endosc 2008; 67:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/32\">",
"      Godwin JD 2nd. Carcinoid tumors. An analysis of 2,837 cases. Cancer 1975; 36:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/33\">",
"      Nakamura S, Iida M, Yao T, Fujishima M. Endoscopic features of gastric carcinoids. Gastrointest Endosc 1991; 37:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/34\">",
"      Soga J. Histogenesis of carcinoids in relation to ordinary carcinomas. Acta Med Biol (Niigata) 1982; 30:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/35\">",
"      Tada S, Iida M, Yao T, et al. Granular cell tumor of the esophagus: endoscopic ultrasonographic demonstration and endoscopic removal. Am J Gastroenterol 1990; 85:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/36\">",
"      Martin RC, Stulc JP. Multifocal granular cell tumor of the biliary tree: case report and review. Gastrointest Endosc 2000; 51:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/37\">",
"      Orlowska J, Pachlewski J, Gugulski A, Butruk E. A conservative approach to granular cell tumors of the esophagus: four case reports and literature review. Am J Gastroenterol 1993; 88:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/38\">",
"      Narra SL, Tombazzi C, Datta V, Ismail MK. Granular cell tumor of the esophagus: report of five cases and review of the literature. Am J Med Sci 2008; 335:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/39\">",
"      Onoda N, Kobayashi H, Satake K, et al. Granular cell tumor of the duodenum: a case report. Am J Gastroenterol 1998; 93:1993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/40\">",
"      White JG, el-Newihi HM, Hauser CJ. Granular cell tumor of the stomach presenting as gastric outlet obstruction. Am J Gastroenterol 1994; 89:2259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/41\">",
"      Palazzo L, Landi B, Cellier C, et al. Endosonographic features of esophageal granular cell tumors. Endoscopy 1997; 29:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/42\">",
"      Norberto L, Urso E, Angriman I, et al. Yttrium-aluminum-garnet laser therapy of esophageal granular cell tumor. Surg Endosc 2002; 16:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/43\">",
"      Geller A, Wang KK, DiMagno EP. Diagnosis of foregut duplication cysts by endoscopic ultrasonography. Gastroenterology 1995; 109:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/44\">",
"      Woolfolk GM, McClave SA, Jones WF, et al. Use of endoscopic ultrasound to guide the diagnosis and endoscopic management of a large gastric duplication cyst. Gastrointest Endosc 1998; 47:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/45\">",
"      Faigel DO, Burke A, Ginsberg GG, et al. The role of endoscopic ultrasound in the evaluation and management of foregut duplications. Gastrointest Endosc 1997; 45:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/46\">",
"      Coit DG, Mies C. Adenocarcinoma arising within a gastric duplication cyst. J Surg Oncol 1992; 50:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/47\">",
"      Van Dam J, Rice TW, Sivak MV Jr. Endoscopic ultrasonography and endoscopically guided needle aspiration for the diagnosis of upper gastrointestinal tract foregut cysts. Am J Gastroenterol 1992; 87:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/48\">",
"      Wildi SM, Hoda RS, Fickling W, et al. Diagnosis of benign cysts of the mediastinum: the role and risks of EUS and FNA. Gastrointest Endosc 2003; 58:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/49\">",
"      Banner K, Helft S, Kadam J, et al. An unusual cause of dysphagia in a young woman: esophageal duplication cyst. Gastrointest Endosc 2008; 68:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/50\">",
"      Matsushita M, Hajiro K, Okazaki K, Takakuwa H. Gastric aberrant pancreas: EUS analysis in comparison with the histology. Gastrointest Endosc 1999; 49:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/51\">",
"      Lucena JF, Alvarez OA, Gross GW. Endoscopic resection of heterotopic pancreas of the minor duodenal papilla: case report and review of the literature. Gastrointest Endosc 1997; 46:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/52\">",
"      Kim JY, Lee JM, Kim KW, et al. Ectopic pancreas: CT findings with emphasis on differentiation from small gastrointestinal stromal tumor and leiomyoma. Radiology 2009; 252:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/53\">",
"      Minamoto T, Ueda H, Ooi A, et al. A limitation of endoscopic ultrasound: an unusual case of early gastric cancer overlying a pancreatic rest. Am J Gastroenterol 1991; 86:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/54\">",
"      Shim CS, Jung IS. Endoscopic removal of submucosal tumors: preprocedure diagnosis, technical options, and results. Endoscopy 2005; 37:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/55\">",
"      Soon MS, Lin OS. Inflammatory fibroid polyp of the duodenum. Surg Endosc 2000; 14:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/13/1242/abstract/56\">",
"      American Gastroenterological Association Institute. American Gastroenterological Association Institute medical position statement on the management of gastric subepithelial masses. Gastroenterology 2006; 130:2215.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2666 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-83C710A96E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1242=[""].join("\n");
var outline_f1_13_1242=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H44\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PRINCIPLES FOR IMAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Technical considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Description of the lesion's characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      General principals of tissue sampling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ACCURACY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      EXTRAMURAL LESIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Endoscopic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Endosonographic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      GASTROINTESTINAL STROMAL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Endoscopic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Endosonographic findings in GISTs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Histologic diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Observation versus resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      LEIOMYOMAS AND LEIOMYOSARCOMAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      LIPOMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Endoscopic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Endosonographic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Diagnosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      CARCINOID TUMOR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Endoscopic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Endosonographic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Diagnosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      GRANULAR CELL TUMOR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Endoscopic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Endosonographic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Diagnosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      DUPLICATION CYSTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Endoscopic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Endosonographic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Diagnosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      PANCREATIC REST",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Endoscopic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Endosonographic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Diagnosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      VARICES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Endoscopic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Endosonographic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      Diagnosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      UNCOMMON LESIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      AMERICAN GASTROENTEROLOGICAL ASSOCIATION GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2666\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2666|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?13/39/13938\" title=\"algorithm 1\">",
"      Approach subepithelial lesion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2666|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/40/40582\" title=\"diagnostic image 1\">",
"      Gastrointestinal leiomyoma EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/38/32356\" title=\"diagnostic image 2\">",
"      Lipoma EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/53/33617\" title=\"diagnostic image 3\">",
"      Duodenal carcinoid EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/44/26309\" title=\"diagnostic image 4\">",
"      Duplication cyst EUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2666|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/48/32527\" title=\"figure 1\">",
"      EUS normal layers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2666|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/56/19328\" title=\"picture 1\">",
"      Duplication cyst Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/8/21632\" title=\"picture 2\">",
"      Duodenal carcinoid Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/0/41999\" title=\"picture 3\">",
"      Granular cell tumor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2666|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/34/44587\" title=\"table 1\">",
"      Submucosal tumor layer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/23/36220\" title=\"table 2\">",
"      GIST progn site size mit",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/34/33321?source=related_link\">",
"      Adjuvant and neoadjuvant imatinib for gastrointestinal stromal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/18/2346?source=related_link\">",
"      Benign lesions of the esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/60/969?source=related_link\">",
"      Clinical characteristics of carcinoid tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/8/14471?source=related_link\">",
"      Endoscopic ultrasound guided trucut biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3561?source=related_link\">",
"      Endoscopic ultrasound-guided fine-needle aspiration biopsy in the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35689?source=related_link\">",
"      Endoscopic variceal ligation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/35/35386?source=related_link\">",
"      Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/56/1928?source=related_link\">",
"      General principles of the management of variceal hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/7/34938?source=related_link\">",
"      Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4970?source=related_link\">",
"      Overview of endoscopic resection of gastrointestinal tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39897?source=related_link\">",
"      Treatment and surveillance of non-metastatic carcinoid tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23514?source=related_link\">",
"      Treatment of active variceal hemorrhage",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_13_1243="Adherence improvement actions";
var content_f1_13_1243=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F68684&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F68684&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Interventions to improve adherence",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Pharmacist-based adherence encounters and clinics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multidisciplinary adherence encounters at each visit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reminders, alarms, pagers, or timers on pillboxes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patient education aids, including regimen pictures, calendars, or",
"stickers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clinician education aids (eg, medication guides, pictures, or calendars)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     file://aidsinfo.nih.gov.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1243=[""].join("\n");
var outline_f1_13_1243=null;
var title_f1_13_1244="FTT historical clues of organic disease";
var content_f1_13_1244=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Historical clues to potential organic causes of failure to thrive (undernutrition) in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Historical clues",
"       </td>",
"       <td class=\"subtitle1\">",
"        Potential significance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diarrhea",
"       </td>",
"       <td>",
"        Malabsorption (celiac disease, cystic fibrosis, secondary lactase deficiency)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic constipation",
"       </td>",
"       <td>",
"        May cause decreased appetite",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recent travel to developing country, camping, housing in shelter, day care",
"       </td>",
"       <td>",
"        Infectious diarrhea (eg, giardiasis, nematodes, enteric pathogens)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic otitis media",
"       </td>",
"       <td>",
"        Immune deficiency; structural abnormality that impairs intake",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Snoring or mouth breathing",
"       </td>",
"       <td>",
"        Adenoidal hypertrophy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of wheezing",
"       </td>",
"       <td>",
"        Mechanical obstruction (eg, vascular ring), chronic pulmonary disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vomiting or spitting up",
"       </td>",
"       <td>",
"        Gastroesophageal reflux, delayed gastric emptying, intestinal obstruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gagging, tactile hypersensitivity, prolonged feeding time",
"       </td>",
"       <td>",
"        Oral motor dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polyuria, polydipsia, polyphagia",
"       </td>",
"       <td>",
"        Diabetes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frequent infections",
"       </td>",
"       <td>",
"        Immune deficiency",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Frank D, Silva M, Needlman R. Failure to thrive: Mystery, myth and method. Contemp Pediatr 1993; 10:114.",
"       </li>",
"       <li>",
"        Committee on Nutrition American Academy of Pediatrics. Failure to thrive In: Pediatric Nutrition Handbook, 6th ed, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.601.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1244=[""].join("\n");
var outline_f1_13_1244=null;
var title_f1_13_1245="Pathogenesis C diff diarrhea";
var content_f1_13_1245=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51819&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51819&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of clostridium difficile diarrhea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 238px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1245=[""].join("\n");
var outline_f1_13_1245=null;
var title_f1_13_1246="Treatment of uncomplicated vaginal candidiasis";
var content_f1_13_1246=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of uncomplicated vaginal candidiasis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug and trade name(s)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Requires a prescription in US&nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Preparation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Intravaginal*&nbsp;dose for adult",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Clotrimazole",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gyne-Lotrimin",
"        <sup>",
"         &reg;&bull;",
"        </sup>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        1 percent cream",
"       </td>",
"       <td>",
"        1 applicatorful (~5 g) daily for 7 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gyne-Lotrimin 3",
"        <sup>",
"         &reg;&bull;",
"        </sup>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        2 percent cream",
"       </td>",
"       <td>",
"        1 applicatorful (~5 g) daily for 3 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gyne-Lotrimin",
"        <sup>",
"         &reg;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Not applicable (not available in US)",
"       </td>",
"       <td>",
"        100 mg vaginal tablet",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Insert 1 vaginal tablet daily for 7 days or 2 tablets daily for 3 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Miconazole",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monistat",
"        <sup>",
"         &reg;",
"        </sup>",
"        7",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        2 percent cream",
"       </td>",
"       <td>",
"        1 applicatorful (~5 g) daily for 7 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monistat",
"        <sup>",
"         &reg;",
"        </sup>",
"        3",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        4&nbsp;percent cream",
"       </td>",
"       <td>",
"        1 applicatorful (~5 g) daily for 3 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monistat",
"        <sup>",
"         &reg;",
"        </sup>",
"        7",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        100 mg vaginal suppository",
"       </td>",
"       <td>",
"        1 suppository daily for 7 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monistat",
"        <sup>",
"         &reg;",
"        </sup>",
"        3",
"        <sup>",
"         &bull;",
"        </sup>",
"        , Vagistat-3",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        Yes (except kit)",
"       </td>",
"       <td>",
"        200 mg vaginal suppository (combination kit may include 2 percent miconazole&nbsp;cream for external use)",
"       </td>",
"       <td>",
"        1 suppository daily for&nbsp;3 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monistat",
"        <sup>",
"         &reg;",
"        </sup>",
"        1 Day Ovule",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        1200 mg vaginal suppository (combination kit may include 2 percent miconazole cream for external use)",
"       </td>",
"       <td>",
"        1 suppository for 1 day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Nystatin",
"         <sup>",
"          &loz;",
"         </sup>",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nystatin vaginal",
"        <sup>",
"         &bull;",
"        </sup>",
"        (former US trade name Mycostatin",
"        <sup>",
"         &reg;",
"        </sup>",
"        )",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        100,000 unit vaginal tablet",
"       </td>",
"       <td>",
"        Insert 1 vaginal tablet daily for 14 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Terconazole",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Terazole 7",
"        <sup>",
"         &reg;",
"        </sup>",
"        , Zazole",
"        <sup>",
"         &reg;&bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        0.4 percent cream",
"       </td>",
"       <td>",
"        1 applicatorful (~5 g) daily at bedtime for 7 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Terazole 3",
"        <sup>",
"         &reg;",
"        </sup>",
"        , Zazole",
"        <sup>",
"         &reg;&bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        0.8 percent cream",
"       </td>",
"       <td>",
"        1 applicatorful (~5 g) daily at bedtime for&nbsp;3 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Terazole 3",
"        <sup>",
"         &reg;",
"        </sup>",
"        , Zazole",
"        <sup>",
"         &reg;&bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        80 mg vaginal suppository",
"       </td>",
"       <td>",
"        1 suppository daily at bedtime&nbsp;for&nbsp;3 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Tioconazole",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vagistat-1",
"        <sup>",
"         &reg;",
"        </sup>",
"        , 1-Day",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        6.5 percent ointment",
"       </td>",
"       <td>",
"        1 applicatorful (~5 g) at bedtime&nbsp;as a single dose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Butoconazole*",
"         <sup>",
"          &Delta;",
"         </sup>",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Femstat",
"        <sup>",
"         &reg;&Delta;",
"        </sup>",
"        , Gynazole-1",
"        <sup>",
"         &reg;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Not applicable (not available in US)",
"       </td>",
"       <td>",
"        2 percent cream",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1 applicatorful (~5 g) as a single dose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         <hr/>",
"         <p>",
"          Fluconazole",
"          <sup>",
"          </sup>",
"          ORAL ADMINISTRATION",
"          <sup>",
"           &sect;",
"          </sup>",
"         </p>",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diflucan",
"        <sup>",
"         &reg;&bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        150 mg oral tablet",
"       </td>",
"       <td>",
"        Single dose by mouth",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    There are no significant differences inefficacy among topical and systemic azoles (cure rates &gt;80 percent for uncomplicated vulvovaginal candidiasis).",
"    <div class=\"footnotes\">",
"     g: grams",
"     <br>",
"      * Except fluconazole (oral administration)",
"      <br>",
"       &bull; Generic&nbsp;equivalent preparation(s) are&nbsp;available in US",
"       <br>",
"        &Delta; Not available in US",
"        <br>",
"         &loz;&nbsp;Cure rate with nystatin is 70 to 80 percent.",
"         <br>",
"          &sect; Itraconazole is another oral antifungal that appears to be effective. Pitsouni, E, et al. Am J Obstet Gynecol 2008; 198:153.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      Data from: Lexicomp Online. Copyright &copy; 1978-2013 Lexicomp, Inc. All Rights Reserved.",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1246=[""].join("\n");
var outline_f1_13_1246=null;
var title_f1_13_1247="Buffering of acid load";
var content_f1_13_1247=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F68428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F68428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sites of buffering of acid load",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 212px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADUAW8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pqOSeKJgskqIx6BmAJqSvKfif4Z1DxF440yK00+3ngfTbiFp7yFnghZjwcgHDjqOla0acakuWTsjKrNwjeKuerUV4p44j8VaJFZ6foJ12WTTtOt0iuLeOSWO6kViGyqgqDjrvJyAAB3O3N/wkq6Z4y1F5NdnmgvpoLCwixEHhJjxJGdhY4BbBBOQCAM81t9U0UlJa/1+pn9Z1a5XoeoUV4vpcvjCTTGtTNroRtctY0uGtpFlW1df3jDzFJ2g92zjv6VPokfjO11LTSLnWrjdNqVqyXqZiEaIxt3c7R958fOTz0HHFN4O1/eX9K4lir291/07HsNFeCfY/F2r+FdetNQk1yWaXTN0lrNbSDNwrqSEdhtII3fImQQB0rQ1yTxYslkum3HiGDT1skNrL9kkeTzgx3iZFXOeAAHAXb781X1LW3OhfW9L8rPa6K4rwfDrVz4i1y71e71KO3huzHa2roEheMxqdwyu4gHOMNjrXa1yVIcjte50Qlzq9goooqCwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK5b4lzarZ+ELy/wBBnaK9sdt1tCgiWNDl0OexXPTniqhHnko9yZy5YuXY6mivKYPHl3dW2seIrK5j/sp7i30/TIJ42IklIBkOF5JJbA5A+U81V0/xzquq6zoM0yfZmhbVYbm2ic+XM8EaFSRk9z6nvzXT9Sqa+X+V/wDgeph9ah/XrY9goryq4+Kxi0u0u47S2uWk0ZtSlihlyY5AyrsPXAyxyTzwa6bwB4j1LXjfx6rZwQtb+U8U0BOyZHB6KSSMFTz0PaonhakIucloVHEQnLlizr6K8ytviLfSaim+zs/sdxNe28MSyN9oia3VjukHTB29BjGRya6nwRrOpa34dg1bU7S1gS5hSeCO2kaRipXJ3ZUYOewz9aVTDzpq8v6/qw4V4TdonSUV43rPjXXdU8GRarazaZaJdSxPbw29ywuUH2hEKue4IJDEDjIGDmta48fataQajaXkGmx6xa6iljGsYkkjm3x7xtHB3Y9SB/I6fU6lv68v8yPrUD06ivJtP+I+uatZ2Y07TdNS8ksrq6l8+V9imCTYQu0HOfr+Pql98UNQ/s5ryysbCJLfSYdSnS5lbdI0nASPHYdyfpij6lVva34/IPrdO1z1qivMn+IWpyeK5LC00qF7K2uYLe4LMRIBIFJkBJAAG4YB+9jqK9NrGpRlStzdTWnVjUvy9AoorlfGGt3vhy5t74R/atOlQwNBuVNkucht2CTkBhjpx71kaHVUV58vjW+sJdPhutNvL+fUc3gjt4Xc29uzhUUGNGDHocuUGD1yMVE/ju/tG1CI6bHcXFncSGdZL3aqRCRYx5bCHLHLZ2sB/vGgD0aivKT418Qf8IfcEQWp1ZYxcQ3Bn+V4ftHlksPKwr9toDDHO7PFeqRFzGhlVVkIG5VbcAe4BwMj8BQA6ivPPD3je8utDiY2y3d6ZxaBppRAHnZ22gqEJWPav39pz2B5Ndd4X1V9b0G01CW3W2kmB3RLJ5gUhipAbAyOOuBQBq0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU11WRGR1DKwwQRkEelOooAzv7D0n+yv7M/sux/s3Ofsn2dPJ65+5jHXnp1otND0mzeJ7TS7CB4mdo2it0UoXADkYHBYAZ9cDNaNFVzy7k8sexl2nh7RbORns9I063dlZGaK2RSVb7wOB0OBkd6m0vSNM0kSjStOs7ISkGQW0CxbyOhO0DNXqKHOT3YKMVsigujaYt7Pdrp1kLudSk0wgXfIp6hmxkj2NWrW3htLaO3tYY4IIlCpHGoVUA6AAcAVLRScm92NJLYyT4c0MzzTHRtNM0xDSyfZU3SEEMCxxzggHnuBUt3oek3izrd6XYTrO4lmEtujCRwMBmyOSBwCa0aKfPLuLkj2M620PSbXb9m0uwh2o8a+XbouEY5ZRgdCeSO9c/4l+Hmi+IJbX7UJILa3hECW1tHEiBAScA7C6g5wdrLwKz5db1pdDvw955l9/bL2MbWsCJIY88LEJMoHx0Mh29cnpWnol9rV94Tv/Ik8zVoJpII/tSoJVKkcSbP3ZkwTynyZx71Uas4PmT1FKlCSs1obtxoWk3N5Dd3Gl2M13Djyp5LdGkTHTDEZGK0a5HwBqep3smrW+pLqBS0mSOOW/Fv5zErl1Y258o4OBgcjvXXVDbe5SSWwVR1D+zbjdb6j9jl8tPtBin2naoyN+D0A5GavVw/jHw5qmra3c3Gn3t5ZQnSZLcNbeQfOkLEiNvMRsDHcY+tIZtTXnhea/s7Wa40WS9s4/tVtC7xGSBNv+sReqrt/iHGKo63onhrxFp1lf3E1i2lxz/bBNEIDFMxIG7zCpIJIHzIyk9M9qz/AAbpmpaTFFpl9ofnqbgXf2x5YjDD8qjAGS/mAg9F2/7VSLomqp8OIdPhW4g1WF96LBc+UwPnFuWVgCNpOQTg0AdUbDTbWB3NpZwwrC0bny1VRFkllPH3epI6VW0m0024uU1nTbiO5ilt1gt3gdWhWIHOE28EE8559sDiuAuvCfiC78P3VhdNqU32mASyK+pux+0C4yAreZlV8v8AhUhfbNaF/Y+J4NRltrePWJbNHuZUube7ibcjooijAllDFgQeuAM5DZ5oA6/U/Dum32mXFiLa3t0mhMBaO2iYqhbcVCujKRnnBUjPOKl0Oy0/RLK10XT2jjW3hykG4bgmfvY9M+gx2GOlcBFofjAnQlhubqxgQkz7p5LmRH3Z3yB7o/KV42b51BOQO4t6Fa6joviHU9a8QQ3gSKxZJruW7WSOd/NLKIU8w7BtwMbUBPbvQB6NRXI+LLHUtaXSptO/tC3iWGaZ0jumtmEhjzErhWGfm6qcj14rnpPD3id7mKJptUFnHCZ1K6m4Y3BgzgsJNzL5v8JJQdhigD0+q1rqFneTXMNpd2881s/lzpFIrNE2M7WAPynHY155Po/iuKEwo2pTWmEfy01DE3ntFy3mGQN5ay8lN2McBWHFdT4a0/ULTWdWudSCs1xHajzVIxI6R4cgDkDd6gUAdHRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGRff2D/AGTqP27+y/7M3t9u87y/J3cbvNz8uemd3tVP7Z4Rs9L0xvtGgwabKDDYHfCsThhgrF2ORxhetYMvhu+tdDv4bCx8ll1l76BLUxLIIyc74gx8vf1wJPl65FZ9poWuWRvbp9LuruTUrWe2I82ATxs7ZEk/zrHn18rI44WgD0qxs7awtIrWxt4ba1iG2OGFAiIPQKOAKnqno9s9lpFjaylTJBAkTFehKqAce3FXKACuV17xRNp/ivT9DtodLaW7h81WvdRNsz/Nt2xqI33tjnGRXVVR/syH+2/7U3SfaPs/2bbkbdu7dnGM5z70AYdr450aS8e1nmkimEzxj/RrjagVguZWaNRHycfMcdME5qXxB4ri061vWs4PtF1ZOnnW9x5lsTGzBS6FkO8DPVflzxuFRTeB9NmuNSmae8DX+fNAdcDMiyfL8vqo654qsnw70lL7VroXF5v1JFSX/VAgBw/39m9zkdXZjjigDpdT1W00vyDfPJGkz7BIIXZFP+24BVB7sQM8Vzmp/EHSLfRLzUtOF1qMdsVVvItJyhYvsK7xGRuBzkdRxnGRVzxh4O0/xU9m2oS3EZtnDr5YjYcEHgSI205H3k2tjjOOKuR+HLJPDR0NjM9ngjczDfy27OQAMg+3bnNAEF34y0Gz+0G7v/IW3TfI8sMiqvTI3FcFlyNyg5X+ICiLxXYz3tlDbi4K3SSyK0lpcRlljGSUzHh89uRkcrurOl+HmiSX2oXjqxub4L5s3kw+buBBLiTy94LbRld230UVta9oFrrckD3clwhhSVF8l9uRIu054/8AreuRxQBTh8Tx3WsaVbWUKy2d8Jg0rs8UsMkYBKNCyAg4Pcgj0qtrfjvSNNt9TZJGknsDtkSWOSCNiCA4WVl2sVDZO0nA64p3hrwPp3h9LJbOa4f7JNNMmUijUtKAGGyNFUDjgKB+NUY/AaXdzqsur3txIlxdyz20MTIFgDlckfIGLHbghiw9MUAbXhzxRYeIr/U4tKuLW7tbIxqLm2uFlSQsuSMrwCOnU1vVRtNMhtdTv7+NpDNe+X5gYjaNi4GOP8avUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU2UuI3MSq0gB2qzbQT2BODgfgadRQBznh/WtVvdbvtO1TTLG2NpGjtLaXzzgM3IUhooznHORkfSqNn4sv72W3FtpVr5d+Jf7PaS9ZTIY/vCYCI+WODgqZPwrftNIjsob5LS5uImu7hrlpBsLKzEZC5UjHHcGqOleFbXTtQiuEu7yaG33/ZLWUp5dtv+9tKqHbP+2ze2KAHeFdYv9WbUV1GwtbVrSfyA1tdtOjsB8wy0cZBBIHTB7E1vVR0TTIdH0yGxtmkaGLdtMhBY5YtzgDuavUAFcP4xu7SLxJbw67q1xpmmfZC8Dx3j2u+5342gqR5jbf8AlmdwP9013FFAHmWkeJtR0281EXt015YzXV2IDJbuZ4TEitlhuAKnP3Qse3nJA6UtJ+JGrajB9qiTTTa2kbPcAJvNyRMsf7t45nSMfNnrL06+nrVZuv67p3h+yju9XuPs9u8yQK+xny7nCjCgnk9+lAHm998SNWt5r5Y002Ro4w726piXTsylP9ILzIpGAG+YxfeHPr1OuatqZ+H0eqPDDaXpETywly42lwCFeKQYJBBBDEDp81bWjwaXJqGo3tgZJbrzmt55JZJHKMuMou8navQ4XC55rTjuIZJpYY5Y2mix5iKwLJkZGR2yKAOQ8EeJNS1a7EGqCzbz7druJraJo/LUSmPY2523HjO4bfpWD/wkmt6GNVjvr6xaQ6lPskuYXVYkCho48GXrJ91OQM5wG6V6jRQB5rL4h1bS7rxLfajdRwI1vbTWdrLbMfI3L8xO+ZF2g/KzExjd1I6Vb8E63Lr2v2mpbpo477RxM9uLhniDiYruVdxUEgdV/M9a7+igDzfSfHGs3h1SSawtYEtZ1jSF2Uys+4jyNqSO/mMPmDMif7mPmpusa9rXn6PqsV5Z29qn2sXFqYZMLIseUhkYuvz8d169Aa9KooA881vxdrGheCYdb1STTVubkRyxwxQHykUruKNLJNGpY9jlT2CORzE3j3UWgv7mC0tZJIoDImmKHNyi7VImZvumNtxxuEY+U4Y9vSKKAPJ77VNQ1rTtKvruW4tHuLS/XNjflI50SLckoEMzqpz0w7EY+92oTxddXukJo11cRx3slpcM4jmeK6ESQK8cwIcMNzZ+boe1esUUAeRXnxHv9Nkg0+0S3u7j+zo5FF18jCQKmSx8wyMrbvveWo7hn6V3+oXuq6R4Yu728FreX8QLhbaJ0jUEjqCzEhQSSeMgdF7b1FAHk8HxJvIrS7lubzQ7mJXaGzvIFaOG7lEqrtTMrbjtYnaGJ4z0qe4+IGpXPia60TSjYrL9qiijnuLfJhVmKkPEs+8txkFvKP8Askc16RY2NvY/aPssfl+fM08nzE7nbqeenToOKs0AeXHXNdvrptRS8tbW2m0WZ4rd4pSjTRuwbaRKvzYXPGGAPXjNGneIdX0zUp7rUr21/syYWL7JkkUW8DR/vJd7yEbQcAsRjJ55r1GoL61jvbSW2maZY5BtYwzPE4Hs6EMp9wRQBkeFNeTVvDWnaldzWsbXhKxlGwjncwULknJIHqc1h614i1uHxLdWNjLpsdqs9taR+davI4eZS28kSqCox93AJz94V1SaNp6RWMaWyiKyO6CPJ2q397GcFupycnJJ6mtCgDzCx8a69qc6m2Ol28LywWarJbSSMJZA37wkSrlRs+5gHn73HNnTPGt9qmoWFrJb28SXW2JrdS4nmVtweeJgwKohXng43D5h39GooA5z4eSSy+DdOaeaaeTDqZJpGkdsOwGWYkk4A5Jro6KKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoqpPqdlBaXN1JdQiC2JWVwwIRh1U4/i5HHXkVlXXi/SrV7ZJV1RpriHz0hi0q6kkCZxlkWMsnPZgDQB0FFNicSxpIoYKwDAMpU8+oPIPsadQAUUUUAFYfizRW1y2sbf8AdmGO7SaZXYjdGAQwGO5z7fWtyuf8a6+3hzT7O88vzInu44ZQELtsbOSoBHPHU8DqeKAOHm+H3iKHTLa0tdQ0+Z4NRe6jnZRFJGhZdpDGKQghBtwhQnrvOSK7PRPCFrpPiPUdXiu9Qle724ilvZ5FTAwchpCre2R8vQYqnqfjFtEtNMk1W0mml1CdQi2FrPOkUbdMvGjB3A7DG7PAwMnr4nEsaSKGCsAwDKVPPqDyD7GgB1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU2VBLG8bFgrAqSrFTz6Ecg+4p1NlcRRvIwYqoLEKpY8egHJPsKAPPrr4cJBpt0mn3l9PO9+L5UuNUukBAPCeZvZkb1kUbj3ovPCGo3WmwJe6doOqXQDpHJfyPLNYBj8pjuHjZ5dvX5ghJ/iFaWmeLn8QWmpjR4WsZ7OdozPqdncRxJGvWQhkTLf9M9wI7kVkXnjHWoLeDclqjeW8wnXT5pxdIpwrCJH3W6N18yQsooA9BsIXtrG3glmaeSKNUaVurkDBY9eT1qeoLCc3Njbzsqo0sauVVw4GRnAYcEe461PQAUUUUAFVr6xt777P9qj8zyJlnj+Yja69Dx169DxVmuY8fWt/d2mkrpW1bpNSgcSPA0yRgZyzKrKSo/3h9aANm20mwtoVhitY/JSYzojDcsb5zlAc7eScAYAyavV5BZaVJDrN9J4y0mbVbZ55/I8jTJZENwXBEkaDeYiV6SFgP9qrn9mMda+fRbyTWf7R80zyWxdmsNv+qN0coRjgxmTn0oA9Tory7wLotxZX2svoFjpumzXBVjdy+H5LRYgD/wAe/leYvmADnzEbaT13cV6VYrcpaRLfTQzXQH7ySGIxIx9QpZiB7bjQBPRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUU2UOY3ETKshB2sy7gD2JGRkfiKAMzV/D+m6tp09hd27LazyebKtvK9uXfOcloypJyB35xVSTwhpEkMUco1B/LyPMfUrlpHUnJR3Mm50/wBhiV9qzPEukXV14avD4istH8RXcXNokelYEbNhdwSR5ckZzxjgY965PVPDDaXqlrZWOntILeOBLORbB5XBB+cwXA+SzGckh857YFAHrsUaRRpHEipGgCqqjAUDoAOwp1FFABRRRQAVn63qsWkWiTSRTTySyLDDBCF3yyN0UFiFB4PLED3rQrK8R6U+q2kCwXC291bTpcwSPH5iB1zjcoKll5PAYH3oArW3iRZdR0+yn0vUrSa8EuPPRAI2jGWVsOcnByGXcp/vVvVzVx4YfU5NPfxBdW+peR53nQvaKIZRIoG0IScKMdGLH3rZ0rS7DSLQWuk2NrY2oJYQ20SxICep2qAM0AXKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoopssaSxvHKivG4KsrDIYHqCO4oAzLrXrGDS9Svw000Onl1nWGF3cMgyyhQMk/Tj3qjq/ig6dpdvqMejale2UsAnaWB7dRGCAQGEkqEscjhc+lR6Z4H0TR7HV4NGsbWyk1ESK8sVuilA4xtG0D5B1C1butB+0aNpenNc/ubN4TKDHlbhYxjay56EgHnPTvQBWtfF9rcXsUP2DUI7eSYW32qREVFnIz5LLv8wMOhOzbnvXS1yv/AAis39reZ9vj/sz7d/aX2f7OfO8//rrv27P9nZn/AGq6qgArg/GF9r3/AAl1vYaJJqmz7CZ/LsltNvmeZtBlM43bPXy/m613lR/Z4ftP2jyo/tGzy/N2jdtznbnrjPOKAOAuviJcWcuowvoV1dNYDy5JoFkWJ5l2hlDsnlhSW+X5yx/iC9a17jxPqFpdQ217pVrFN5f2mcfbwBFCXCKQzIqtJk8qSFHZm4zvS6Rps1zPcTafZyXE6LHNK0ClpFU5VWOMkA8gHpUGvyaJaR2+oeIH02CO1k3Q3N8UUQueMqz/AHWPTg5oA5GD4iXV6SunaBMxlukt7aW6aa3hkyxX5pDCRuBUnCeYMfxDpV7w/wCJdS1nxZbJHBDFo82mmcq02ZFkEpQnGzkZBH3unOAeK6DTbPRLuP8AtDTbfTZ47qQXX2m3RGEzjgSbh95h0DZzU9nb6a2z7FFZn7I7xp5Sr+5Y/eUY+6eeRQByOo/EBtMn1E32l/6JBNNBA8E5kkleILncmwbQdwxtLn2oh+IEptJpLjRLi3mht/PaOYyRbj5oj+USRq+3nIZlUnHTvXYtplgzMzWNqWYuxJhXJLjDnp/EOD696qzeHNEmtLO1m0bTZLazO62he1QpAfVFxhT9MUAcjpvizxAL+exm0q1vLqfUrm2ttl7sSJI1DfOfKB289QGbnoas694ulF5f6PBut7r7FLJFe2m6URTRpudCZIvLyOOAWb1Va3rO/wDDd7qySWV3o9xqb79jRSRvM2z5XwQdxx0Pp0p9zZ+HT4hVrm30k67cQMqmRI/tMsI4YDPzFOx7UAcha+MdcXdDBp9rqF+wthHBJf8AlGUPEGLqFgOD1LBiVHZu1XJviEYNQ1KCXRbxobLMbTxpIY/OG0FS5jEYXLAAhi3XKCul1DwxoOooqahoml3arjAntI3AwNo6jsOB7U42eiW13cMbfTYbprULMdiK5t14Abv5Y6c8CgDk5PEGur4J8RX0xt4tVtL54YkjcPGgDoAocxjIwT8xTPPSpz49eL7fHPparc2MZM6pc7k3iVYyqsUBK/MDuIB7YHWtezj8JLGfDdmmgiOePzjpUQhxIjc7vJHVTwc4xWNrVv4F1TSbRZtU0ODR9HuApSGS2WGKTtGWIJiOR/AUb37UAdxum+07fLj+z7M7953bs9NuMYx3z+HepKz9KvNK1dRqek3FjfKQYRdWzpLkA5K71zxntmtCgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKz9R1vStMimk1LU7G0jhKrK1xcJGIy33QxJGCe2etSaVqlhq9oLrSb61vrUkqJraVZUJHUblJGaALlFFFABRRRQAVyvxEsdQvtJsv7JjvJLiC+inP2NoRMqrnJTzv3ZPPRq6qs3xJqn9i6LcX/k+d5O393u25ywXrg+tAHPXMGuXdzDcQ2+qW9oUi+120t5Es0xB/g2EqhH8W1lDdBjrWVaeD9Rg1x4EuNWg0ue/uLq5lg1J8Sxug2LkvvXkHJXaemDWvqfxB0i20O81GyF1dm3KjyRaTozgvs3KDHlkByNwBXIxnmtWx8VaTf3txaWc1xPcW+4TolpMfKKjJVztwrYPCnBPYGgDk9csPGLeJ7gaOs0Gmm1MQlN0XV8AbeXlJWQ/MMiJecEyN2bcaP4smvNG+w3OoWGnI5Pl3E4uprf5sgykTIHG3Iwxnxnoeo6weLtEK25N4ymYldrQSK0RBx+9UrmIZwMybeSBVPV/GVpb6dd3GlCO+ltXTzI5GeANGXCF42KESAE4yuVyMbgaAOc1bw1r0txJLp8bQyi/vLhJVnVDscJtwQcgttI/ngVOth4kup4tQfTrhJkuL544Lu7QNFHJGqxrujdsdDgK3HqvUbmmeMrRxqKauI7G5sZnSRI2eZSiuEDhtg6lhxjI+nNS6d4riaGZtXg+xNHfSWW6LzJ4gVIwzSBAEByPvYGeMmgDmPB2heJrq8hPii41a3sYI3EcKXpjLkSApvKTSOSBnrI2ejEjitTxj4c1TVtbubjT728soTpMluGtvIPnSFiRG3mI2BjuMfWuh0PxHpeuvKNJnkuVjyGkEEgjBBIK7yoUsCOVByO4qDUfFukadLNFeS3STRSLF5Qsp2kkLdDGoQmRc8bkBGe9AHK6Noeq22h3Og3OiLM1wWmW9lmi8iAtGFHcyeYp9Ex/tU6PTtdaNp00zULNrfTE0w+Vc263EhDZaSAkunQceYUP0rfvfGmmxXel21izXsl9PHFmJHKRB88u4UqrcfcYgnn0qQ+LbGHxLfaRfbrVrcRlLiRX8p9ylsGTbsVuOFLZPYUAUfDmh6suj2UU2q6lpSWxKpbxpaF5I85Hnny3XzOuTGQDnPXmuxrmpPHGgIkTNdXBMjlFRbKcuMDduKhMqmOd5AUjkHFaFn4g0u81I2NrdrLPjIKq3lvxkhZMbWYAglQSQDyBQBq0Vytt430s3OqQX5ksnsbh4MvFIVlCkDKNt2sfmGVUkjvTdZ8a21rqVrp2m2817ezzyQn9zMIo/LGZMukb/MAeABz6jrQB1lFcdoPjyw1G3S5u0ayt7iQra+Yk3mFAdu+ZTGBEu7gEkqTxuzxV638a6Fc2809tdzTQxHYXitJmDPkjy0wnzyZB+Rct7UAdHRUFjdR3tpFcwrMscg3KJoXicD3RwGU+xAqegAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqO6SSS2lSCXyZmQhJNobYxHDYPXHXFSVBfzPbWNxPFC08kUbOsS9XIGQo68npQB51o/hnxHoY8S5lW6F6IcT6ci21zK20h5FMski+Z/v4B7EYArrvBFpeWPh6C2v4miMRKxJJ5fmiPt5vl/IZOuSvB/OsXw94s13W4ZhFoen216iK62t3eXVu5BPJIktFOB0yoYZ4yK3/CWrXOt6OL27tIbVmkdEEM5mR1U43BiiHBIPBUHigDZooooAKKKKACqOt6ZDrGmTWNy0iwy7dxjIDDDBuMg9xV6igDmI/BOmJbGBpLp4/sptfmcZ2mXzN3AHzBvw45Bq9B4eto9L1Cxae6kS+keWaQuFfcwGcFQBjjpjHUHI4rZrmviQ0y+CdU+zXNxaTMios9vIUkjy6jKsOh560AUdC+Hum6JHEun32oQlXYyGHyofNRmDeWRHGoRcjP7sIe2ccVLZ/D7Q7K11S3tYvJXUHDO8cUKyKAwfaJAgZhuGfnLH3rjH8Z6r4dt/ETai8n2qwmt7dftKZhkCxkllaSWNRvGPmLZLZwrdK67TNX8T33ii0b+zLOPQZ7FJ9/2pyVLEHP+pwXwcbN2Mc57UAS6j4D0+8luZFvdQtnupmkuDC0Z81S4fyzuQ4XcoPGG96i1v4d6TrD7ri4vFP2trw48pwHJBIUOjbPuj5lw2ON2Ki1fxXqlt45XRbe0t0tPJEjTzvGuV2ktKN0qsVTjKqjZzyy1Wm8Z6gLJpZP7PsceWvnXEchREYkG7O4p+54AxkHJ5YcZAOz0TTIdH0yGxtmkaGLdtMhBY5YtzgDua5q1+Hek2/iKTWEuLw3LzJNtPlYyrFhuYJvfk9XZjjgECsXTvE+qxeIri6uJoZtNmktLdrdIpiVZ0Y+ZEWIIU7c7PLJbIw3c0rL4jatqd1Pb6edNBtpJmkmkh3h40i8wIEjnbY/GCWYkd0XpQB1lr4D0+0ubKW2vdQjS3mSd4Q0ZWd0LFC+ULDG4jClR65qzqHg6x1DWri/vLm8khn2GSy3IIWdFKq+QvmAgE9Hx7Vx158R9UjvM29vYuzQSSLpW0m6CqissxbeAYzuPVAPlPzdx3HgjVrzW/D0F9qEMMckhOx4ZI2SZB0ceXJIoB9A7Yx1oAoweBdOifzHur6aby3h8x2QHy2j8sLgKBhV4Bxn1LVL4f8AA+jaFrEmpWMCm6eMR75IYi4IABYSbPMyQBkbtvoBXT0UAcnN4F064u76a7ur6eO5kkmSB2QJbyPjcyFUDE/KOGLDjpVnR/Cdvp1xb3L319eXUM81wZZzGDI8oAbcERRjAGMAfjXR0UAci/w+0OSXSZZovPfTdwjNxDDNvUuX2neh2/Mc5Ta3HWr1x4WtpPC39gx3VxFachmMcMzOpYsVZZY2QjJ/u10FFAFbTLKPTtPt7OBpGihQIpkYsxA9T/kDoMCrNFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABTZUEsbxsWCsCpKsVPPoRyD7inVHdbPs0vmeZs2Hd5e7djHONvzZ9Mc+lAGHa+F4Y/tjXeo6hfzXFu1oJblo90UJz8i7EXPJzltzepNbNjbJZWNvaxFjHBGsSlupCgAZ9+K8ZtdYubC31eTS79blZZ40a4/t+5ubaytySCJJZVY283ckq2M9q9P8EX8eoeHoHhRhHGTEr/a3u0lx/Gk7/NKh7MetAG9RRRQAUUUUAFFFFABVbUr6302yku72TyrePG5tpOMkAcDnqRVmsbxlpMuueGr3TYHVJLgKoZnZMYYE/MvIOAeRQBbXVrA/aybqNUtHEc0j/KiMf4d5+UnkZAPBODV6uM1LwWdT8OSaHdXckNrC4NpPbTSQsVyCRKkbIrEdMknOd2Aetnxh4Zm1TwmukaZcyJ5bo2LmYy+eoPMcjyrLkH1dX6dDQB1VVr6+t7H7P9qk8vz5lgj+Unc7dBx06dTxXHReDruFbRY5YZoreOJJIrmZm+2lTn98VVVwnRcIegyMfKKP/CAT3BSHUbfSbi2F7HNcPJvdr9QzMXmUjbvAIUAhjgffA4oA9IoryzUvAviO5/shUvNP/wBEhkheXftcRtu/d7jEzspBXgOigDBVuDVPxB4IuNK0CSG3srG8sBHHHHpMcMjQvMYdjSFEicKwf5gxXGeSy9aAPUf7KtDq39pMkj3YTYpeZ2WMd9iE7UJ7lQCe+avV594K8F3+k+IP7U1C8kbNuqKiyJn7gHlOBFuZUwdv71hk8KK9BoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDBl8XaImmvfpeNcWq3Rs91rBJOWmBwUVUUljn0BFaWlahDqloLm2S6SMkri5tZbd8j/AGJFVse+K52fw1M+k6rbz2Wj6n9p1F7xLW/QvC6nGAxKna3H3trY9DWl4P0mbR9Ja3nW3h3TPKlrbEmG2U9IoyQuVH+6vXoKANyiiigAooooAKKKKACsrxRqj6NoN3fxRrJJEBtVjgZLBQT7DOcfyrVqC+tIL60ltbuJZYJRtdG7/wCB9+1AHMalqXiDRU05tQm0u5SW+SCV7e0lVpI2B+6nmMVYEer7vQVs2GvWV7Y3V2i30MFsC0hu7Ge2IAGSQsiKWGPQGo7TwxpVtFGiQTSMk63IlnuZZpTIv3S0jsWbGTgEkD0rXljSWN45UV43BVlYZDA9QR3FAHC2fxQ0a/iR9Ntry+Jdw62zwP5SKm8uzCXbjbztBLjoVB4pw8fCHVdRjudLvnsEktorSW3iV2mMylh8octg+6jA610KeGNKSCGEwTSRwiVYxLcyyFFkXaygsxIXHAHQdsU7/hG9J863lFpteDytm2RwMxjCEgHDEDjJyccUAU4/Flv9oFtc2N9a3XnwW7RSiMlHlBK5Kuw4A5wT+NdHXNax4Ui1PxNp2qmfyFtXWV44vMVp5FzsLYfYQASPmQt6MK6WgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACoL65Sysbi6lDGOCNpWC9SFBJx78VPTZY0ljeOVFeNwVZWGQwPUEdxQBzXgrxGdfjmknkWORws0Vq1lPbSRxHoSZceaP9tVC5456109ZWj6Bp2jyySWMc3mONu6a4knKL2RC7NsT/ZXA9q1aACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Summary of data from the infusion of HCl into five nephrectomized dogs to quantitate the contributions of the extracellular, intracellular, and bone buffers. Extracellular Cl- increased by 170 meq but 180 meq (as HCl) were given; therefore, 10 meq of Cl- entered the cells with H+ as it was buffered. (Data from Swan, RC, Pitts, JF, J Clin Invest 1955; 34:215.)",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_13_1247=[""].join("\n");
var outline_f1_13_1247=null;
